Original Article
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
N Engl J Med 1996; 335:1933-1940December 26, 1996
- Abstract
Background
Unsustained ventricular tachycardia in patients with previous myocardial infarction and left ventricular dysfunction is associated with a two-year mortality rate of about 30 percent. We studied whether prophylactic therapy with an implanted cardioverter–defibrillator, as compared with conventional medical therapy, would improve survival in this high-risk group of patients.
Methods
Over the course of five years, 196 patients in New York Heart Association functional class I, II, or III with prior myocardial infarction; a left ventricular ejection fraction <0.35; a documented episode of asymptomatic unsustained ventricular tachycardia; and inducible, nonsuppressible ventricular tachyarrhythmia on electrophysiologic study were randomly assigned to receive an implanted defibrillator (n = 95) or conventional medical therapy (n = 101). We used a two-sided sequential design with death from any cause as the end point.
Results
The base-line characteristics of the two treatment groups were similar. During an average follow-up of 27 months, there were 15 deaths in the defibrillator group (11 from cardiac causes) and 39 deaths in the conventional-therapy group (27 from cardiac causes) (hazard ratio for overall mortality, 0.46; 95 percent confidence interval, 0.26 to 0.82; P = 0.009). There was no evidence that amiodarone, beta-blockers, or any other antiarrhythmic therapy had a significant influence on the observed hazard ratio.
Conclusions
In patients with a prior myocardial infarction who are at high risk for ventricular tachyarrhythmia, prophylactic therapy with an implanted defibrillator leads to improved survival as compared with conventional medical therapy.
Media in This Article
Figure 3
Kaplan–Meier Analysis of the Probability of the Discharge of a First Shock with the Implanted Cardioverter–Defibrillator.Figure 2
Kaplan–Meier Analysis of the Probability of Survival, According to Assigned Treatment.Article Activity
- Article
Unsustained ventricular tachycardia in patients who have had a previous myocardial infarction and have left ventricular dysfunction has been associated with a two-year mortality rate in the range of 30 percent.1-3 Antiarrhythmic therapy has been widely used for unsustained ventricular tachycardia, but there has been no evidence of improved survival with this treatment.4-6 In December 1990, we initiated a prophylactic trial in which high-risk patients with coronary heart disease and asymptomatic unsustained ventricular tachycardia were randomly assigned to receive an implantable cardioverter–defibrillator or conventional medical therapy. To ensure a population at high risk for malignant ventricular arrhythmias,7,8 eligible patients had to have an inducible, sustained, nonsuppressible ventricular tachyarrhythmia on electrophysiologic testing. The end point of the trial was overall mortality during a five-year follow-up period.
Methods
Organization of the Trial
The Multicenter Automatic Defibrillator Implantation Trial enrolled patients from 32 hospital centers (30 in the United States and 2 in Europe). The protocol was approved by the institutional review boards of the participating centers. A data and safety monitoring committee independently reviewed the results at regular intervals throughout the trial. The study was totally supported by a research grant from CPI/Guidant. All investigators agreed in writing in advance of their participation in this study not to hold stock in CPI/Guidant or any other defibrillator-manufacturing company and to abide by the conflict-of-interest standards described by Healy et al.9
Recruitment of Patients
Enrollment in the trial began on December 27, 1990. Patients of either sex who were 25 to 80 years of age were eligible for the study if they had had a Q-wave or enzyme-positive myocardial infarction three weeks or more before entry; had had an episode of asymptomatic, unsustained ventricular tachycardia (a run of 3 to 30 ventricular ectopic beats at a rate >120 beats per minute) unrelated to an acute myocardial infarction that was documented by 12-lead, ambulatory, or exercise electrocardiography; had an ejection fraction <0.35, as assessed by angiography, radionuclide scanning, or echocardiography; were in New York Heart Association functional class I, II, or III; and had no indications for coronary-artery bypass grafting or coronary angioplasty on the basis of a cardiac evaluation within the past three months.
Patients were excluded from consideration for enrollment if one or more of the following conditions were present: previous cardiac arrest or ventricular tachycardia causing syncope that was not associated with an acute myocardial infarction; symptomatic hypotension while in a stable rhythm; and myocardial infarction within the past three weeks. Patients who had undergone coronary-artery bypass grafting within the past two months or coronary angioplasty within the past three months were excluded from the study, as were women of childbearing age who were not using medically prescribed contraceptives, patients with advanced cerebrovascular disease, patients with any condition other than cardiac disease that was associated with a reduced likelihood of survival for the duration of the trial, and patients who were participating in other clinical trials.
Eligible patients were referred for electrophysiologic study10 at the discretion of the patients' attending physicians. Patients qualified for enrollment if sustained ventricular tachycardia or fibrillation was reproducibly induced and not suppressed after the intravenous administration of procainamide (or an equivalent intravenous antiarrhythmic agent if the patient had had a previous reaction to procainamide) according to a prespecified protocol, as previously described.11 The enrolling centers did not keep consistent logs of the eligible patients who had no inducible ventricular tachyarrhythmia or in whom the inducible tachycardia was suppressed by procainamide. A total of 253 patients qualified in terms of clinical eligibility and electrophysiologic testing, and 196 of the qualified patients gave informed consent for enrollment. The clinical characteristics of the enrolled patients and the 57 eligible, qualified patients who did not consent to enrollment were similar.
Within 30 days after completing the qualifying electrophysiologic study, the patients were randomly assigned to receive either an implanted defibrillator or conventional medical therapy. The choice of conventional medical therapy, including the decision whether to use antiarrhythmic medications, was left to the patient's attending physician. Antiarrhythmic drugs approved and released by the Food and Drug Administration could be administered to patients in either group. The randomization scheme included stratification according to the interval between the most recent myocardial infarction and enrollment (<6 months or >6 months) and according to center.
Defibrillator Devices and Implantation
Only defibrillators and lead systems approved and released by the Food and Drug Administration were used in the trial. Investigational devices were specifically excluded. CPI/Guidant (St. Paul, Minn.) provided the pulse generators and lead systems. Monophasic (n = 79) and biphasic (n = 11) pulse generators were used.
When the trial began in December 1990, only transthoracic implants were approved for use. Nonthoracotomy transvenous leads were incorporated into the trial after full-market approval of the transvenous lead on August 27, 1993. Once transvenous devices were approved at a given center, a new stratum consisting of patients assigned to transvenous implantable cardioverter–defibrillators or conventional therapy was initiated. Standard techniques were used to implant the defibrillators. Defibrillation testing was carried out during the implantation procedure; every effort was made to achieve defibrillation with a 10-J safety margin.
Data Acquisition and Follow-up
Definitions for all variables were prespecified in a manual of operations. The qualifying episode of unsustained ventricular tachycardia required electrocardiographic documentation. Base-line electrocardiograms were coded according to the Manhattan criteria.12
Patients were seen in the follow-up clinic one month after randomization and every three months thereafter until the trial was stopped. At each follow-up visit, an appropriate clinical evaluation was carried out, medication use was recorded, and the defibrillator was tested. The patients underwent a final evaluation within one month after the completion of the study. The first patient enrolled was followed for 61 months, and the last patient enrolled was followed for less than 1 month. The average duration of follow-up for the 196 enrolled patients was 27 months, with an average of 37 months for the earlier transthoracic stratum (n = 98 patients) and 16 months for the later transvenous stratum (n = 98).
End Points
The primary end point was death from all causes. A two-member end-point subcommittee reviewed information on the causes and circumstances of deaths occurring on or before March 24, 1996. Each death was categorized as due to either a cardiac or a noncardiac cause, and the classification of Hinkle and Thaler13 was used to evaluate the suspected mechanism of death from cardiac causes (arrhythmic or nonarrhythmic).
Statistical Analysis
When planned in 1990, the trial was designed to have an 85 percent power to detect a 46 percent reduction in the mortality rate among the defibrillator-treated patients as compared with a postulated two-year mortality rate of 30 percent among the patients randomly assigned to conventional therapy, with a two-sided significance level of 0.05. A triangular sequential design modified for two-sided alternatives14 (Figure 1Figure 1
Sequential Monitoring in the Triangular Design.) was used, with preset boundaries to permit termination of the trial if the efficacy or inefficacy of implantable cardioverter–defibrillators was established or if there was evidence that there was no difference in outcome between the two treatment groups. The data were analyzed weekly, beginning at the point at which 10 deaths had been reported. The trial was designed to be terminated when the path of the log-rank statistic, measuring imbalance between the survival curves for the two randomized groups, crossed one of the preset termination boundaries (efficacy, inefficacy, or no difference in outcome) of the sequential design.The executive committee was unaware of the results of the study throughout the trial. During the course of the trial, the sequential design was revised by the executive committee on two occasions. On September 1, 1993, transvenous leads were introduced into the trial. Since this change could alter the type of patient referred for entry into the trial, the power requirement of the trial was increased from 85 to 90 percent so as not to compromise the credibility of the study. Because of the slow rate of enrollment and before the first patient enrolled had reached the fifth year of the study, it was decided on November 12, 1995, that data on patients would be censored for analytic purposes at five years, with subsequent follow-up information on such patients censored from the ongoing sequential analysis.
Analyses were stratified according to the type of device (transthoracic or transvenous) and followed the intention-to-treat principle. All analyses and potential covariates were specified in advance of the trial's completion. After termination of the trial, sequential-analysis methods were used to calculate a P value and hazard ratio (median unbiased), along with a 95 percent confidence interval based on the P-value function.14,15 Secondary analyses were performed with the Cox proportional-hazards regression model,16 with adjustment for relevant covariates. Separate Cox regression analyses were carried out in the transthoracic and transvenous strata to determine whether the efficacy of defibrillators was similar in these two groups. Preselected base-line covariates and prescribed cardiac medications recorded at the one-month clinic visit were evaluated in the Cox model to determine their effect on the risk of death per unit of time in the defibrillator group as compared with that in the conventional-therapy group (the hazard ratio). Survival curves for patients assigned to defibrillator treatment and conventional treatment were determined according to the method of Kaplan and Meier.17
Results
Study Population and Similarity of Treatment Groups
Of the 196 patients enrolled, 98 were in the transthoracic stratum (45 in the defibrillator group and 53 in the conventional-therapy group) and 98 in the transvenous stratum (50 in the defibrillator group and 48 in the conventional-therapy group). The base-line characteristics of the defibrillator group (n = 95) and the conventional-therapy group (n = 101) are shown in Table 1Table 1
Base-Line Characteristics of 196 Randomized Patients.. The two groups were clinically similar. The distribution of the qualifying Q-wave myocardial infarctions in terms of anterior, inferior, and posterior locations was similar in the two treatment groups. The prevalence of the use of cardiac medications one month after enrollment and at the last contact with the patient is shown in Table 2Table 2
Cardiac Medications One Month after Enrollment and at the Last Contact, According to Treatment Group..Sixteen crossovers occurred. Eleven patients in the conventional-therapy group received a defibrillator during the course of the trial because of an adverse drug reaction (n = 2), unexplained syncope (n = 2), episodes of ventricular tachyarrhythmia that were of concern to the investigator (n = 6), and aborted cardiac arrest (ventricular fibrillation) (n = 1). Five patients assigned to the defibrillator group never had a defibrillator implanted (one because of a high defibrillation threshold and four because of the patient's preference). Two patients had their defibrillators deactivated during the course of the trial.
The therapy-related adverse events in the two treatment groups are shown in Table 3Table 3
Adverse Events Related to Antiarrhythmic Therapy or to the Defibrillator.. There were no operative deaths (death in the first 30 days). There were 1838 scheduled follow-up clinic visits during the course of the trial. The defibrillator-treated patients attended 92 percent of the scheduled visits, and the conventionally treated patients had an attendance record of 86 percent. Three patients were lost to follow-up, two in the conventional-therapy group and one in the defibrillator group.Termination of the Trial
The efficacy boundary of the sequential design was crossed when 51 deaths were reported, and the study was officially stopped at that time. The final sample path of the sequential trial, which included three additional deaths that occurred before the stopping date but were identified during the close-out procedure, is presented in Figure 1. The trajectory of the sample path indicates the superiority of the defibrillator over conventional medical treatment, with a P value of 0.009 (two-sided).
End-Point Analyses
The five-year overall mortality, the distribution of deaths from cardiac and noncardiac causes, and the cardiac causes of death are presented in Table 4Table 4
Frequency Distribution of Deaths, According to Treatment Group.. The hazard ratio comparing the risk of death per unit of time in the defibrillator group with that in the conventional-therapy group was 0.46 (95 percent confidence interval, 0.26 to 0.82). The Kaplan–Meier life-table cumulative-survival curves for the two treatment groups are shown in Figure 2Figure 2Kaplan–Meier Analysis of the Probability of Survival, According to Assigned Treatment.. The two survival curves separate early and remain well separated throughout the five-year study.The hazard ratio and confidence intervals derived from the Cox model with adjustment for relevant covariates were similar to those obtained with the sequential-analysis design (Table 4). There was no evidence that the effects of the defibrillator differed between patients implanted with transthoracic leads and those who received transvenous leads (ratio of the hazard ratios, 0.86; P = 0.78).
Additional Analyses
Separate Cox regression analyses revealed no evidence that antiarrhythmic medications, including amiodarone and beta-blockers, or other cardiac medications being given one month after enrollment (Table 2) or any of the 11 preselected base-line variables (Table 1) had a meaningful influence on the hazard ratio (P value >0.2 for all interactions). However, the power of the analysis for these interactions is limited, especially in the case of amiodarone, since only two patients in the defibrillator group received the drug. In the conventional-therapy group, overall mortality was slightly higher among those who were receiving amiodarone at one month than among those who were not receiving the drug (36 percent vs. 26 percent).
The cumulative time to the first shock in the defibrillator group is presented in Figure 3Figure 3
Kaplan–Meier Analysis of the Probability of the Discharge of a First Shock with the Implanted Cardioverter–Defibrillator.. Sixty percent of the patients with an implanted defibrillator had a shock discharge within two years after enrollment. The overall appropriateness of the defibrillator discharges could not be assessed reliably, since only a small number of patients had pulse generators with electrogram storage and these units were implanted late in the clinical trial.We evaluated the consistency of the beneficial effect of defibrillator therapy in each of the two centers with the highest enrollments (42 and 21 patients) and compared the results in the high-enrollment centers with the results in the 30 centers with lower enrollment (a total of 133 patients). The reductions in mortality with the defibrillator were similar among these groups.
Discussion
The implantable defibrillator was introduced into clinical medicine in 1980,18 and several reports have substantiated the ability of this device to terminate ventricular fibrillation automatically.19-24 In this trial we found a significant reduction in overall mortality associated with the implantation of a defibrillator in high-risk patients with coronary disease and left ventricular dysfunction, asymptomatic unsustained ventricular tachycardia, and inducible sustained ventricular tachycardia. Prescribed medications, including beta-blockers, had no discernible effect on the survival benefit derived from the defibrillator in this population. Patients randomly assigned to receive the defibrillator had a much lower rate of death from primary arrhythmia than patients assigned to conventional therapy (Table 4). It is noteworthy that there were more deaths from nonarrhythmic causes in the conventional-therapy group than in the defibrillator group, possibly reflecting inaccuracy in classifying the cause of death or conceivably related to the higher rate of use of amiodarone in the conventional-therapy group.
When we designed the study, we did not include a comparison group that received no treatment because we thought that such a stipulation would make enrollment extremely difficult in this high-risk, arrhythmia-prone population. We did not prespecify an antiarrhythmic-drug protocol since we anticipated that the safety and efficacy of antiarrhythmic drugs would change over the course of the study. The attending physicians were allowed to prescribe antiarrhythmic medications for patients in either treatment group. We anticipated that more amiodarone therapy would be prescribed for patients in the conventional-therapy group than in the defibrillator group, and this was indeed the case. Amiodarone therapy was ultimately discontinued in 46 percent of conventionally treated patients, a rate similar to that observed by others when amiodarone is used prophylactically in high-risk patients.25 The specific reasons for this high rate of discontinuation are unclear but are probably related to physicians' knowledge of the potential of amiodarone to cause adverse effects during long-term administration. Only a small number of patients received sotalol and class I antiarrhythmic agents. Beta-blockers were used more frequently in the defibrillator group, but less than 30 percent of the patients in this group received beta-blockers during the course of the study.
The question is whether these imbalances in antiarrhythmic-medication use between the two groups contributed to the observed results. No evidence was found by Cox regression analyses that an imbalance in antiarrhythmic-medication use in the two treatment groups had a meaningful influence on the observed hazard ratio; in other words, there were no significant interactions between any of the antiarrhythmic medications, including amiodarone and beta-blockers, and the assigned treatment. In a recent double-blind, placebo-controlled study of patients with congestive heart failure, amiodarone did not reduce the incidence of sudden death or prolong survival in patients with chronic coronary heart disease, asymptomatic ventricular arrhythmias, and impaired ventricular function.25
We believe that the use of electrophysiologic testing enhanced the process of stratification for arrhythmia and helped select a population at particularly high risk that benefited from the defibrillator. The mortality rate in the conventional-therapy group was high (32 percent at two years), but it was consistent with that previously reported for a similar group of patients with inducible or nonsuppressible ventricular tachycardia.8 Similarly, the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure reported a two-year mortality rate of 30 percent in both the amiodarone group and the placebo group; these patients had ischemic cardiomyopathy, ejection fractions of 0.40 or less, mild-to-moderate heart failure, and ventricular ectopy.25
A limitation of this study is that we do not know how many patients attending physicians screened to identify patients who were eligible. In addition, the enrolling centers did not keep consistent logs of eligible patients who did not qualify on the basis of the electrophysiologic study. Thus, we do not know the true denominator from which the study population was drawn or the magnitude of selection bias that may have occurred during enrollment.
The triangular, fully sequential design used in this trial is highly effective for conducting a focused trial that minimizes the number of both deaths and patients required for a statistically significant conclusion.14 In clinical trials using fixed-sample or group-sequential design,26 safety and efficacy monitoring is carried out infrequently or when prespecified numbers or anticipated percentages of end points are accumulated. In contrast, the sequential design permits termination of the trial on early evidence of benefit, of the absence of a difference between groups, or of harm, and the stopping boundaries take into account the multiple data analyses. A limitation associated with the sequential design is that early termination minimizes the amount of information collected, thereby reducing the power for exploratory subgroup analyses.
In the present study, the implanted defibrillator provided effective protection against death in high-risk patients with coronary heart disease and left ventricular dysfunction, spontaneous asymptomatic unsustained ventricular tachycardia, and inducible and nonsuppressible ventricular tachyarrhythmia on electrophysiologic testing. Prophylactic defibrillator therapy may reduce mortality among other high-risk patients with cardiac disease who are selected on the basis of different or less restrictive criteria. However, until the results of other randomized trials of defibrillators become available,27,28 the findings from this investigation should be applied only to the narrowly defined population of patients described in this study.
Supported by a research grant from CPI/Guidant Corporation, St. Paul, Minn.
We are indebted to the patients who participated in this trial; to the attending physicians who referred their patients to this study; and to CPI/Guidant Corporation for its support and sustained commitment, for supplying the defibrillators, and for the independence it provided to the investigators to conduct the study.
Source Information
From the Cardiology Unit, Department of Medicine (A.J.M., J.P.D.), the Department of Biostatistics (W.J.H., M.H.), and the Department of Community and Preventive Medicine (M.W.B.), University of Rochester School of Medicine and Dentistry, Rochester, N.Y.; Good Samaritan Hospital, Los Angeles (D.S.C.); Scripps Memorial Hospital, La Jolla, Calif. (S.L.H.); University Hospital, Magdeburg, Germany (H.K.); St. Francis Hospital–Heart Center, Roslyn, N.Y. (J.H.L.); Eastern Heart Institute, Passaic, N.J. (S.S.); the Department of Medicine, Case Western Reserve University, and University Hospitals of Cleveland, Cleveland (A.L.W.); and the Cardiology Unit, University of Chicago, Chicago (D.W.).
Address reprint requests to Dr. Moss at the Heart Research Follow-up Program, Box 653, University of Rochester Medical Center, Rochester, NY 14642.
The other investigators who participated in the Multicenter Automatic Defibrillator Implantation Trial are listed in the Appendix.
Appendix
The following investigators also participated in the Multicenter Automatic Defibrillator Implantation Trial: S. Sridhar, Affiliated Cardiologists, Phoenix, Ariz.; T. Mattioni, Arizona Heart Institute and Foundation, Phoenix; J. Maloney and B. Wilkoff, Cleveland Clinic Hospital, Cleveland; R. Krol, Eastern Heart Institute, Passaic, N.J.; A. Leon, Emory Clinic, Atlanta; R. Cierpka and H.-J. Trappe, Hanover Medical School, Hanover, Germany; S. Kutalek, Hahnemann University Hospital, Philadelphia; J. Rottman, Jewish Hospital of St. Louis, St. Louis; T. Guanieri and G. Tomaselli, Johns Hopkins University Hospital, Baltimore; B. Olshansky, Loyola University Medical Center, Maywood, Ill.; J. Salerno, Matteo Hospital, Pavia, Italy; B. Crevey, Methodist Hospital, Indianapolis; C. Pratt and D. Zhu, Methodist Hospital, Houston; M. Pritzker, Minneapolis Heart Institute, Minneapolis; S. Winters, Morristown Memorial Hospital, Morristown, N.J.; A. Kadish, Northwestern Memorial Hospital, Chicago; F. Abi-Samra, Ochsner Clinic, New Orleans; B. Halperin, J. Kron, and J. McAnulty, Oregon Health Sciences University, Portland; J. Steinberg, Roosevelt–St. Luke's Medical Center, New York; S. Greenberg and D. Hoch, Saint Francis Hospital–Heart Center, Roslyn, N.Y.; J. Gallagher, Sanger Clinic–Carolina Heart Institute, Charlotte, N.C.; J. Ilvento, Santa Barbara Cottage Hospital, Santa Barbara, Calif.; R. Winkle, Sequoia Hospital, Palo Alto, Calif.; M. Lehmann, Sinai Hospital, Detroit; M. Scheinman, University of California Medical Center, San Francisco; R. Myerburg, University of Miami Medical Center, Miami; T. Akiyama, A. Mushlin, and W. Zareba, University of Rochester Medical Center, Rochester, N.Y.; R. Ruffy, University of Utah School of Medicine, Salt Lake City; and E. Platia, Washington Hospital Center, Washington, D.C.; Data and Safety Monitoring Committee — D. Goldblatt, W. Hood, Jr. (chair), D. Oakes, and M. Tanner; End-Point Review Committee — L. Cobb and R. Goldstein (chair); Rochester Coordination and Data Center — M. Andrews, E. Garcia, N. Kellogg, B. MacKecknie, D. Ramsell, and P. Severski; and statistical support — J. Whitehead and S. Chen.
- References
References
1
Anderson KP ,DeCamilla J ,Moss AJ . Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 1978;57:890-897
Web of Science | Medline2
Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM, Multicenter Post-Infarction Research Group
CrossRef | Web of Science | Medline3
Buxton AE ,Marchlinski FE ,Waxman HL ,Flores BT ,Cassidy DM ,Josephson ME . Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984;53:1275-1279
CrossRef | Web of Science | Medline4
Ruskin JN ,McGovern B ,Garan H ,DiMarco JP ,Kelly E . Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med 1983;309:1302-1306
Full Text | Web of Science | Medline5
Echt DS ,Liebson PR ,Mitchell LB , et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788
Full Text | Web of Science | Medline6
Mason JW . A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458
Full Text | Web of Science | Medline7
Spielman SR ,Greenspan AM ,Kay HR , et al. Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function. J Am Coll Cardiol 1985;6:31-40
CrossRef | Web of Science | Medline8
Wilber DJ ,Olshansky B ,Moran JF ,Scanlon PJ . Electrophysiological testing and nonsustained ventricular tachycardia: use and limitation in patients with coronary artery disease and impaired ventricular function. Circulation 1990;82:350-358
CrossRef | Web of Science | Medline9
Healy B ,Campeau L ,Gray R , et al. Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med 1989;320:949-951
Full Text | Web of Science | Medline10
Morady F ,Kou WH ,Schmaltz S , et al. Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing. Am J Cardiol 1988;61:93-98
CrossRef | Web of Science | Medline11
MADIT Executive Committee
CrossRef | Web of Science | Medline12
Greenberg H, Gillespie J, Dwyer EM Jr, Multicenter Post-Infarction Research Group
CrossRef | Web of Science | Medline13
Hinkle LE Jr ,Thaler HT . Clinical classification of cardiac deaths. Circulation 1982;65:457-464
CrossRef | Web of Science | Medline14
Whitehead J. The design and analysis of sequential clinical trials. 2nd ed. Chichester, England: Ellis Horwood, 1992.
15
Brunier H, Whitehead J. PEST: planning and evaluation of sequential trials, version 3.0: operating manual. Reading, England: PEST Project, University of Reading, 1993 (and software).
16
Cox DR . Regression models and life-tables. J R Stat Soc [B] 1972;34:187-22017
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science18
Mirowski M ,Reid PR ,Mower MM , et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324
Full Text | Web of Science | Medline19
Echt DS ,Armstrong K ,Schmidt P ,Oyer PE ,Stinson EB ,Winkle RA . Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985;71:289-296
CrossRef | Web of Science | Medline20
Kelly PA ,Cannom DS ,Garan H , et al. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988;11:1278-1286
CrossRef | Web of Science | Medline21
Lehmann MH ,Steinman RT ,Schuger CD ,Jackson K . The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-805
CrossRef | Web of Science | Medline22
Winkle RA ,Mead RH ,Ruder MA , et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-1361
CrossRef | Web of Science | Medline23
Fogoros RN ,Elson JJ ,Bonnet CA . Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1989;12:1465-1473
CrossRef | Web of Science | Medline24
Levine JH ,Mellits ED ,Baumgardner RA , et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991;84:558-566
Web of Science | Medline25
Singh SN ,Fletcher RD ,Fisher SG , et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82
Full Text | Web of Science | Medline26
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology
Web of Science | Medline27
Bigger JT Jr. Should defibrillators be implanted in high-risk patients without a previous sustained ventricular tachyarrhythmia? In: Naccarelli GV, Veltri EP, eds. Implantable cardioverter–defibrillators. Boston: Blackwell Scientific, 1993:284-317.
28
Greene HL . Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study. Am Heart J 1994;127:1171-1178
CrossRef | Web of Science | Medline
- Citing Articles (1064)
Citing Articles
1
Heejung Bang, Hongwei Zhao. (2012) Average Cost-Effectiveness Ratio with Censored Data. Journal of Biopharmaceutical Statistics 22:2, 401-415
CrossRef2
M. Bracht, L. Skoljarev, M.W. Prull, H.-J. Trappe. (2012) Einfluss myokardialer Narben auf die Häufigkeit ventrikulärer Rhythmusstörungen bei ICD-Trägern. Der Kardiologe
CrossRef3
D. G. Katritsis, M. E. Josephson. (2012) Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?. Europace
CrossRef4
L. M. Biasucci, F. Bellocci, M. Landolina, R. Rordorf, A. Vado, E. Menardi, G. Giubilato, S. Orazi, M. Sassara, A. Castro, R. Massa, A. Kheir, G. Zaccone, C. Klersy, F. Accardi, F. Crea. (2012) Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study. European Heart Journal
CrossRef5
D. P. Morin, M. N. Saad, O. F. Shams, J. S. Owen, J. Q. Xue, F. M. Abi-Samra, S. Khatib, O. S. Nelson-Twakor, R. V. Milani. (2012) Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace
CrossRef6
Hou Yu, Fang Pi-hua, Wu Yuan, Li Xiao-feng, Liu Jun, Li Zhi, Lei Sen, Shu Zhang. (2012) Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. Journal of Electrocardiology 45:1, 60-65
CrossRef7
Przemyslaw Guzik, Jaroslaw Piskorski, Petra Barthel, Axel Bauer, Alexander Müller, Nadine Junk, Kurt Ulm, Marek Malik, Georg Schmidt. (2012) Heart rate deceleration runs for postinfarction risk prediction. Journal of Electrocardiology 45:1, 70-76
CrossRef8
Larry R. Jackson, James P. Daubert, Kevin L. Thomas. (2012) Expanding the Benefits of Implantable Cardioverter-Defibrillator Therapy: “Is Less More”?. Progress in Cardiovascular Diseases 54:4, 372-378
CrossRef9
Paban Saha, Jeffrey J. Goldberger. (2011) Risk Stratification for Prevention of Sudden Cardiac Death. Current Treatment Options in Cardiovascular Medicine
CrossRef10
H. Furushima, M. Chinushi, K. Iijima, K. Hasegawa, A. Sato, D. Izumi, H. Watanabe, Y. Aizawa. (2011) Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases?. Europace
CrossRef11
Daniel B. Kramer, Mark E. Josephson. (2011) Expanding the Use of Cardiac Resynchronization Therapy: Words of Caution. Cardiac Electrophysiology Clinics 3:4, 529-537
CrossRef12
Ashok J. Shah, Shinsuke Miyazaki, Amir S. Jadidi, Daniel Scherr, Stephen B. Wilton, Laurent Roten, Patrizio Pascale, Michala Pedersen, Nicolas Derval, Sebastien Knecht, Frederic Sacher, Pierre Jais, Michel Haissaguerre, Meleze Hocini. (2011) Catheter Ablation of Ventricular Fibrillation Storms: Will this Replace Defibrillators?. Cardiac Electrophysiology Clinics 3:4, 689-695
CrossRef13
Renee M. Sullivan, Brian Olshansky. (2011) Is a Dual-Chamber ICD Always Better in Patients Requiring an ICD?. Cardiac Electrophysiology Clinics 3:4, 577-592
CrossRef14
Stavros E. Mountantonakis, Mathew D. Hutchinson. (2011) Indications for Implantable Cardioverter-Defibrillator Placement in Ischemic Cardiomyopathy and after Myocardial Infarction. Current Heart Failure Reports 8:4, 252-259
CrossRef15
Mohan Rao, Ilan Goldenberg, Arthur J. Moss, Helmut Klein, David T. Huang, Nicole R. Bianco, Steven J. Szymkiewicz, Wojciech Zareba, Andrew Brenyo, Jonathan Buber, Alon Barsheshet. (2011) Wearable Defibrillator in Congenital Structural Heart Disease and Inherited Arrhythmias. The American Journal of Cardiology 108:11, 1632-1638
CrossRef16
M. E. Stone, B. Salter, A. Fischer. (2011) Perioperative management of patients with cardiac implantable electronic devices. British Journal of Anaesthesia 107:suppl 1, i16-i26
CrossRef17
M. Licka, L. Jahn, K. Kelemen, F. Voss, K. Trappe, R. Becker, O. Bikou, M. Hauck, M. Koch, H.A. Katus, A. Bauer. (2011) Is the determination of the defibrillation threshold in patients with an implantable cardioverter–defibrillator still required?. Herzschrittmachertherapie + Elektrophysiologie
CrossRef18
U. Mezu, I. Ch, I. Halder, B. London, S. Saba. (2011) Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Europace
CrossRef19
R. Bastiaenen, V. Batchvarov, M. M. Gallagher. (2011) Ventricular automaticity as a predictor of sudden death in ischaemic heart disease. Europace
CrossRef20
J. Thijssen, C. J. W. Borleffs, J. B. van Rees, M. K. de Bie, E. T. van der Velde, L. van Erven, J. J. Bax, S. C. Cannegieter, M. J. Schalij. (2011) Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. European Heart Journal 32:21, 2678-2687
CrossRef21
Daniel Jacoby, Oltjan Albajrami, Lavanya Bellumkonda. (2011) Natural History of End-stage LV Dysfunction: Has It Improved from the Classic Franciosa and Cohn Graph?. Cardiology Clinics 29:4, 485-495
CrossRef22
Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidência de arritmias ventriculares em doentes com disfunção sistólica ventricular esquerda grave: existe benefício após terapêutica de ressincronização cardíaca. Revista Portuguesa de Cardiologia 30:11, 823-828
CrossRef23
Mihály K. de Bie, Johannes B. van Rees, J. Thijssen, C. Jan Willem Borleffs, Serge A. Trines, Suzanne C. Cannegieter, Martin J. Schalij, Lieselot van Erven. (2011) Cardiac Device Infections are associated with a significant mortality risk. Heart Rhythm
CrossRef24
Ana Teresa Timóteo, Mário Martins Oliveira, Manuel Nogueira Silva, Alexandra Toste, Ruben Ramos, Joana Feliciano, Pedro Silva Cunha, Rui Soares, Sofia Santos, Rui Cruz Ferreira. (2011) Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?. Revista Portuguesa de Cardiologia (English Edition) 30:11, 823-828
CrossRef25
J. S. Perkiomaki, P.-E. Bloch Thomsen, A. M. Kiviniemi, M. D. Messier, H. V. Huikuri, . (2011) Risk factors of self-terminating and perpetuating ventricular tachyarrhythmias in post-infarction patients with moderately depressed left ventricular function, a CARISMA sub-analysis. Europace 13:11, 1604-1611
CrossRef26
A. Lazarus, N. Biondi, J.-F. Thebaut, I. Durand-Zaleski, M. Chauvin. (2011) Implantable cardioverter-defibrillators in France: practices and regional variability. Europace 13:11, 1568-1573
CrossRef27
M. Saeed, M. Razavi, C. G. Neason, S. Petrutiu. (2011) Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study. Europace 13:11, 1648-1652
CrossRef28
Joep Thijssen, C. Jan Willem Borleffs, Johannes B. van Rees, SumChe Man, Mihály K. de Bie, Jeroen Venlet, Enno T. van der Velde, Lieselot van Erven, Martin J. Schalij. (2011) Implantable Cardioverter-Defibrillator Longevity under Clinical Circumstances: an Analysis According to Device Type, Generation, and Manufacturer. Heart Rhythm
CrossRef29
H. I. Lehmann, A. Goette, J. Martens-Lobenhoffer, M. Hammwohner, F.-W. Rohl, A. Bukowska, A. Ghanem, H. U. Klein, S. M. Bode-Boger. (2011) Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Europace 13:10, 1428-1435
CrossRef30
YOSUKE MIWA, MUTSUMI MIYAKOSHI, KYOKO HOSHIDA, RYOJI YANAGISAWA, ATSUKO ABE, TAKEHIRO TSUKADA, HARUHISA ISHIGURO, HISAAKI MERA, SATORU YUSU, HIDEAKI YOSHINO, TAKANORI IKEDA. (2011) Heart Rate Turbulence Can Predict Cardiac Mortality Following Myocardial Infarction in Patients With Diabetes Mellitus. Journal of Cardiovascular Electrophysiology 22:10, 1135-1140
CrossRef31
Leonardo Calò, Tiziana De Santo, Francesca Nuccio, Luigi Sciarra, Lucia De Luca, Lorenza Mangoni di S. Stefano, Enrico Piroli, Lorenzo Zuccaro, Marco Rebecchi, Ermenegildo de Ruvo, Ernesto Lioy. (2011) Predictive Value of Microvolt T-Wave Alternans for Cardiac Death or Ventricular Tachyarrhythmic Events in Ischemic and Nonischemic Cardiomyopathy Patients: A Meta-Analysis. Annals of Noninvasive Electrocardiology 16:4, 388-402
CrossRef32
Gina Magyar-Russell, Brett D. Thombs, Jennifer X. Cai, Tarun Baveja, Emily A. Kuhl, Preet Paul Singh, Marcela Montenegro Braga Barroso, Erin Arthurs, Michelle Roseman, Nivee Amin, Joseph E. Marine, Roy C. Ziegelstein. (2011) The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. Journal of Psychosomatic Research 71:4, 223-231
CrossRef33
Fabrice Extramiana, Antoine Leenhardt. (2011) Prolonged QRS duration and sudden cardiac death risk stratification: Not yet ready for prime time. Heart Rhythm 8:10, 1568-1569
CrossRef34
T. Reichlin, M. Kuhne, C. Sticherling, S. Osswald, B. Schaer. (2011) Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation. QJM 104:10, 849-857
CrossRef35
Florian Streitner, Juergen Kuschyk, Claudia Dietrich, Eva Mahl, Ines Streitner, Christina Doesch, Christian Veltmann, Rainer Schimpf, Christian Wolpert, Martin Borggrefe. (2011) Comparison of Ventricular Tachyarrhythmia Characteristics in Patients With Idiopathic Dilated or Ischemic Cardiomyopathy and Defibrillators Implanted for Primary Prevention. Clinical Cardiology 34:10, 604-609
CrossRef36
Brian C Hiestan. (2011) Research in acute decompensated heart failure: challenges and opportunities. Clinical Investigation 1:10, 1361-1373
CrossRef37
T. Smith, P. F. Dessel, D. A. M. J. Theuns, A. Muskens-Heemskerk, R. T. Domburg, A. A. Wilde, L. Jordaens. (2011) Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Netherlands Heart Journal 19:10, 405-411
CrossRef38
Samir Saba, Haider Mehdi, Hemal Shah, Zahid Islam, Elie Aoun, Sammy Termanini, Reem Mahjoub, Ryan Aleong, Charles F. McTiernan, Barry London. (2011) Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction. Heart Rhythm
CrossRef39
J. B. van Rees, C. J. W. Borleffs, J. Thijssen, M. K. de Bie, L. van Erven, S. C. Cannegieter, J. J. Bax, M. J. Schalij. (2011) Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace
CrossRef40
David J. Whellan, Suzanne Adams, Lisa Bowerman. (2011) Review of Advanced Heart Failure Device Diagnostics Examined in Clinical Trials and the Potential Benefit from Monitoring Capabilities. Progress in Cardiovascular Diseases 54:2, 107-114
CrossRef41
David M. Charytan, Amanda R. Patrick, Jun Liu, Soko Setoguchi, Charles A. Herzog, M. Alan Brookhart, Wolfgang C. Winkelmayer. (2011) Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States. American Journal of Kidney Diseases 58:3, 409-417
CrossRef42
Lara Dabiri Abkenari, Dominic A. M. J. Theuns, Suzanne D. A. Valk, Yves Belle, Natasja M. Groot, David Haitsma, Agnes Muskens-Heemskerk, Tamas Szili-Torok, Luc Jordaens. (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clinical Research in Cardiology 100:9, 737-744
CrossRef43
Kärstin Bolse, Ingela Johansson, Anna Strömberg. (2011) Organisation of care for Swedish patients with an implantable cardioverter defibrillator, a national survey. Journal of Clinical Nursing 20:17-18, 2600-2608
CrossRef44
Tamam Mohamad, Sony Jacob, Naga VA Kommuri, Shalini Modi, Rajeev Aravindhakshan, Randy Lieberman. (2011) Low Referral Pattern for Implantable Defibrillator Therapy in a Tertiary Hospital: Referral Physician Survey and Monte Carlo Simulation. American Journal of Therapeutics 18:5, 350-354
CrossRef45
Afschin Gandjour, Astrid Holler Dipl-Ges-Ök, Charles Christian Adarkwah. (2011) Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-Up Data (MADIT II). Value in Health 14:6, 812-817
CrossRef46
Marwan Refaat, Samir Saba. (2011) Total Subcutaneous Defibrillators: The Current Status and Future Prospect of a New Technology. Cardiac Electrophysiology Clinics 3:3, 403-408
CrossRef47
James V. Freeman, Aditya Ullal, Mintu P. Turakhia. (2011) Cost-effectiveness of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. Cardiac Electrophysiology Clinics 3:3, 421-440
CrossRef48
T. Jared Bunch, Heidi T. May, Tami L. Bair, Brian G. Crandall, J. Peter Weiss, Jeffrey S. Osborn, Jeffrey L. Anderson, Joseph B. Muhlestein, Benjamin D. Horne, Donald L. Lappe, John D. Day. (2011) Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart Rhythm 8:9, 1460-1466
CrossRef49
Jordan M. Prutkin, Jeanne E. Poole. (2011) Complications of ICD Generator Change and Implantations. Cardiac Electrophysiology Clinics 3:3, 389-401
CrossRef50
ARTHUR SHIYOVICH, AMOS KATZ. (2011) The “Shock Factor”: ICD Configuration and Programming to Optimize Shock Treatment. Journal of Cardiovascular Electrophysiology 22:9, 1030-1033
CrossRef51
Thomas A. Dewland, Jeffrey E. Olgin, Byron K. Lee. (2011) Indications for a Wearable Cardioverter-Defibrillator. Cardiac Electrophysiology Clinics 3:3, 339-347
CrossRef52
Ashish K Govil, Mohit D Gupta, MP Girish, Sanjay Tyagi. (2011) Prediction and Prevention in Sudden Cardiac Death. Apollo Medicine 8:3, 228-237
CrossRef53
Y. Wang, P. S. Cuculich, J. Zhang, K. A. Desouza, R. Vijayakumar, J. Chen, M. N. Faddis, B. D. Lindsay, T. W. Smith, Y. Rudy. (2011) Noninvasive Electroanatomic Mapping of Human Ventricular Arrhythmias with Electrocardiographic Imaging. Science Translational Medicine 3:98, 98ra84-98ra84
CrossRef54
M. K. de Bie, D. A. Fouad, C. J. W. Borleffs, J. B. van Rees, J. Thijssen, S. A. Trines, M. Bootsma, M. J. Schalij, L. van Erven. (2011) Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures. Europace
CrossRef55
Leon A. Cannizzaro, Jonathan P. Piccini, Uptal D. Patel, Adrian F. Hernandez. (2011) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:9, 889-896
CrossRef56
Eric C. Stecker, Sumeet S. Chugh. (2011) Prediction of sudden cardiac death: next steps in pursuit of effective methodology. Journal of Interventional Cardiac Electrophysiology 31:2, 101-107
CrossRef57
Philipp Boyé, Hassan Abdel-Aty, Udo Zacharzowsky, Steffen Bohl, Carsten Schwenke, Rob J. van der Geest, Rainer Dietz, Alexander Schirdewan, Jeanette Schulz-Menger. (2011) Prediction of Life-Threatening Arrhythmic Events in Patients With Chronic Myocardial Infarction by Contrast-Enhanced CMR. JACC: Cardiovascular Imaging 4:8, 871-879
CrossRef58
Johannes B. van Rees, Mihály K. de Bie, Joep Thijssen, C. Jan Willem Borleffs, Martin J. Schalij, Lieselot van Erven. (2011) Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices. Journal of the American College of Cardiology 58:10, 995-1000
CrossRef59
S. McNicholas, B. McAdam, M. Flynn, H. Humphreys. (2011) The challenges of implantable cardiac device infection due to Helcococcus kunzii. Journal of Hospital Infection 78:4, 337-338
CrossRef60
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, 1340-1356
CrossRef61
Daniel Scharfstein, Georgiana Onicescu, Steven Goodman, Rachel Whitaker. (2011) Analysis of subgroup effects in randomized trials when subgroup membership is missing: application to the second Multicenter Automatic Defibrillator Intervention Trial. Journal of the Royal Statistical Society: Series C (Applied Statistics) 60:4, 607-617
CrossRef62
Johannes Holzmeister, Christophe Leclercq. (2011) Implantable cardioverter defibrillators and cardiac resynchronisation therapy. The Lancet 378:9792, 722-730
CrossRef63
Deepak Bhakta, Lynne D. Foreman. (2011) Implantable cardioverter-defibrillator shock reduction: The new paradigm. Heart Rhythm
CrossRef64
Gail K. Larsen, John Evans, William E. Lambert, Yiyi Chen, Merritt Raitt. (2011) Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm
CrossRef65
SEK Y. CHAIR, CHUI K. LEE, KAI C. CHOI, SAMUEL F. SEARS. (2011) Quality of Life Outcomes in Chinese Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 34:7, 858-867
CrossRef66
Andrea Alcaraz, Jorge González-Zuelgaray, Federico Augustovski. (2011) Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina. Value in Health 14:5, S33-S38
CrossRef67
Mauro Biffi, Matteo Ziacchi, Matteo Bertini, Beatrice Gardini, Andrea Mazzotti, Giulia Massaro, Cristian Martignani, Igor Diemberger, Giuseppe Boriani, Daniela Corsini. (2011) How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost?. International Journal of Technology Assessment in Health Care 27:03, 201-206
CrossRef68
Peter Bernhardt, Sascha Stiller, Eva Kottmair, Ludwig Binner, Jochen Spieß, Georg Großmann, Volker Rasche, Daniel Walcher, Vinzenz Hombach. (2011) Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up. The International Journal of Cardiovascular Imaging 27:6, 893-900
CrossRef69
GUIDO H. VAN WELSENES, JOHANNES B. VAN REES, JOEP THIJSSEN, SERGE A. TRINES, LIESELOT VAN ERVEN, MARTIN J. SCHALIJ, C.J.W. BORLEFFS. (2011) Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back-Up After an Event-Free First Battery Service-Life. Journal of Cardiovascular Electrophysiologyno-no
CrossRef70
John D. Fisher. (2011) Advances in syncope. Journal of Interventional Cardiac Electrophysiology
CrossRef71
M. Hudec, G. Kaliska. (2011) Case report of out-of-hospital heat dissipation of an implantable cardioverter-defibrillator. Europace 13:6, 902-904
CrossRef72
N. A. Mark Estes, Munther Homoud, Jonathan Weinstock, Caroline Foote, Ania Garlitski, Mark Link, Afshin Ehsan. (2011) Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. Journal of Interventional Cardiac Electrophysiology 31:1, 91-99
CrossRef73
Michael W. Fong, Luanda Grazette, David Cesario, Michael Cao, Leslie Saxon. (2011) Treatment of Ventricular Tachycardia in Patients with Heart Failure. Current Cardiology Reports 13:3, 203-209
CrossRef74
Sandra L. Carroll, Patricia H. Strachan, Sonya de Laat, Lisa Schwartz, Heather M. Arthur. (2011) Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Health Expectationsno-no
CrossRef75
John R. Wilson. (2011) Rhetorical Strategies Used in the Reporting of Implantable Defibrillator Primary Prevention Trials. The American Journal of Cardiology 107:12, 1806-1811
CrossRef76
Domenico Corrado, Maria Silvano, Federico Migliore, Alessio Marinelli, Loira Leoni, Gaetano Thiene, Sabino Iliceto, Gianfranco Buja. (2011) Implantable Cardioverter Defibrillator in Arrhythmogenic Cardiomyopathy. Cardiac Electrophysiology Clinics 3:2, 311-321
CrossRef77
Spyridon Deftereos, Georgios Giannopoulos, Charalampos Kossyvakis, Andreas Kaoukis, Konstantinos Raisakis, Vasiliki Panagopoulou, Olga Ntzouvara, Anastasia Perpinia, Ilias Rentoukas, Vlasios Pyrgakis, Antonios S. Manolis, Christodoulos Stefanadis. (2011) Relation of Ventricular Tachycardia/Fibrillation to Beta-Blocker Dose Maximization Guided by Pacing Mode Analysis in Nonpacemaker-Dependent Patients With Implantable Cardioverter–Defibrillator. The American Journal of Cardiology 107:12, 1812-1817
CrossRef78
E. T. Locati. (2011) Can non-invasive parameters of sympatho-vagal modulation derived from Holter monitoring contribute to risk stratification for primary implantable cardiac-defibrillator implantation?. Europace 13:6, 776-779
CrossRef79
Endre Zima. (2011) Intensive management of electrical storm and incessant ventricular arrhythmias. Interventional Medicine and Applied Science 3:2, 47-54
CrossRef80
Tjebbe W. Galema, Arjen R.T. van de Ven, Osama I. I. Soliman, Ron T. van Domburg, Wim B. Vletter, Bas M. van Dalen, Attila Nemes, Folkert J. ten Cate, Marcel L. Geleijnse. (2011) Contrast Echocardiography Improves Interobserver Agreement for Wall Motion Score Index and Correlation with Ejection Fraction. Echocardiography 28:5, 575-581
CrossRef81
F. Leyva, I. Fernandez Lozano, J. Morgan. (2011) Cardioverter-defibrillators: a cost or an investment?. Europace 13:Supplement 2, ii25-ii31
CrossRef82
Tara Bourke, Nilesh Mathuria, Yoav Michowitz, Kalyanam Shivkumar. (2011) Hybrid techniques and neuraxial modulation for treatment of ventricular tachycardia. Future Cardiology 7:3, 273-276
CrossRef83
F. Streitner, J. Kuschyk, C. Veltmann, E. Mahl, C. Dietrich, R. Schimpf, C. Doesch, I. Streitner, C. Wolpert, M. Borggrefe. (2011) Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace 13:5, 668-674
CrossRef84
PETER STEMPNIEWICZ, ALAN CHENG, ALLISON CONNOLLY, XIN YUAN WANG, HUGH CALKINS, GORDON F. TOMASELLI, RONALD D. BERGER, LARISA G. TERESHCHENKO. (2011) Appropriate and Inappropriate Electrical Therapies Delivered by an Implantable Cardioverter-Defibrillator: Effect on Intracardiac Electrogram. Journal of Cardiovascular Electrophysiology 22:5, 554-560
CrossRef85
Douglas L. Packer, Anne M. Gillis, Hugh Calkins, Thomas F. Deering, Richard I. Fogel, Bruce L. Wilkoff. (2011) ICDs: Evidence, guidelines and glitches. Heart Rhythm 8:5, 800-803
CrossRef86
Maria Teresa La Rovere. 2011. Evaluation of the Autonomic Nervous System: From Algorithms to Clinical Practice. , 83-97.
CrossRef87
2011. Appendix. , 386-418.
CrossRef88
2011. Arrhythmias in Different Heart Diseases and Situations. , 360-385.
CrossRef89
Peem Lorvidhaya, Kamel Addo, Adam Chodosh, Venkat Iyer, Jeremy Lum, Alfred E. Buxton. (2011) Sudden Cardiac Death Risk Stratification in Patients with Heart Failure. Heart Failure Clinics 7:2, 157-174
CrossRef90
Ayesha Hasan, Benjamin Sun. (2011) Defibrillators and Cardiac Resynchronization Therapy as a Bridge to Cardiac Transplantation. Heart Failure Clinics 7:2, 227-239
CrossRef91
Andrea M. Russo. (2011) Risk stratification early post-MI after percutaneous coronary intervention: Should programmed ventricular stimulation be revisited?. Heart Rhythm 8:4, 500-502
CrossRef92
M. Santini, C. Pignalberi. (2011) Timing of defibrillator implant after acute myocardial infarction: what's new?. Europace 13:4, 455-457
CrossRef93
Ragavendra R. Baliga, James B. Young. (2011) Editorial: Sudden Death in Heart Failure: An Ounce of Prediction is Worth a Pound of Prevention. Heart Failure Clinics 7:2, xiii-xviii
CrossRef94
Anurag Gupta, Amin Al-Ahmad, Paul J. Wang. (2011) Subcutaneous Implantable Cardioverter-Defibrillator Technology. Heart Failure Clinics 7:2, 287-294
CrossRef95
Samir Saba. (2011) Sudden Cardiac Death Risk Stratification and Assessment: Primary Prevention Based on Ejection Fraction Criteria. Heart Failure Clinics 7:2, 175-183
CrossRef96
Mahmoud Houmsse, Veronica Franco, William T. Abraham. (2011) Epidemiology of Sudden Cardiac Death in Patients with Heart Failure. Heart Failure Clinics 7:2, 147-155
CrossRef97
M. Falip, M. Codina. (2011) Epilepsia. Medicine - Programa de Formación Médica Continuada Acreditado 10:74, 4991-5001
CrossRef98
Kenji Nakai, Shin Takahashi, Atsushi Suzuki, Nobuhisa Hagiwara, Keisuke Futagawa, Morio Shoda, Tsuyoshi Shiga, Ken Takahashi, Hitoshi Okabayashi, Manabu Itoh, Hiroshi Kasanuki. (2011) Novel algorithm for identifying T-wave current density alternans using synthesized 187-channel vector-projected body surface mapping. Heart and Vessels 26:2, 160-167
CrossRef99
G. H. van Welsenes, J. B. van Rees, C. J. W. Borleffs, S. C. Cannegieter, J. J. Bax, L. van Erven, M. J. Schalij. (2011) Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 13:3, 389-394
CrossRef100
Saurabh Malhotra, Mithilesh K Das. (2011) Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. Future Cardiology 7:2, 203-217
CrossRef101
Melissa H. Kong, Gregg C. Fonarow, Eric D. Peterson, Anne B. Curtis, Adrian F. Hernandez, Gillian D. Sanders, Kevin L. Thomas, David L. Hayes, Sana M. Al-Khatib. (2011) Systematic Review of the Incidence of Sudden Cardiac Death in the United States. Journal of the American College of Cardiology 57:7, 794-801
CrossRef102
Sana M. Al-Khatib, Gillian D. Sanders, Sean M. O’Brien, Daniel Matlock, Louise O. Zimmer, Frederick A. Masoudi, Eric Peterson. (2011) Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?. Annals of Noninvasive Electrocardiology 16:1, 77-84
CrossRef103
Pil Sang Song, June Soo Kim, Dae-Hee Shin, Jung Wae Park, Ki In Bae, Chang Hee Lee, Dong Chae Jung, Dong Ryeol Ryu, Young Keun On. (2011) Electrical Storms in Patients with an Implantable Cardioverter Defibrillator. Yonsei Medical Journal 52:1, 26
CrossRef104
P. Santangeli, A. Dello Russo, M. Casella, G. Pelargonio, L. Di Biase, A. Natale. (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?. Internal Medicine Journal 41:1a, 55-60
CrossRef105
Akihiko Shimizu. (2011) Indication of Implantable Devices for the Prevention of Sudden Cardiac Death. Journal of Arrhythmia 27:1, 87-90
CrossRef106
JÉRÔME SCHWARTZ, HUGUES BLANGY, PIERRE YVES ZINZIUS, LUC FREYSZ, ETIENNE ALIOT, NICOLAS SADOUL. (2011) Recall Alerts in Implantable Cardioverter-Defibrillator Recipients: Implications for Patients and Physicians. Pacing and Clinical Electrophysiology 34:1, 96-103
CrossRef107
Saurabh Kumar, Gopal Sivagangabalan, Sarah Zaman, Pramesh Kovoor. (2011) Author Reply—ICD Implantation Early After Acute ST Elevation Myocardial Infarction. Heart Rhythm 8:1, e2
CrossRef108
David Bello, Arnold Einhorn, Rishi Kaushal, Satish Kenchaiah, Aidan Raney, David Fieno, Jagat Narula, Jeffrey Goldberger, Kalyanam Shivkumar, Haris Subacius, Alan Kadish. (2011) Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magnetic Resonance Imaging 29:1, 50-56
CrossRef109
Tim Smith, Dominic A.M.J. Theuns, Kadir Caliskan, Luc Jordaens. (2011) Long-Term Follow-Up of Prophylactic Implantable Cardioverter-Defibrillator-Only Therapy: Comparison of Ischemic and Nonischemic Heart Disease. Clinical Cardiologyn/a-n/a
CrossRef110
G. H. Welsenes, C. J. W. Borleffs, J. B. Rees, J. Z. Atary, J. Thijssen, E. E. Wall, M. J. Schalij. (2011) Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy. Netherlands Heart Journal 19:1, 24-30
CrossRef111
A. Ghani, A. H. E. M. Maas, P. P. H. M. Delnoy, A. R. Ramdat Misier, J. P. Ottervanger, A. Elvan. (2010) Sex-Based Differences in Cardiac Arrhythmias, ICD Utilisation and Cardiac Resynchronisation Therapy. Netherlands Heart Journal
CrossRef112
K. Kraaier, T. McCracken, J. Palen, A. A. M. Wilde, M. F. Scholten. (2010) Is T-Wave Alternans Testing Feasible in Candidates for Prophylactic Implantable Defibrillators?. Netherlands Heart Journal
CrossRef113
H.H. Klein, A. Krämer, B.M. Pieske, H.-J. Trappe, H. Vries. (2010) Fahreignung bei kardiovaskulären Erkrankungen. Der Kardiologe 4:6, 441-473
CrossRef114
I. Battipaglia, L. Barone, L. Mariani, F. Infusino, R. Remoli, G. Careri, G. Pinnacchio, P. Tarzia, G. A. Lanza, F. Crea. (2010) Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 12:12, 1725-1731
CrossRef115
Zeliha Koyak, Joris R de Groot, Barbara JM Mulder. (2010) Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease. Expert Review of Cardiovascular Therapy 8:12, 1753-1766
CrossRef116
MOHAMMAD SAEED, CURTIS G. NEASON, MEHDI RAZAVI, SHANKER CHANDIRAMANI, JOSEPH ALONSO, SENTHIL NATARAJAN, JOHN H. IP, DARREN F. PERESS, SUMATI RAMADAS, ALI MASSUMI. (2010) Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial. Journal of Cardiovascular Electrophysiology 21:12, 1349-1354
CrossRef117
Wilbert S Aronow. (2010) Use of implantable cardioverter-defibrillators. Future Cardiology 6:6, 859-870
CrossRef118
J. Z. Atary, C. J. W. Borleffs, J. G. van der Bom, S. A. I. P. Trines, M. Bootsma, K. Zeppenfeld, L. van Erven, M. J. Schalij. (2010) Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease. Europace 12:11, 1581-1588
CrossRef119
Shibaji Shome, Dan Li, Julie Thompson, Aaron McCabe. (2010) Improving contemporary algorithms for implantable cardioverter-defibrillator function. Journal of Electrocardiology 43:6, 503-508
CrossRef120
Arthur E. Fass. (2010) Chronic Coronary Disease in the Post-COURAGE Era. Cardiology in Review 18:6, 292-297
CrossRef121
Eric C. Stecker. (2010) Is there new hope for sudden cardiac death prevention early after myocardial infarction?. Heart Rhythm 7:11, 1598-1599
CrossRef122
D. A. M. J. Theuns, T. Smith, M. G. M. Hunink, G. H. Bardy, L. Jordaens. (2010) Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 12:11, 1564-1570
CrossRef123
Massimo Volpe, Pietro Francia, Giuliano Tocci, Speranza Rubattu, Sara Cangianiello, Maria Assunta Elena Rao, Bruno Trimarco, Mario Condorelli. (2010) Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study. Clinical Cardiology 33:11, 700-707
CrossRef124
Casey S. Hager, Sunil Jain, Jeffry Blackwell, Benjamin Culp, Juhee Song, Christopher D. Chiles. (2010) Effect of Renal Function on Survival After Implantable Cardioverter Defibrillator Placement. The American Journal of Cardiology 106:9, 1297-1300
CrossRef125
Wilbert S Aronow. (2010) Implantable Cardioverter-Defibrillators. American Journal of Therapeutics 17:6, e208-e220
CrossRef126
Saurabh Kumar, Gopal Sivagangabalan, Sarah Zaman, Elizabeth B. West, Arun Narayan, Aravinda Thiagalingam, Pramesh Kovoor. (2010) Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction. Heart Rhythm 7:11, 1589-1597
CrossRef127
Dan Sorajja, Win-Kuang Shen. (2010) Driving Guidelines and Restrictions in Patients With a History of Cardiac Arrhythmias, Syncope,or Implantable Devices. Current Treatment Options in Cardiovascular Medicine 12:5, 443-456
CrossRef128
Palaniappan Saravanan, Gavin Freeman, Neil C. Davidson. (2010) Risk assessment for sudden cardiac death in dialysis patients: How relevant are conventional cardiac risk factors?. International Journal of Cardiology 144:3, 431-432
CrossRef129
Matthew J. O'Connor, David N. Rosenthal, Robert E. Shaddy. (2010) Outpatient Management of Pediatric Heart Failure. Heart Failure Clinics 6:4, 515-529
CrossRef130
Riccardo Cappato, Gabriele Zanotto, Carlo Menozzi, Antonio Coppola, Antonio Curnis, Valerio Freggiaro, Tommaso Sanna, Gianfranco Sinagra, Fabrizio Pizzetti, Sergio Sermasi, Alessandro Locatelli, Gabriele Zaccone, Domenico Pecora, Giovanni Raciti, Francesco Accardi. (2010) Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study. International Journal of Cardiology 144:2, 268-269
CrossRef131
E. Maffei, G. Messalli, A. Palumbo, C. Martini, S. Seitun, A. Aldrovandi, A. Cuttone, E. Emiliano, R. Malagò, A. Weustink, N. Mollet, F. Cademartiri. (2010) Left ventricular ejection fraction: real-world comparison between cardiac computed tomography and echocardiography in a large population. La radiologia medica 115:7, 1015-1027
CrossRef132
Giuseppe Boriani, Igor Diemberger, Cinzia Valzania, Mauro Biffi, Cristian Martignani, Emanuel Raschi, Valentina Mantovani, Matteo Ziacchi, Matteo Bertini, Fabrizio De Ponti, Angelo Branzi. (2010) Role of drugs and devices in patients at risk of sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, 575-594
CrossRef133
Kei Nishiyama, Satoshi Shizuta, Takahiro Doi, Takeshi Morimoto, Takeshi Kimura. (2010) Sudden cardiac death after PCI and CABG in the bare-metal stent era: Incidence, prevalence, and predictors. International Journal of Cardiology 144:2, 263-266
CrossRef134
EATHAR RAZAK, SWAPNA KAMIREDDY, SAMIR SABA. (2010) Implantable Cardioverter-Defibrillators Confer Survival Benefit in Patients with Chronic Obstructive Pulmonary Disease. Pacing and Clinical Electrophysiology 33:9, 1125-1130
CrossRef135
LAUREN D. VAZQUEZ, JAMIE B. CONTI, SAMUEL F. SEARS. (2010) Female-Specific Education, Management, and Lifestyle Enhancement for Implantable Cardioverter Defibrillator Patients: The FEMALE-ICD Study. Pacing and Clinical Electrophysiology 33:9, 1131-1140
CrossRef136
Cara N. Pellegrini, Melvin M. Scheinman. (2010) Clinical Management of Ventricular Tachycardia. Current Problems in Cardiology 35:9, 453-504
CrossRef137
Judith Z. Goldfinger, Eric D. Adler. (2010) End-of-Life Options for Patients with Advanced Heart Failure. Current Heart Failure Reports 7:3, 140-147
CrossRef138
Anoop K Shetty, Miles WH Behan, Julian Bostock, C Aldo Rinaldi. (2010) Device therapy for the management of cardiac tachyarrhythmias. Expert Review of Cardiovascular Therapy 8:9, 1257-1266
CrossRef139
Francisco J. Pastor-Pérez, Sergio Manzano-Fernández, Rebeca Goya-Esteban, Domingo A. Pascual-Figal, Oscar Barquero-Pérez, Jose Luis Rojo-Álvarez, Maria Dolores Martinez Martinez-Espejo, Mariano Valdés Chavarri, Arcadio García-Alberola. (2010) Comparison of Detection of Arrhythmias in Patients With Chronic Heart Failure Secondary to Non-Ischemic Versus Ischemic Cardiomyopathy by 1 Versus 7-Day Holter Monitoring. The American Journal of Cardiology 106:5, 677-681
CrossRef140
Brian Feingold, Gaurav Arora, Steven A. Webber, Kenneth J. Smith. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children With Dilated Cardiomyopathy. Journal of Cardiac Failure 16:9, 734-741
CrossRef141
S. M. Al-Khatib, G. Hafley, K. L. Lee, A. E. Buxton. (2010) Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial. Europace 12:8, 1112-1118
CrossRef142
Faris Khan, Evan Adelstein, Samir Saba. (2010) Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients. Journal of Interventional Cardiac Electrophysiology 28:2, 117-123
CrossRef143
Christopher Adlbrecht, Martin Hülsmann, Marianne Gwechenberger, Senta Graf, Franz Wiesbauer, Guido Strunk, Cesar Khazen, Isabella Brodnjak, Stephanie Neuhold, Thomas Binder, Gerald Maurer, Richard Pacher. (2010) Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome. European Journal of Clinical Investigation 40:8, 678-684
CrossRef144
H. V. Huikuri. (2010) Timing of implantation of cardioverter-defibrillator after acute myocardial infarction. Europace 12:8, 1057-1058
CrossRef145
Roger A. Winkle. (2010) The Effectiveness and Cost Effectiveness of Public-Access Defibrillation. Clinical Cardiology 33:7, 396-399
CrossRef146
Badri Chandrasekaran, Peter J Cowburn. (2010) Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy. Expert Review of Medical Devices 7:4, 461-467
CrossRef147
Michael C. Sanguinetti. (2010) HERG1 channelopathies. Pflügers Archiv - European Journal of Physiology 460:2, 265-276
CrossRef148
Mina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Edwin Zishiri, Mark J. Niebauer, Bruce D. Lindsay, Patrick J. Tchou. (2010) Aggregate National Experience With the Wearable Cardioverter-Defibrillator. Journal of the American College of Cardiology 56:3, 194-203
CrossRef149
Gillian D. Sanders, Melissa H. Kong, Sana M. Al-Khatib, Eric D. Peterson. (2010) Cost-effectiveness of implantable cardioverter defibrillators in patients ≥65 years of age. American Heart Journal 160:1, 122-131
CrossRef150
Sandra L. Carroll, Heather M. Arthur. (2010) A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death. International Journal of Nursing Studies 47:7, 836-845
CrossRef151
C.W. Israel. (2010) ICD-Therapie zur Primärprävention des plötzlichen Herztods. Herzschrittmachertherapie + Elektrophysiologie 21:2, 102-108
CrossRef152
Mark J. Boogers, C. Jan Willem Borleffs, Maureen M. Henneman, Rutger J. van Bommel, Jan van Ramshorst, Eric Boersma, Petra Dibbets-Schneider, Marcel P. Stokkel, Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax. (2010) Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 55:24, 2769-2777
CrossRef153
STEVEN M. KURTZ, JORGE A. OCHOA, EDMUND LAU, YAKOV SHKOLNIKOV, BEHZAD B. PAVRI, DANIEL FRISCH, ARNOLD J. GREENSPON. (2010) Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993-2006. Pacing and Clinical Electrophysiology 33:6, 705-711
CrossRef154
Guy Amit, David S. Rosenbaum, Dennis M. Super, Otto Costantini. (2010) Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: Implications for identifying patients at risk for sudden cardiac death. Heart Rhythm 7:6, 763-768
CrossRef155
(2010) Section 9: Electrophysiology Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 16:6, e115-e121
CrossRef156
T. Sellmann, M. Winterhalter, U. Herold, P. Kienbaum. (2010) Implantation von Kardioverter-Defibrillatoren. Der Anaesthesist 59:6, 507-518
CrossRef157
Scott M. Berry, K. Jack Ishak, Bryan R. Luce, Donald A. Berry. (2010) Bayesian Meta-Analyses for Comparative Effectiveness and Informing Coverage Decisions. Medical Care 48, S137-S144
CrossRef158
Mark J. Boogers, Martin J. Schalij, Jeroen J. Bax. (2010) Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?. Journal of Nuclear Cardiology 17:3, 354-358
CrossRef159
P. Tassani-Prell, G. Juchem. (2010) Erfahrene Anästhesisten unverzichtbar. Der Anaesthesist 59:6, 505-506
CrossRef160
BRETT D. ATWATER, JAMES P. DAUBERT. (2010) Can We Improve the Identification of Ventricular Scar to Guide Substrate-Based Ventricular Tachycardia Ablation?. Journal of Cardiovascular Electrophysiology 21:6, 685-687
CrossRef161
Heart Failure Society of America. (2010) Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. Journal of Cardiac Failure 16:6, 475-539
CrossRef162
Dawood Darbar. (2010) Genomics, heart failure and sudden cardiac death. Heart Failure Reviews 15:3, 229-238
CrossRef163
Matthew Jolley, Jeroen Stinstra, Jess Tate, Steve Pieper, Rob MacLeod, Larry Chu, Paul Wang, John K. Triedman. (2010) Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Heart Rhythm 7:5, 692-698
CrossRef164
Chi-Wen Kao, Erika Friedmann, Sue A. Thomas. (2010) Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Quality of Life Research 19:3, 307-315
CrossRef165
Massimo Giammaria, Claudio Bruna, Roberto Gnavi. (2010) Trend in implantable cardioverter defibrillators and relation to need. Journal of Cardiovascular Medicine 11:4, 265-270
CrossRef166
Noel C.F. Codella, Matthew D. Cham, Richard Wong, Christopher Chu, James K. Min, Martin R. Prince, Yi Wang, Jonathan W. Weinsaft. (2010) Rapid and accurate left ventricular chamber quantification using a novel CMR segmentation algorithm: A clinical validation study. Journal of Magnetic Resonance Imaging 31:4, 845-853
CrossRef167
Jenny Tagney. (2010) A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs). Journal of Clinical Nursingno-no
CrossRef168
SERGIO THAL, TALAL MOUKABARY, RAVICHANDRA BOYELLA, MADHAN SHANMUGASUNDARAM, MARY K. PIERCE, HOANG THAI, STEVEN GOLDMAN. (2010) The Relationship between Warfarin, Aspirin, and Clopidogrel Continuation in the Peri-procedural Period and the Incidence of Hematoma Formation after Device Implantation. Pacing and Clinical Electrophysiology 33:4, 385-388
CrossRef169
S. A. Lubitz, P. Leong-Sit, N. Fine, D. B. Kramer, J. Singh, P. T. Ellinor. (2010) Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. European Journal of Heart Failure 12:4, 360-366
CrossRef170
C. JAN WILLEM BORLEFFS, JOEP THIJSSEN, MIHÁLY K. De BIE, JOHANNES B. Van REES, GUIDO H. Van WELSENES, LIESELOT Van ERVEN, JEROEN J. BAX, SUZANNE C. CANNEGIETER, MARTIN J. SCHALIJ. (2010) Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications. Pacing and Clinical Electrophysiologyno-no
CrossRef171
ANDREW VOIGT, ALAA SHALABY, SAMIR SABA. (2010) Continued Rise in Rates of Cardiovascular Implantable Electronic Device Infections in the United States: Temporal Trends and Causative Insights. Pacing and Clinical Electrophysiology 33:4, 414-419
CrossRef172
Beena B Johnson, Johnson Francis, Beena B Johnson. 2010. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators. .
CrossRef173
DREW ERTEL, KAVITA PHATAK, KEVIN MAKATI, MARIAN HOLLAND, SARA BAIG, MICHAEL H. KIM, MARK LINK, ROD PASSMAN. (2010) Predictors of Early Mortality in Patients Age 80 and Older Receiving Implantable Defibrillators. Pacing and Clinical Electrophysiology
CrossRef174
C. Jan Willem Borleffs, Johannes B. van Rees, Guido H. van Welsenes, Enno T. van der Velde, Lieselot van Erven, Jeroen J. Bax, Martin J. Schalij. (2010) Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 55:9, 879-885
CrossRef175
HELMUT U. KLEIN, ULF MELTENDORF, SVEN REEK, JAN SMID, SEBASTIAN KUSS, IWONA CYGANKIEWICZ, CHRISTIAN JONS, STEVEN SZYMKIEWICZ, FRANK BUHTZ, ANKE WOLLBRUECK, WOJCIECH ZAREBA, ARTHUR J. MOSS. (2010) Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD). Pacing and Clinical Electrophysiology 33:3, 353-367
CrossRef176
Rodrigo Antonini Ribeiro, Steffan Frosi Stella, Suzi Alves Camey, Leandro Ioschpe Zimerman, Maurício Pimentel, Luis Eduardo Rohde, Carísi Anne Polanczyk. (2010) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brazil: Primary Prevention Analysis in the Public Sector. Value in Health 13:2, 160-168
CrossRef177
JAMES D. DANIELS, JUSTIN SAUNDERS, SUNTHOSH PARVATHANENI, AMANDA BYRD, JOSE A. JOGLAR, OWEN OBEL. (2010) Electrocardiographic Findings, Device Therapies, and Comorbidities in Octogenarian Implantable Defibrillator Recipients. Journal of Cardiovascular Electrophysiology 21:3, 236-241
CrossRef178
SAURABH KUMAR, GOPAL SIVAGANGABALAN, MAN-CHUN CHOI, VICKI EIPPER, ARAVINDA THIAGALINGAM, PRAMESH KOVOOR. (2010) Long-Term Outcomes of Inducible Very Fast Ventricular Tachycardia (Cycle Length 200-250 ms) in Patients With Ischemic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 21:3, 262-269
CrossRef179
ANDREA NATALE, ANTONIO RAVIELE, AMIN AL-AHMAD, OTTAVIO ALFIERI, ETIENNE ALIOT, JESUS ALMENDRAL, GÜNTER BREITHARDT, JOSEP BRUGADA, HUGH CALKINS, DAVID CALLANS, RICCARDO CAPPATO, JOHN A. CAMM, PAOLO DELLA BELLA, GERARD M. GUIRAUDON, MICHEL HAÏSSAGUERRE, GERHARD HINDRICKS, SIEW YEN HO, KARL H. KUCK, FRANCIS MARCHLINSKI, DOUGLAS L. PACKER, ERIC N. PRYSTOWSKY, VIVEK Y. REDDY, JEREMY N. RUSKIN, MAURICIO SCANAVACCA, KALYANAM SHIVKUMAR, KYOKO SOEJIMA, WILLIAM J. STEVENSON, SAKIS THEMISTOCLAKIS, ATUL VERMA, DAVID WILBER, . (2010) Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation. Journal of Cardiovascular Electrophysiology 21:3, 339-379
CrossRef180
Barry J. Maron. (2010) Muerte súbita cardiaca en cardiopatías genéticas y esperanzas de prevención. Revista Española de Cardiología 63:3, 257-260
CrossRef181
Hannah Asghar, Peter S. Rahko. (2010) Quality of Heart Failure Management: A Comparison of Care Between a Comprehensive Heart Failure Program and a General Cardiology Practice. Congestive Heart Failure 16:2, 65-70
CrossRef182
Jason Bradfield, Noel G. Boyle. (2010) The paradox of ICD shocks: Sudden cardiac death prevention—Heart failure death acceleration. Heart Rhythm 7:3, 361-362
CrossRef183
J. Z. Atary, C. J. W. Borleffs, S. S. Liem, J. J. Bax, B. L. van der Hoeven, M. Bootsma, E. E. van der Wall, L. van Erven, M. J. Schalij. (2010) Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study. Europace 12:3, 378-384
CrossRef184
S. Kachboura, A. Ben Halima, M. Ben Miled. (2010) Orage rythmique secondaire à une hypokaliémie chez un patient porteur d’un défibrillateur automatique implantable. Annales de Cardiologie et d'Angéiologie 59:1, 54-58
CrossRef185
MAYURKUMAR BHAKTA, CHEDOZIE C. OBIOHA, DAN SORAJJA, KOMADOOR SRIVATHSAN, FRANCISCO A. ARABIA, PATRICK A. DEVALERIA, DAWN E. JAROSZEWSKI, LUIS R. SCOTT, GREGORY T. ALTEMOSE. (2010) Nontraditional Implantable Cardioverter Defibrillator Placement in Adult Patients with Limited Venous Access: A Case Series. Pacing and Clinical Electrophysiology 33:2, 217-225
CrossRef186
Alfred E Buxton, Kristin E Ellison, Peem Lorvidhaya, Ohad Ziv. (2010) Left Ventricular Ejection Fraction for Sudden Death Risk Stratification and Guiding ICD Implantation. Journal of Cardiovascular Pharmacology1
CrossRef187
Mithilesh K Das, Douglas P Zipes. (2010) Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention. Journal of Cardiovascular Pharmacology1
CrossRef188
Bharat K Kantharia. (2010) Cardiac arrhythmias in congestive heart failure. Expert Review of Cardiovascular Therapy 8:2, 137-140
CrossRef189
KARIN KRAAIER, PASCAL F.H.M. VAN DESSEL, JOB VAN DER PALEN, ARTHUR A.M. WILDE, MARCOEN F. SCHOLTEN. (2010) ECG Quantification of Myocardial Scar Does Not Differ between Primary and Secondary Prevention ICD Recipients with Ischemic Heart Disease. Pacing and Clinical Electrophysiology 33:2, 192-197
CrossRef190
JOGIEN H.M. HEERSCHE, NICO A. BLOM, FREEK VAN DE HEUVEL, CHRISTIAAN BLANK, ANNETTE G. REIMER, SALLY-ANN CLUR, MAARTEN WITSENBURG, A. DERK JAN TEN HARKEL. (2010) Implantable Cardioverter Defibrillator Therapy for Prevention of Sudden Cardiac Death in Children in The Netherlands. Pacing and Clinical Electrophysiology 33:2, 179-185
CrossRef191
H.-J. Trappe. (2010) Kardiale Resynchronisationstherapie bei Hochrisikopatienten mit Herzinsuffizienz der NYHA-Stadien I–II. Der Kardiologe 4:1, 23-26
CrossRef192
Aamir Cheema, Tejwant Singh, Manreet Kanwar, Karuna Chilukuri, Viqar Maria, Fareena Saleem, Katrina Johnson, John Frank, Luis Pires, Sohail Hassan. (2010) Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cardiology Research and Practice 2010, 1-6
CrossRef193
Nam-Ho Kim, Kyeong Ho Yun, Seok Kyu Oh. (2010) Sudden Cardiac Death. Journal of the Korean Medical Association 53:3, 214
CrossRef194
Naomichi Matsumoto, Koichiro Kumagai, Masahiro Ogawa, Kunihiro Matsuo, Tomoo Yasuda, Hideo Takashima, Chiharu Mitsutake, Soichi Muraoka, Akira Matsunaga, Shin-ichiro Miura, Keijiro Saku. (2010) Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator. Journal of Arrhythmia 26:2, 103-110
CrossRef195
Shepard D. Weiner, LeRoy E. Rabbani. (2010) Secondary prevention strategies for coronary heart disease. Journal of Thrombosis and Thrombolysis 29:1, 8-24
CrossRef196
Michiro Kiryu, Shinichi Niwano, Jun Kishihara, Yuya Aoyama, Shoko Ishikawa, Masami Murakami, Sayaka Kurokawa, Yoshihiro Yumoto, Ryuta Imaki, Hidehira Fukaya, Hiroe Niwano, Tohru Izumi. (2010) Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural Heart Diseases. Journal of Arrhythmia 26:4, 250-258
CrossRef197
Karl-Heinz Kuck, Anselm Schaumann, Lars Eckardt, Stephan Willems, Rodolfo Ventura, Etienne Delacrétaz, Heinz-Friedrich Pitschner, Josef Kautzner, Burghard Schumacher, Peter S Hansen. (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. The Lancet 375:9708, 31-40
CrossRef198
Jing Ai, Rong Zhang, Yue Li, Jielin Pu, Yanjie Lu, Jundong Jiao, Kang Li, Bo Yu, Zhuqin Li, Rongrong Wang, Lihong Wang, Qiang Li, Ning Wang, Hongli Shan, Zhongyu Li, Baofeng Yang. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications 391:1, 73-77
CrossRef199
D. P. Morin, L. Oikarinen, M. Viitasalo, L. Toivonen, M. S. Nieminen, S. E. Kjeldsen, B. Dahlof, M. John, R. B. Devereux, P. M. Okin. (2009) QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. European Heart Journal 30:23, 2908-2914
CrossRef200
Carsten Stoepel, Jean Boland, Rachele Busca, Gauri Saal, Mário Oliveira. (2009) Usefulness of Remote Monitoring in Cardiac Implantable Device Follow-Up. Telemedicine and e-Health 15:10, 1026-1030
CrossRef201
Beat Andreas Schaer, Michael Theodor Koller, Christian Sticherling, David Altmann, Lucas Joerg, Stefan Osswald. (2009) Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:12, 1737-1743
CrossRef202
Stavros Mountantonakis, Mathew D. Hutchinson. (2009) Who should receive an implantable cardioverter-defibrillator after myocardial infarction?. Current Heart Failure Reports 6:4, 236-244
CrossRef203
Nathaniel Hall, T Jared Bunch. (2009) Defining new risk factors for out-of-hospital cardiac arrest: A hot opportunity for discovery*. Critical Care Medicine 37:12, 3178-3179
CrossRef204
C. Adlbrecht, M. H
lsmann, M. Gwechenberger, G. Strunk, C. Khazen, F. Wiesbauer, M. Elhenicky, S. Neuhold, T. Binder, G. Maurer, I. M. Lang, R. Pacher. (2009) Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment. European Journal of Clinical Investigation 39:12, 1073-1081
CrossRef205
C. J. W. Borleffs, G. H. van Welsenes, R. J. van Bommel, E. T. van der Velde, J. J. Bax, L. van Erven, H. Putter, J. G. van der Bom, F. R. Rosendaal, M. J. Schalij. (2009) Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease. European Heart Journal
CrossRef206
M. Gasparini, C. Menozzi, A. Proclemer, M. Landolina, S. Iacopino, A. Carboni, E. Lombardo, F. Regoli, M. Biffi, V. Burrone, A. Denaro, G. Boriani. (2009) A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. European Heart Journal 30:22, 2758-2767
CrossRef207
JORGE E. SCHLIAMSER, MOEEN A. SALEEM, JEFFREY J. GOLDBERGER. (2009) Use of a Custom-Designed Adapter to Manage ICD Lead Fracture. Journal of Cardiovascular Electrophysiology 20:11, 1284-1286
CrossRef208
Axel Bauer, Petra Barthel, Alexander Müller, Kurt Ulm, Heikki Huikuri, Marek Malik, Georg Schmidt. (2009) Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. Journal of Electrocardiology 42:6, 597-601
CrossRef209
Sascha Rolf, Wilhelm Haverkamp. (2009) Grenzen und Möglichkeiten der invasiven Risikostratifikation. Herz 34:7, 528-538
CrossRef210
E. M. Kanoupakis, E. G. Manios, P. E. Vardas. (2009) Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11:11, 1434-1439
CrossRef211
Joseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas A. Burkart, William M. Miles, Jamie B. Conti, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda. (2009) Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Journal of the American College of Cardiology 54:22, 1993-2000
CrossRef212
SAMIR SABA, LAKSHMI PRASAD RAVIPATI, ANDREW VOIGT. (2009) Recent Trends in Utilization of Implantable Cardioverter-Defibrillators in Survivors of Cardiac Arrest in the United States. Pacing and Clinical Electrophysiology 32:11, 1444-1449
CrossRef213
Stuart Berger, Anwer Dhala, Joseph A. Dearani. (2009) State-of–the-Art Management of Hypertrophic Cardiomyopathy in Children. Cardiology in the Young 19:S2, 66
CrossRef214
Jeffrey J. Goldberger, Rod Passman. (2009) Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction. Journal of the American College of Cardiology 54:22, 2001-2005
CrossRef215
G. Breithardt. (2009) MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. European Heart Journal 30:21, 2551-2553
CrossRef216
Giuseppe Stabile, Assunta Iuliano, Pietro Turco, Carmine Ciardiello, Antonio De Simone. (2009) Cardiac resynchronization therapy: a review of CRT-D versus CRT-P. Future Cardiology 5:6, 567-572
CrossRef217
Brenda S. Thompson. (2009) Sudden Cardiac Death and Heart Failure. AACN Advanced Critical Care 20:4, 356-365
CrossRef218
H.-J. Trappe. (2009) 25 Jahre Defibrillatortherapie in Deutschland. Der Kardiologe 3:5, 413-424
CrossRef219
Nina Ghosh, Iqwal Mangat, Suzan S O’Donnell, Arnold Pinter, Victoria Korley, Chris Lane, Paul Dorian. (2009) Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?. Canadian Journal of Cardiology 25:10, e342-e346
CrossRef220
Byron K. Lee, Jeffery E. Olgin. (2009) Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 11:5, 360-365
CrossRef221
K. Kraaier, P. M.J. Verhorst, J. van der Palen, P. F.H.M. van Dessel, A. A.M. Wilde, M. F. Scholten. (2009) Microvolt T-wave alternans during exercise and pacing are not comparable. Europace 11:10, 1375-1380
CrossRef222
S. Thavapalachandran, D. P. Leong, M. K. Stiles, B. John, H. Dimitri, D. H. Lau, P. J. Psaltis, A. G. Brooks, M. Alasady, H. S. Lim, G. D. Young, P. Sanders. (2009) Evidence-based management of heart failure in clinical practice: a review of device-based therapy use. Internal Medicine Journal 39:10, 669-675
CrossRef223
Arthur J. Moss. (2009) QRS Duration in the Selection of Patients for Cardiac Resynchronization Therapy. Annals of Noninvasive Electrocardiology 14:4, 317-318
CrossRef224
EMILY C. SIMONS, DAVID Y. FEIGENBLUM, DMITRY NEMIROVSKY, GRANT R. SIMONS. (2009) Alert Tones Are Frequently Inaudible among Patients with Implantable Cardioverter-Defibrillators. Pacing and Clinical Electrophysiology 32:10, 1272-1275
CrossRef225
PAUL KNOPS, DOMINIC A. M. J. THEUNS, JAN C. J. RES, LUC JORDAENS. (2009) Analysis of Implantable Defibrillator Longevity Under Clinical Circumstances: Implications for Device Selection. Pacing and Clinical Electrophysiology 32:10, 1276-1285
CrossRef226
Moss, Arthur J., Hall, W. Jackson, Cannom, David S., Klein, Helmut, Brown, Mary W., Daubert, James P., Estes, N.A. Mark III, Foster, Elyse, Greenberg, Henry, Higgins, Steven L., Pfeffer, Marc A., Solomon, Scott D., Wilber, David, Zareba, Wojciech, . (2009) Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. New England Journal of Medicine 361:14, 1329-1338
Full Text227
ANDREA M. RUSSO, JOHN D. DAY, KIRA STOLEN, CHRISTOPHER M. MULLIN, VINAYAK DORAISWAMY, DARIN L. LEREW, BRIAN OLSHANSKY. (2009) Implantable Cardioverter Defibrillators: Do Women Fare Worse Than Men? Gender Comparison in the INTRINSIC RV Trial. Journal of Cardiovascular Electrophysiology 20:9, 973-978
CrossRef228
ALAN H. KADISH, DAVID BELLO, J. PAUL FINN, ROBERT O. BONOW, ANDI SCHAECHTER, HARIS SUBACIUS, CHRISTINE ALBERT, JAMES P. DAUBERT, CARISSA G. FONSECA, JEFFREY J. GOLDBERGER. (2009) Rationale and Design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial. Journal of Cardiovascular Electrophysiology 20:9, 982-987
CrossRef229
Ilknur Can, Venkatakrishna N. Tholakanahalli. (2009) Current status of implantable cardioverter-defibrillator therapy in heart failure. Current Heart Failure Reports 6:3, 199-209
CrossRef230
PIETRO FRANCIA, CRISTINA BALLA, ARIANNA UCCELLINI, RICCARDO CAPPATO. (2009) Arrhythmia Detection in Single- and Dual-Chamber Implantable Cardioverter Defibrillators: The More Leads, the Better?. Journal of Cardiovascular Electrophysiology 20:9, 1077-1082
CrossRef231
WENJIE XU, HANS J. MOORE, PAMELA E. KARASIK, MICHAEL R. FRANZ, STEVE N. SINGH, ROSS D. FLETCHER. (2009) Management Strategies When Implanted Cardioverter Defibrillator Leads Fail: Survey Findings. Pacing and Clinical Electrophysiology 32:9, 1130-1141
CrossRef232
Adam T. Hirsh, Samuel F. Sears, Jamie B. Conti. (2009) Cognitive and Behavioral Treatments for Anxiety and Depression in a Patient with an Implantable Cardioverter Defibrillator (ICD): A Case Report and Clinical Discussion. Journal of Clinical Psychology in Medical Settings 16:3, 270-279
CrossRef233
Weiwei Li, Brian Olshansky. (2009) Electrophysiological device therapy (implantable defibrillators) in older adults. Current Cardiovascular Risk Reports 3:5, 347-354
CrossRef234
YEN-HUNG LIN, LIAN-YU LIN, YING-SHREN CHEN, HUI-CHUN HUANG, JEN-KUANG LEE, YI-LWUN HO, LIN-CHU LIAO, WEN-JONE CHEN. (2009) The Association between T-Wave Morphology and Life-Threatening Ventricular Tachyarrhythmias in Patients with Congestive Heart Failure. Pacing and Clinical Electrophysiology 32:9, 1173-1177
CrossRef235
Andrew E. Epstein. (2009) Update on primary prevention implantable cardioverter-defibrillator therapy. Current Cardiology Reports 11:5, 335-342
CrossRef236
Andrea Colella, Marzia Giaccardi, Raffaele Molino Lova, Carmine Liccardi, Gian Franco Gensini. (2009) Ventricular tachycardia inducibility after radiofrequency ablation affects the outcomes in patients with coronary artery disease and implantable cardioverter-defibrillators: The role of left ventricular function. Journal of Interventional Cardiac Electrophysiology 25:3, 229-234
CrossRef237
Florian Streitner, Juergen Kuschyk, Christian Veltmann, Desiree Ratay, Nina Schoene, Ines Streitner, Martina Brueckmann, Burghard Schumacher, Martin Borggrefe, Christian Wolpert. (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:3, 166-172
CrossRef238
Robert J. Myerburg, Vivek Reddy, Agustin Castellanos. (2009) Indications for Implantable Cardioverter-Defibrillators Based on Evidence and Judgment. Journal of the American College of Cardiology 54:9, 747-763
CrossRef239
Tetsuo Sasano, Kamilla Kelemen, Ian D. Greener, J. Kevin Donahue. (2009) Ventricular tachycardia from the healed myocardial infarction scar: Validation of an animal model and utility of gene therapy. Heart Rhythm 6:8, S91-S97
CrossRef240
, J. Vijgen, G. Botto, J. Camm, C.-J. Hoijer, W. Jung, J.-Y. Le Heuzey, A. Lubinski, T. M. Norekval, M. Santomauro, M. Schalij, J.-P. Schmid, P. Vardas. (2009) Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11:8, 1097-1107
CrossRef241
Sébastien Knecht, Frédéric Sacher, Matthew Wright, Mélèze Hocini, Akihiko Nogami, Thomas Arentz, Bertrand Petit, Robert Franck, Christian De Chillou, Dominique Lamaison, Jéronimo Farré, Thomas Lavergne, Thierry Verbeet, Isabelle Nault, Seiichiro Matsuo, Lionel Leroux, Rukshen Weerasooriya, Bruno Cauchemez, Nicolas Lellouche, Nicolas Derval, Sanjiv M. Narayan, Pierre Jaïs, Jacques Clementy, Michel Haïssaguerre. (2009) Long-Term Follow-Up of Idiopathic Ventricular Fibrillation Ablation. Journal of the American College of Cardiology 54:6, 522-528
CrossRef242
JONATHAN P. PICCINI, GAIL E. HAFLEY, KERRY L. LEE, JOHN D. FISHER, MARK E. JOSEPHSON, ERIC N. PRYSTOWSKY, ALFRED E. BUXTON, . (2009) Mode of Induction of Ventricular Tachycardia and Prognosis in Patients with Coronary Disease: The Multicenter UnSustained Tachycardia Trial (MUSTT). Journal of Cardiovascular Electrophysiology 20:8, 850-855
CrossRef243
E. Marijon, S. Boveda, N. Combes, J.-P. Albenque, J.-Y. Le Heuzey. (2009) Comment évaluer le risque de mort subite dans les suites d’un infarctus du myocarde ?. Annales de Cardiologie et d'Angéiologie 58:4, 220-225
CrossRef244
Giovanni Lucignani. (2009) Metaiodobenzylguanidine (mIBG) molecular imaging in implantable cardioverter defibrillator (ICD) therapy planning: a health technology assessment issue. European Journal of Nuclear Medicine and Molecular Imaging 36:8, 1346-1350
CrossRef245
Larisa G. Tereshchenko, Mitchell N. Faddis, Barry J. Fetics, Karl E. Zelik, Igor R. Efimov, Ronald D. Berger. (2009) Transient Local Injury Current in Right Ventricular Electrogram After Implantable Cardioverter-Defibrillator Shock Predicts Heart Failure Progression. Journal of the American College of Cardiology 54:9, 822-828
CrossRef246
S. Genovesi, M. G. Valsecchi, E. Rossi, D. Pogliani, I. Acquistapace, V. De Cristofaro, A. Stella, A. Vincenti. (2009) Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrology Dialysis Transplantation 24:8, 2529-2536
CrossRef247
Akli Otmani, Ludovic Trinquart, Eloi Marijon, Thomas Lavergne, Xavier Waintraub, Antoine Lepillier, Gilles Chatellier, Jean-Yves Le Heuzey. (2009) Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: Results from the EVADEF cohort study. American Heart Journal 158:2, 230-237.e1
CrossRef248
DAVID FOO, BRUCE D. WALKER, DENNIS L. KUCHAR, CHARLES W. THORBURN, ANDRE TAY, CHRISTOPHER S. HAYWARD, PETER MACDONALD, ANNE KEOGH, EUGENE KOTLYAR, PHILIP SPRATT, PAUL JANSZ. (2009) Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series. Pacing and Clinical Electrophysiology 32:7, 879-887
CrossRef249
Komandoor Srivathsan, Daniel WC Ng, Farouk Mookadam. (2009) Ventricular tachycardia and ventricular fibrillation. Expert Review of Cardiovascular Therapy 7:7, 801-809
CrossRef250
M. K. de Bie, B. van Dam, A. Gaasbeek, M. van Buren, L. van Erven, J. J. Bax, M. J. Schalij, T. J. Rabelink, J. W. Jukema. (2009) The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. European Heart Journal 30:13, 1559-1564
CrossRef251
CHARLES I. BERUL. (2009) Implantable Cardioverter Defibrillator Criteria for Primary and Secondary Prevention of Pediatric Sudden Cardiac Death. Pacing and Clinical Electrophysiology 32, S67-S70
CrossRef252
SJOERD A. MOLLEMA, PATRICK KLEIN, JOGIEN HEERSCHE, MARTIN J. SCHALIJ, ERNST E. VAN DER WALL, MICHEL I.M. VERSTEEGH, ROBERT J.M. KLAUTZ, LIESELOT VAN ERVEN, JEROEN J. BAX. (2009) Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction. Pacing and Clinical Electrophysiology 32:7, 913-917
CrossRef253
Wenwen Li, Crystal M. Ripplinger, Qing Lou, Igor R. Efimov. (2009) Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. Heart Rhythm 6:7, 1020-1027
CrossRef254
Andreas Wolfgang Schoenenberger, Richard Kobza, Peiman Jamshidi, Michel Zuber, Antonio Abbate, Andreas Ernst Stuck, Matthias Pfisterer, Paul Erne. (2009) Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). The American Journal of Cardiology 104:2, 158-163
CrossRef255
Carlo Briguori, Tiziana Claudia Aranzulla, Flavio Airoldi, John Cosgrave, Davide Tavano, Iassen Michev, Matteo Montorfano, Mauro Carlino, Alfredo Castelli, Massimo Giuseppe Sangiorgi, Antonio Colombo. (2009) Stent implantation in patients with severe left ventricular systolic dysfunction. International Journal of Cardiology 135:3, 376-384
CrossRef256
ANGELO BIVIANO, DONNA MANCINI, YOSHIFUMI NAKA, JERRY ARELLANO, HASAN GARAN. (2009) Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable. Pacing and Clinical Electrophysiology 32:7, 945-948
CrossRef257
MAULLY J. SHAH. (2009) Implantable Cardioverter Defibrillator-Related Complications in the Pediatric Population. Pacing and Clinical Electrophysiology 32, S71-S74
CrossRef258
Paul Khairy, Annie Dore, Nancy Poirier, François Marcotte, Reda Ibrahim, François-Pierre Mongeon, Lise-Andrée Mercier. (2009) Risk stratification in surgically repaired tetralogy of Fallot. Expert Review of Cardiovascular Therapy 7:7, 755-762
CrossRef259
Frank Grothues, Ruediger Braun-Dullaeus. (2009) Serial Assessment of Ventricular Morphology and Function. Heart Failure Clinics 5:3, 301-314
CrossRef260
William H. Maisel, Robert G. Hauser, Stephen C. Hammill, Robert G. Hauser, Kenneth A. Ellenbogen, Andrew E. Epstein, David L. Hayes, Joseph S. Alpert, Ronald D. Berger, Anne B. Curtis, Anne M. Dubin, N.A. Mark Estes, Melanie T. Gura, Andrew D. Krahn, Rachel Lampert, Bruce D. Lindsay, Bruce L. Wilkoff. (2009) Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines. Heart Rhythm 6:6, 869-885
CrossRef261
MOHAMAD A. ALAITI, ANJLI MAROO, THOMAS B. EDEL. (2009) Troponin Levels after Cardiac Electrophysiology Procedures: Review of the Literature. Pacing and Clinical Electrophysiology 32:6, 800-810
CrossRef262
C. Cevik, A. Perez-Verdia, K. Nugent. (2009) Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11:6, 710-715
CrossRef263
M. R. Cowie, D. Marshall, M. Drummond, N. Ferko, M. Maschio, M. Ekman, L. de Roy, H. Heidbuchel, Y. Verboven, F. Braunschweig, C. Linde, G. Boriani. (2009) Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace 11:6, 716-726
CrossRef264
M. Meine, T. Smith, R. N.W. Hauer. (2009) The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?. Europace 11:6, 689-691
CrossRef265
Markus Stühlinger, Florian Hintringer, Thomas Berger. (2009) Palpitationen beim Leistungssportler. Herz 34:4, 315-322
CrossRef266
Massimo Santini, Riccardo Cappato, Dietrich Andresen, Johannes Brachmann, D. Wyn Davies, John Cleland, Alessandro Filippi, Edoardo Gronda, Richard Hauer, Gerhard Steinbeck, David Steinhaus. (2009) Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator. Journal of Interventional Cardiac Electrophysiology 25:1, 83-88
CrossRef267
Derek V. Exner. (2009) Noninvasive risk stratification after myocardial infarction: Rationale, current evidence and the need for definitive trials. Canadian Journal of Cardiology 25, 21A-27A
CrossRef268
Wilbert S. Aronow. (2009) Treatment of Ventricular Arrhythmias in the Elderly. Cardiology in Review 17:3, 136-146
CrossRef269
STEFANO BIANCHI, RENATO P. RICCI, FRANCESCO BISCIONE, FABRIZIO SGRECCIA, NATALE DI BELARDINO, PIETRO ROSSI, SILVIA GIULI, ANDREA GRAMMATICO, TIZIANA DE SANTO, ELISABETTA SANTI, MONICA MERICO, GIANFRANCO PICCIRILLO, PAOLO AZZOLINI, MASSIMO SANTINI, ANDREA PUGLISI. (2009) Primary Prevention Implantation of Cardioverter Defibrillator without Defibrillation Threshold Testing: 2-Year Follow-up. Pacing and Clinical Electrophysiology 32:5, 573-578
CrossRef270
Daniel R. Frisch, Evaldas Giedrimas, Satishkumar Mohanavelu, Amy Shui, Kalon K.L. Ho, C. Michael Gibson, Mark E. Josephson, Peter J. Zimetbaum. (2009) Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction. The American Journal of Cardiology 103:9, 1206-1209
CrossRef271
D. R. Tomlinson, Y. Bashir, T. R. Betts, K. Rajappan. (2009) Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11:5, 638-642
CrossRef272
Christopher R. Ellis, Jeffrey N. Rottman. (2009) Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads. Heart Rhythm 6:5, 619-624
CrossRef273
Maria A. Castel, Herbert Nägele. (2009) Sudden Cardiac Arrest in Patients With Severe Nonischemic Heart Failure: Risk Stratification With the Heart Failure Survival Score. Congestive Heart Failure 15:3, 112-116
CrossRef274
Fanny Jacq, Gael Foulldrin, Arnaud Savouré, Frédéric Anselme, Audrey Baguelin-Pinaud, Alain Cribier, Florence Thibaut. (2009) A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. General Hospital Psychiatry 31:3, 266-273
CrossRef275
Amy S. Kelley, M. Carrington Reid, David H. Miller, Joseph J. Fins, Mark S. Lachs. (2009) Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey. American Heart Journal 157:4, 702-708.e1
CrossRef276
ALESSANDRO PROCLEMER, MARCO GHIDINA, DOMENICO FACCHIN, LUCA REBELLATO, DOMENICO CORRADO, MAURIZIO GASPARINI, DARIO GREGORI. (2009) Use of Implantable Cardioverter-Defibrillator in Inherited Arrhythmogenic Diseases: Data from Italian ICD Registry for the Years 2001-6. Pacing and Clinical Electrophysiology 32:4, 434-445
CrossRef277
Kristian B. Filion, Xuanqian Xie, Charlotte J. van der Avoort, Nandini Dendukuri, James M. Brophy. (2009) Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study. International Journal of Technology Assessment in Health Care 25:02, 151
CrossRef278
Iwona Cygankiewicz, John Gillespie, Wojciech Zareba, Mary W. Brown, Ilan Goldenberg, Helmut Klein, Scott McNitt, Slava Polonsky, Mark Andrews, Edward M. Dwyer, W. Jackson Hall, Arthur J. Moss. (2009) Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 6:4, 468-473
CrossRef279
GRZEGORZ PIETRASIK, ILAN GOLDENBERG, SCOTT McNITT, BRONISLAVA POLONSKY, ARTHUR J. MOSS, WOJCIECH ZAREBA. (2009) Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 20:4, 395-400
CrossRef280
DAVID LAWRENCE, NICHOLAS VON BERGEN, IAN H. LAW, DAVID J. BRADLEY, MACDONALD DICK II, PATRICIO A. FRIAS, MARGARET J. STREIPER, PETER S. FISCHBACH. (2009) Inappropriate ICD Discharges in Single-Chamber Versus Dual-Chamber Devices in the Pediatric and Young Adult Population. Journal of Cardiovascular Electrophysiology 20:3, 287-290
CrossRef281
Bruce L. Wilkoff, Peter J. Kudenchuk, Alfred E. Buxton, Arjun Sharma, James R. Cook, Anil K. Bhandari, Michael Biehl, Gery Tomassoni, Anna Leonen, Linette R. Klevan, Alfred P. Hallstrom. (2009) The DAVID (Dual Chamber and VVI Implantable Defibrillator) II Trial. Journal of the American College of Cardiology 53:10, 872-880
CrossRef282
JASON BRADFIELD, ALBERTA WARNER, MALCOLM M. BERSOHN. (2009) Low Referral Rate for Prophylactic Implantation of Cardioverter-Defibrillators in a Tertiary Care Medical Center. Pacing and Clinical Electrophysiology 32, S194-S197
CrossRef283
Paul S. Chan, John D. Birkmeyer, Harlan M. Krumholz, John A. Spertus, Brahmajee K. Nallamothu. (2009) Racial and Gender Trends in the Use of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries Between 1997 and 2003. Congestive Heart Failure 15:2, 51-57
CrossRef284
Guy Amit, Otto Costantini, David S. Rosenbaum. (2009) Can we alternate between T-wave alternans testing methods?. Heart Rhythm 6:3, 338-340
CrossRef285
Mishi Bhushan, Samuel J. Asirvatham. (2009) The conundrum of ventricular arrhythmia and cardiomyopathy: Which abnormality came first?. Current Heart Failure Reports 6:1, 7-13
CrossRef286
Rahul Sakhuja, Mary Keebler, Tai-Shuan Lai, Cara McLaughlin Gavin, Ranjan Thakur, Deepak L. Bhatt. (2009) Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator. The American Journal of Cardiology 103:5, 735-741
CrossRef287
Michael J. Mirro. (2009) Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice. Heart Rhythm 6:3, S45-S48
CrossRef288
Christina M. Holmgren, Britta M. Nyström, Thomas K. Karlsson, Johan D. Herlitz, Nils G. Edvardsson. (2009) Presumed arrhythmic death in consecutive survivors of acute myocardial infarction – implications for primary implantable cardioverter defibrillator implantation. Coronary Artery Disease 20:2, 155-162
CrossRef289
Jeffrey J. Goldberger. (2009) Evidence-based analysis of risk factors for sudden cardiac death. Heart Rhythm 6:3, S2-S7
CrossRef290
A. Bauer, P. Barthel, R. Schneider, K. Ulm, A. Muller, A. Joeinig, R. Stich, A. Kiviniemi, K. Hnatkova, H. Huikuri, A. Schomig, M. Malik, G. Schmidt. (2009) Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). European Heart Journal 30:5, 576-583
CrossRef291
Vikas Kuriachan, Derek V. Exner. (2009) Role of risk stratification after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 11:1, 10-21
CrossRef292
Gregory K. Feld, Paul Clopton. (2009) Comparability of Noninvasive Microvolt T-Wave Alternans Versus Invasive Ventricular Programmed Stimulation to Guide Implantable Cardioverter-Defibrillator Implantation in Patients at Risk of Sudden Death
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 53:6, 480-482
CrossRef293
SILVIA G. PRIORI, ANGELO AURICCHIO, SEAH NISAM, PATRICK YONG. (2009) To Replace or Not to Replace: A Systematic Approach to Respond to Device Advisories. Journal of Cardiovascular Electrophysiology 20:2, 164-170
CrossRef294
Mithilesh Das. (2009) Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Expert Review of Cardiovascular Therapy 7:2, 181-195
CrossRef295
Otto Costantini, Stefan H. Hohnloser, Malcolm M. Kirk, Bruce B. Lerman, James H. Baker, Barathi Sethuraman, Mary M. Dettmer, David S. Rosenbaum. (2009) The ABCD (Alternans Before Cardioverter Defibrillator) Trial. Journal of the American College of Cardiology 53:6, 471-479
CrossRef296
James F. Neuenschwander. (2009) Cardiac Devices in Emergency Department Heart Failure Patients. Heart Failure Clinics 5:1, 63-73
CrossRef297
Melanie Hauck, Alexander Bauer, Frederik Voss, Slawomir Weretka, Hugo A. Katus, Ruediger Becker. (2009) “Home monitoring” for early detection of implantable cardioverter-defibrillator failure. Clinical Research in Cardiology 98:1, 19-24
CrossRef298
Doo Sun Sim, Myung Ho Jeong, Song Choi, Nam Sik Yoon, Hyun Ju Yoon, Jae Youn Moon, Young Joon Hong, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2009) Myocardial Infarction in a Young Man due to a Hypoplastic Coronary Artery. Korean Circulation Journal 39:4, 163
CrossRef299
Samer H. Sayyed, Mark M. Cassidy, M. Azam Hadi. (2009) Use of multidetector computed tomography for evaluation of global and regional left ventricular function. Journal of Cardiovascular Computed Tomography 3:1, S23-S34
CrossRef300
Fabian J. Arnaldo, Nikolaos Anatoliotakis, Carlos Palacio, David R. Nabert, Steve S. Hsu. (2009) Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies. Heart & Lung: The Journal of Acute and Critical Care 38:1, 10-16
CrossRef301
Massimo Santini, Renato P. Ricci, Maurizio Lunati, Maurizio Landolina, Giovanni B. Perego, Maurizio Marzegalli, Milena Schirru, Chiara Belvito, Roberto Brambilla, Giuseppe Guenzati, Serena Gilardi, Sergio Valsecchi. (2009) Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. Journal of Interventional Cardiac Electrophysiology 24:1, 53-61
CrossRef302
S. Valk, L. Jordaens. (2008) Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction. Europace 11:4, 407-408
CrossRef303
M. Santini, M. Russo, G. Botto, M. Lunati, A. Proclemer, B. Schmidt, A. Erdogan, E. Helmling, W. Rauhe, M. Desaga, E. Santi, M. Messier, G. Boriani. (2008) Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 11:4, 476-482
CrossRef304
RONG BAI, LUIGI DI BIASE, CLAUDE ELAYI, CHI KEONG CHING, CONOR BARRETT, KAREN PHILIPPS, PASCAL LIM, DIMPI PATEL, TOM CALLAHAN, DAVID O. MARTIN, MAURICIO ARRUDA, ROBERT A. SCHWEIKERT, WALID I. SALIBA, BRUCE WILKOFF, ANDREA NATALE. (2008) Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors. Journal of Cardiovascular Electrophysiology 19:12, 1259-1265
CrossRef305
Antonio Curnis, Giosue Mascioli, Luca Bontempi, Manuel Cerini, Tommaso Bignotti, Gabriele Bonetti, Livio Dei Cas. (2008) Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience. Journal of Cardiovascular Medicine 9:12, 1241-1245
CrossRef306
Michael J. Root. (2008) Implantable Cardiac Rhythm Device Batteries. Journal of Cardiovascular Translational Research 1:4, 254-257
CrossRef307
Alfred P. Hallstrom, D. George Wyse, John McAnulty, . (2008) Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. Journal of Interventional Cardiac Electrophysiology 23:3, 159-166
CrossRef308
(2008) Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008). Revista Española de Cardiología 61:12, 1329.e1-1329.e70
CrossRef309
ILAN GOLDENBERG, ARTHUR J. MOSS. (2008) Implantable Cardioverter Defibrillator Efficacy and Chronic Kidney Disease: Competing Risks of Arrhythmic and Nonarrhythmic Mortality. Journal of Cardiovascular Electrophysiology 19:12, 1281-1283
CrossRef310
LAUREN D. VAZQUEZ, EMILY A. KUHL, JULIE BISHOP SHEA, ANN KIRKNESS, JIM LEMON, DAVID WHALLEY, JAMIE B. CONTI, SAMUEL F. SEARS. (2008) Age-Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study. Pacing and Clinical Electrophysiology 31:12, 1528-1534
CrossRef311
Lorne J. Gula, George J. Klein, Anne S. Hellkamp, David Massel, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, Jill Anderson, George W. Johnson, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy. (2008) Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 156:6, 1196-1200
CrossRef312
Myerburg, Robert J., . (2008) Implantable Cardioverter–Defibrillators after Myocardial Infarction. New England Journal of Medicine 359:21, 2245-2253
Full Text313
Theodore Chow, Dean J. Kereiakes, John Onufer, Alan Woelfel, Sinan Gursoy, Brett J. Peterson, Mark L. Brown, Wenji Pu, David G. Benditt. (2008) Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias in Patients With Ischemic Cardiomyopathy and Prophylactic Defibrillators?. Journal of the American College of Cardiology 52:20, 1607-1615
CrossRef314
Maurizio Gasparini, Maurizio Lunati, Maurizio Landolina, Massimo Santini, Luigi Padeletti, Gianni Perego, Antonio Vincenti, Antonio Curnis, Angelo Carboni, Alessandra Denaro, Alessia Spotti, Andrea Grammatico, François Regoli, Giuseppe Boriani. (2008) Electrical storm in patients with biventricular implantable cardioverter defibrillator: Incidence, predictors, and prognostic implications. American Heart Journal 156:5, 847-854
CrossRef315
Rüdiger Dissmann, Wolfram Kamke, Rona Reibis, Joachim Herbstleb, Karl Wegscheider, Heinz Völler. (2008) Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction. International Journal of Cardiology 130:3, 438-443
CrossRef316
Rajesh Subbiah, Lorne J. Gula, George J. Klein, Allan C. Skanes, James White, Raymond Yee, Andrew D. Krahn. (2008) Workup of the Cardiac Arrest Survivor. Progress in Cardiovascular Diseases 51:3, 195-203
CrossRef317
MICHAEL O SWEENEY, ANNE S HELLKAMP, KENNETH A ELLENBOGEN, GERVASIO A LAMAS. (2008) Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease. Journal of Cardiovascular Electrophysiology 19:11, 1160-1166
CrossRef318
Sumeet S. Chugh, Kyndaron Reinier, Carmen Teodorescu, Audrey Evanado, Elizabeth Kehr, Mershed Al Samara, Ronald Mariani, Karen Gunson, Jonathan Jui. (2008) Epidemiology of Sudden Cardiac Death: Clinical and Research Implications. Progress in Cardiovascular Diseases 51:3, 213-228
CrossRef319
FELIX YANG, BINDI SHAH, SEI IWAI, STEVEN M. MARKOWITZ, BRUCE B. LERMAN, KENNETH M. STEIN. (2008) ICD Implantation and Arrhythmia-Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease. Pacing and Clinical Electrophysiology 31:11, 1419-1424
CrossRef320
John P. Boehmer, Mark D. Carlson, Teresa Marco, Brian E. Jaski, Steven L. Higgins, Charles Kennergren, Andrew E. Epstein. (2008) Adjudication of mortality events in a heart failure–arrhythmia trial by a multiparameter descriptive method: Comparison with methods used in heart failure trials and methods used in arrhythmia trials. Journal of Interventional Cardiac Electrophysiology 23:2, 101-110
CrossRef321
LIANG TANG. (2008) Combination Antiarrhythmic Therapy: 1 + 1>2?. Journal of Cardiovascular Electrophysiology 19:10, 1098-1100
CrossRef322
Sanjeev Saksena, Rangadham Nagarakanti. (2008) The future of implantable defibrillator and cardiac resynchronization therapy trials. Journal of Interventional Cardiac Electrophysiology 23:1, 29-39
CrossRef323
Sana M. Al-Khatib, Gillian D. Sanders, Mark Carlson, Aida Cicic, Anne Curtis, Gregg C. Fonarow, Peter W. Groeneveld, David Hayes, Paul Heidenreich, Daniel Mark, Eric Peterson, Eric N. Prystowsky, Philip Sager, Marcel E. Salive, Kevin Thomas, Clyde W. Yancy, Wojciech Zareba, Douglas Zipes. (2008) Preventing tomorrow's sudden cardiac death today. American Heart Journal 156:4, 613-622
CrossRef324
SANA M AL-KHATIB, ANNE S. HELLKAMP, KERRY L LEE, JILL ANDERSON, JEANNE E. POOLE, DANIEL B. MARK, GUST H. BARDY, . (2008) Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Journal of Cardiovascular Electrophysiology 19:10, 1059-1065
CrossRef325
Ian N. Sabir, Juliet A. Usher-Smith, Christopher L.-H. Huang, Andrew A. Grace. (2008) Risk stratification for sudden cardiac death. Progress in Biophysics and Molecular Biology 98:2-3, 340-346
CrossRef326
, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442
CrossRef327
Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Heart Rhythm 5:10, e1-e21
CrossRef328
BARRY J. MARON, PAOLO SPIRITO. (2008) Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 19:10, 1118-1126
CrossRef329
J. Tebbenjohanns, S. Willems, M. Antz, D. Pfeiffer, K.-H. Seidl, T. Lewalter. (2008) Kommentar zu den „ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary“. Der Kardiologe 2:5, 363-388
CrossRef330
S. Sherazi, J. P. Daubert, R. C. Block, V. Jeevanantham, K. Abdel-Gadir, M. R. DiSalle, J. M. Haley, A. H. Shah. (2008) Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator. Mayo Clinic Proceedings 83:10, 1139-1141
CrossRef331
Mark, Daniel B., Anstrom, Kevin J., Sun, Jie L., Clapp-Channing, Nancy E., Tsiatis, Anastasios A., Davidson-Ray, Linda, Lee, Kerry L., Bardy, Gust H., . (2008) Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure. New England Journal of Medicine 359:10, 999-1008
Full Text332
Jeffrey J. Goldberger, Michael E. Cain, Stefan H. Hohnloser, Alan H. Kadish, Bradley P. Knight, Michael S. Lauer, Barry J. Maron, Richard L. Page, Rod S. Passman, David Siscovick, William G. Stevenson, Douglas P. Zipes. (2008) American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1179-1199
CrossRef333
Kenneth M. Stein. (2008) Noninvasive Risk Stratification for Sudden Death: Signal-Averaged Electrocardiography, Nonsustained Ventricular Tachycardia, Heart Rate Variability, Baroreflex Sensitivity, and QRS Duration. Progress in Cardiovascular Diseases 51:2, 106-117
CrossRef334
Karen E. Thomas, Mark E. Josephson. (2008) The Role of Electrophysiology Study in Risk Stratification of Sudden Cardiac Death. Progress in Cardiovascular Diseases 51:2, 97-105
CrossRef335
Roderick Tung, Peter Zimetbaum, Mark E. Josephson. (2008) A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 52:14, 1111-1121
CrossRef336
Andrew D. Krahn, Jeffrey S. Hoch, Marie Antoinette Rockx, Peter Leong-Sit, Lorne J. Gula, Raymond Yee, Allan C. Skanes, George J. Klein. (2008) Cost of Preimplantation Cardiac Imaging in Patients Referred for a Primary-Prevention Implantable Cardioverter-Defibrillator. The American Journal of Cardiology 102:5, 588-592
CrossRef337
Paul Dorian, Hussein R. Al-Khalidi, Stefan H. Hohnloser, Jose M. Brum, Preston M. Dunnmon, Craig M. Pratt, Michael J. Holroyde, Peter Kowey. (2008) Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial. Journal of the American College of Cardiology 52:13, 1076-1083
CrossRef338
Suhny Abbara, Benjamin J.W. Chow, Antonio J. Pena, Ricardo C. Cury, Udo Hoffmann, Koen Nieman, Thomas J. Brady. (2008) Assessment of left ventricular function with 16- and 64-slice multi-detector computed tomography. European Journal of Radiology 67:3, 481-486
CrossRef339
Lutz Frankenstein, Christian Zugck, Manfred Nelles, Dieter Schellberg, Andrew Remppis, Hugo Katus. (2008) Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials. Clinical Research in Cardiology 97:9, 594-600
CrossRef340
M. Biffi, M. Ziacchi, M. Bertini, D. Sangiorgi, D. Corsini, C. Martignani, I. Diemberger, G. Boriani. (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:11, 1288-1295
CrossRef341
S. Tzeis, G. Andrikopoulos, C. Kolb, P. E. Vardas. (2008) Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 10:11, 1256-1265
CrossRef342
C. N. Pellegrini, K. Lee, J. E. Olgin, M. P. Turakhia, Z. H. Tseng, R. Lee, N. Badhwar, B. Lee, P. D. Varosy. (2008) Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace 10:11, 1296-1301
CrossRef343
L. Ding, W. Hua, H. Niu, K. Chen, S. Zhang. (2008) Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10:9, 1034-1041
CrossRef344
Michael R. Rosen, Peter R. Brink, Ira S. Cohen, Peter Danilo, Richard B. Robinson, Amy B. Rosen, Matthias J. Szabolcs. (2008) Regenerative therapies in electrophysiology and pacing. Journal of Interventional Cardiac Electrophysiology 22:2, 87-98
CrossRef345
Deepak Bhakta, Lynne D. Foreman. (2008) Cosmic radiation: Not science fiction, but clinical reality. Heart Rhythm 5:8, 1204-1205
CrossRef346
Harvey D White, Derek P Chew. (2008) Acute myocardial infarction. The Lancet 372:9638, 570-584
CrossRef347
J. Rosenberg, M. Schou, F. Gustafsson, J. Badskjaer, P. Hildebrandt. (2008) Prognostic threshold levels of NT-proBNP testing in primary care. European Heart Journal 30:1, 66-73
CrossRef348
Charles A. Herzog, J. Michael Mangrum, Rod Passman. (2008) NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients. Seminars in Dialysis 21:4, 300-307
CrossRef349
Ronni Levy, Andrea DellaValle, A. Serdar Atav, Afazal ur Rehman, Allan H. Sklar, Nicolas J. Stamato. (2008) The Relationship Between Glomerular Filtration Rate and Survival in Patients Treated with an Implantable Cardioverter Defibrillator. Clinical Cardiology 31:6, 265-269
CrossRef350
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N. A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 5:6, e1-e62
CrossRef351
J. Philip Saul, Andrew E. Epstein, Michael J. Silka, Charles I. Berul, MacDonald Dick, John P. DiMarco, Richard A. Friedman, Eric Rosenthal, Elizabeth A. Stephenson, Victoria L. Vetter. (2008) Heart Rhythm Society/Pediatric and Congenital Electrophysiology Society Clinical Competency Statement: Training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. Heart Rhythm 5:6, 926-933
CrossRef352
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Heart Rhythm 5:6, 934-955
CrossRef353
Grace Lin, Ryan A. Meverden, David O. Hodge, Daniel Z. Uslan, David L. Hayes, Peter A. Brady. (2008) Age and gender trends in implantable cardioverter defibrillator utilization: A population based study. Journal of Interventional Cardiac Electrophysiology 22:1, 65-70
CrossRef354
Tetsuo Sasano, M. Roselle Abraham, Kuan-Cheng Chang, Hiroshi Ashikaga, Kevin J. Mills, Daniel P. Holt, John Hilton, Stephan G. Nekolla, Jun Dong, Albert C. Lardo, Henry Halperin, Robert F. Dannals, Eduardo Marbán, Frank M. Bengel. (2008) Abnormal Sympathetic Innervation of Viable Myocardium and the Substrate of Ventricular Tachycardia After Myocardial Infarction. Journal of the American College of Cardiology 51:23, 2266-2275
CrossRef355
Ganesh S. Kamath, Suneet Mittal. (2008) The Role of Antiarrhythmic Drug Therapy for the Prevention of Sudden Cardiac Death. Progress in Cardiovascular Diseases 50:6, 439-448
CrossRef356
Ilan Goldenberg, Arthur J. Moss. (2008) Implantable Device Therapy. Progress in Cardiovascular Diseases 50:6, 449-474
CrossRef357
Sandeep Goyal, Sujeeth R. Punnam. (2008) Noninvasive Risk Assessment Early After a Myocardial Infarction. Journal of the American College of Cardiology 51:19, 1910
CrossRef358
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Journal of the American College of Cardiology 51:21, e1-e62
CrossRef359
Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, Michael O. Sweeney. (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. Journal of the American College of Cardiology 51:21, 2085-2105
CrossRef360
Harvinder Singh Arora, Pranav Loyalka, Biswajit Kar, Reynolds Delgado. (2008) Devices for Heart Failure: The Future Is Now. Congestive Heart Failure 14:3, 141-148
CrossRef361
Melvin M. Scheinman, Edmund Keung. (2008) The Year in Review of Clinical Cardiac Electrophysiology. Journal of the American College of Cardiology 51:21, 2075-2081
CrossRef362
Maria Teresa La Rovere, Gian Domenico Pinna, Grzegorz Raczak. (2008) Baroreflex Sensitivity: Measurement and Clinical Implications. Annals of Noninvasive Electrocardiology 13:2, 191-207
CrossRef363
Charles I. Berul, George F. Van Hare, Naomi J. Kertesz, Anne M. Dubin, Frank Cecchin, Kathryn K. Collins, Bryan C. Cannon, Mark E. Alexander, John K. Triedman, Edward P. Walsh, Richard A. Friedman. (2008) Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients. Journal of the American College of Cardiology 51:17, 1685-1691
CrossRef364
Matthew Jolley, Jeroen Stinstra, Steve Pieper, Rob MacLeod, Dana H. Brooks, Frank Cecchin, John K. Triedman. (2008) A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm 5:4, 565-572
CrossRef365
Wolfram Grimm. (2008) Outcomes of elderly heart failure recipients of ICD and CRT. International Journal of Cardiology 125:2, 154-160
CrossRef366
Michael T. Koller, Theo Stijnen, Ewout W. Steyerberg, Jacobus Lubsen. (2008) Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios. Journal of Clinical Epidemiology 61:4, 365-372
CrossRef367
Dominic A.M.J. Theuns, Maximo Rivero-Ayerza, Erik Boersma, Luc Jordaens. (2008) Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. International Journal of Cardiology 125:3, 352-357
CrossRef368
Abeel A. Mangi. (2008) Invited Commentary. The Annals of Thoracic Surgery 85:4, 1281-1282
CrossRef369
Ayman El-Menyar, Nidal Asaad. (2008) T-Wave Alternans and Sudden Cardiac Death. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 7:1, 21-28
CrossRef370
Joseph B. Thibodeau, Jayasree Pillarisetti, Taiyeb M. Khumri, Philip G. Jones, Michael L. Main. (2008) Mortality Rates and Clinical Predictors of Reduced Survival After Cardioverter Defibrillator Implantation. The American Journal of Cardiology 101:6, 861-864
CrossRef371
Steven M Hollenberg. 2008. Management of Complications. , 280-299.
CrossRef372
Damian P. Redfearn. (2008) Non-Gaussian index: Hope yet for the grail seekers?. Heart Rhythm 5:2, 269-270
CrossRef373
Arnt V. Kristen, Thomas J. Dengler, Ute Hegenbart, Stefan O. Schonland, Hartmut Goldschmidt, Falk-Udo Sack, Frederik Voss, Rüdiger Becker, Hugo A. Katus, Alexander Bauer. (2008) Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm 5:2, 235-240
CrossRef374
RYAN ANTHONY, JAMES P. DAUBERT, WOJCIECH ZAREBA, MARK L. ANDREWS, SCOTT McNITT, ETHAN LEVINE, DAVID T. HUANG, W. JACKSON HALL, ARTHUR J. MOSS, . (2008) Mechanisms of Ventricular Fibrillation Initiation in MADIT II Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 31:2, 144-150
CrossRef375
Wilbert S. Aronow. 2008. Management of the Older Patient After Myocardial Infarction. , 327-350.
CrossRef376
Kai Wang, Kazunobu Yamauchi, Ping Li, Hiroki Kato, Makoto Kobayashi, Ken Kato, Yoshiyuki Shimizu. (2008) Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brugada Syndrome Treatment. Journal of Medical Systems 32:1, 51-57
CrossRef377
ANDREAS W. SCHOENENBERGER, PAUL ERNE, STEPHAN AMMANN, GERHARD GILLMANN, RICHARD KOBZA, ANDREAS E. STUCK. (2008) Prediction of Arrhythmic Events after Myocardial Infarction Based on Signal-Averaged Electrocardiogram and Ejection Fraction. Pacing and Clinical Electrophysiology 31:2, 221-228
CrossRef378
Michael W. Rich. 2008. Therapy of Acute Myocardial Infarction. , 293-326.
CrossRef379
Wilbert S. Aronow, Carmine Sorbera. 2008. Ventricular Arrhythmias in the Elderly. , 605-626.
CrossRef380
Randy Lieberman, William J. Havel, Eric Rashba, Paul J. DeGroot, Kurt Stromberg, Stephen R. Shorofsky. (2008) Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients. Heart Rhythm 5:1, 28-34
CrossRef381
James J.H. Chong, Anand N. Ganesan, Vicki Eipper, Pramesh Kovoor. (2008) Comparison of Left Ventricular Ejection Fraction and Inducible Ventricular Tachycardia in ST-Elevation Myocardial Infarction Treated by Primary Angioplasty Versus Thrombolysis. The American Journal of Cardiology 101:2, 153-157
CrossRef382
Shinichi Niwano, Hidehira Fukaya, Masaru Yuge, Ryuta Imaki, Shouji Hirasawa, Takeshi Sasaki, Yoshihiro Yumoto, Takayuki Inomata, Tohru Izumi. (2008) Role of Electrophysiologic Study (EPS)-Guided Preventive Therapy for the Management of Ventricular Tachyarrhythmias in Patients With Heart Failure. Circulation Journal 72:2, 268-273
CrossRef383
Nathan E. Goldstein, Davendra Mehta, Ezra Teitelbaum, Elizabeth H. Bradley, R. Sean Morrison. (2008) “It’s Like Crossing a Bridge” Complexities Preventing Physicians from Discussing Deactivation of Implantable Defibrillators at the End of Life. Journal of General Internal Medicine 23:S1, 2-6
CrossRef384
(2008) CrossRef Listing of Deleted DOIs. CrossRef Listing of Deleted DOIs
CrossRef385
William H. Sauer, Michael R. Bristow. (2008) The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. Journal of Interventional Cardiac Electrophysiology 21:1, 3-11
CrossRef386
Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Takeshi Kimura, Yoshinori Kobayashi, Kyoko Soejima, Shinichi Niwano, Shigeyuki Watanabe, Haruhiko Abe. (2008) Current status of implantable defibrillator devices in patients with left ventricular dysfunction-The first report from the online registry database. Journal of Arrhythmia 24:3, 133-140
CrossRef387
Daniele Camboni, Christian G. Wollmann, Andreas Löher, Rainer Gradaus, Hans Heinrich Scheld, Christof Schmid. (2008) Explantation of Implantable Defibrillator Leads Using Open Heart Surgery or Percutaneous Techniques. The Annals of Thoracic Surgery 85:1, 50-55
CrossRef388
MAURIZIO LUNATI, MAURIZIO GASPARINI, MASSIMO SANTINI, MAURIZIO LANDOLINA, GIOVANNI B. PEREGO, CARLO PAPPONE, MAURIZIO MARZEGALLI, CARLO ARGIOLAS, ANANT MURTHY, SERGIO VALSECCHI, . (2008) Follow-Up of CRT-ICD: Implications for the Use of Remote Follow-Up Systems. Data from the InSync ICD Italian Registry. Pacing and Clinical Electrophysiology 31:1, 38-46
CrossRef389
Ilan Goldenberg, Anant K. Vyas, W. Jackson Hall, Arthur J. Moss, Hongyue Wang, Hua He, Wojciech Zareba, Scott McNitt, Mark L. Andrews. (2008) Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 51:3, 288-296
CrossRef390
Nathan E. Goldstein, Davendra Mehta, Saima Siddiqui, Ezra Teitelbaum, Jessica Zeidman, Magdelena Singson, Elena Pe, Elizabeth H. Bradley, R. Sean Morrison. (2008) “That’s Like an Act of Suicide” Patients’ Attitudes Toward Deactivation of Implantable Defibrillators. Journal of General Internal Medicine 23:S1, 7-12
CrossRef391
Christopher H George, Steven R Barberini-Jammaers, Carsten T Muller. (2008) Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux. Expert Opinion on Therapeutic Patents 18:1, 1-19
CrossRef392
Suneet Mittal. (2008) Selecting Patients for an Implantable Cardioverter-Defibrillator. Journal of the American College of Cardiology 51:3, 297-299
CrossRef393
Susan Todd. 2007. Interim Analyses. .
CrossRef394
H.-J. Trappe. (2007) Plötzlicher Herztod. Der Kardiologe 1:4, 261-271
CrossRef395
J. Michael Bostwick, Christopher L. Sola. (2007) An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of Life. Psychiatric Clinics of North America 30:4, 677-688
CrossRef396
James N Kirkpatrick, Savitri E Fedson, Ralph Verdino. (2007) Ethical dilemmas in device treatment for advanced heart failure. Current Opinion in Supportive and Palliative Care 1:4, 267-273
CrossRef397
Rachel Lampert. (2007) Implantable Cardioverter-Defibrillator Use and Benefit in Women. Cardiology in Review 15:6, 298-303
CrossRef398
Henry W. Sesselberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, James P. Daubert, Mark L. Andrews, W. Jackson Hall, Benjamin McClinitic, David T. Huang. (2007) Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy. Heart Rhythm 4:11, 1395-1402
CrossRef399
Philip B. Adamson, Jamie B. Conti, Andrew L. Smith, William T. Abraham, Mark F. Aaron, Juan M. Aranda, Jr., James Baker, Robert C. Bourge, Lynne Warner-Stevenson, Brandon Sparks. (2007) Reducing Events in Patients with Chronic Heart Failure (REDUCEhf ) Study Design: Continuous Hemodynamic Monitoring with an Implantable Defibrillator. Clinical Cardiology 30:11, 567-575
CrossRef400
Kurt Fritzsche, Florian Forster, Axel Schweickhardt, Hartmut Kanwischer, Arno Drinkmann, Sven Rabung, Günter Bergmann, Annette Geibel, Christoph Herrmann-Lingen. (2007) Depressive coping is a predictor for emotional distress and poor quality of life in a German–Austrian sample of cardioverter-defibrillator implant recipients at 3 months and 1 year after implantation. General Hospital Psychiatry 29:6, 526-536
CrossRef401
Hongwei Zhao, Heejung Bang, Hongkun Wang, Phillip E. Pfeifer. (2007) On the equivalence of some medical cost estimators with censored data. Statistics in Medicine 26:24, 4520-4530
CrossRef402
Guy Amit, Otto Costantini. (2007) SCD in patients with cardiomyopathy: Use of microvolt T-wave alternans and other noninvasive tests for risk stratification and prevention of SCD. Current Treatment Options in Cardiovascular Medicine 9:5, 345-355
CrossRef403
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Heart Failure Clinics 3:4, 519-528
CrossRef404
Jordana Kron, Jamie B. Conti. (2007) Cardiac Resynchronization Therapy for Treatment of Heart Failure in the Elderly. Heart Failure Clinics 3:4, 511-518
CrossRef405
VENKU JAYANTI, MENEKHEM M. ZVIMAN, SAMAN NAZARIAN, HENRY R. HALPERIN, RONALD D. BERGER. (2007) Novel Electrode Design for Potentially Painless Internal Defibrillation Also Allows for Successful External Defibrillation. Journal of Cardiovascular Electrophysiology 18:10, 1095-1100
CrossRef406
Stephan Willems, Lars Eckardt, Ellen Hoffmann, Hanno Klemm, Heinz Friedrich Pitschner, Christopher Reithmann, Jürgen Tebbenjohanns, Bernhard Zrenner. (2007) Leitlinie invasive elektrophysiologische Diagnostik. Clinical Research in Cardiology 96:9, 634-651
CrossRef407
Nipon Chattipakorn, Tanat Incharoen, Natnicha Kanlop, Siriporn Chattipakorn. (2007) Heart rate variability in myocardial infarction and heart failure. International Journal of Cardiology 120:3, 289-296
CrossRef408
Mithilesh K. Das, Rajdeep Gaitonde, John M. Miller. (2007) Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death. Current Cardiology Reports 9:5, 371-380
CrossRef409
Mintu Turakhia, Zian H. Tseng. (2007) Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy. Current Problems in Cardiology 32:9, 501-546
CrossRef410
Kevin L. Thomas, Sana M. Al-Khatib, Richard C. Kelsey, Heather Bush, Lynne Brosius, Eric J. Velazquez, Eric D. Peterson, F. Roosevelt Gilliam. (2007) Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%. The American Journal of Cardiology 100:6, 924-929
CrossRef411
Gudula Christ, Ruediger Becker, Frederik Voss, Kamilla Kelemen, Julia Senges-Becker, Melanie Hauck, Wolfgang Schoels, Ingo Bald, Hugo A. Katus, Alexander Bauer. (2007) Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator. Clinical Research in Cardiology 96:9, 613-620
CrossRef412
HAITHAM HREYBE, EATHAR RAZAK, SAMIR SABA. (2007) Effect of End-Stage Renal Failure and Hemodialysis on Mortality Rates in Implantable Cardioverter-Defibrillator Recipients. Pacing and Clinical Electrophysiology 30:9, 1091-1095
CrossRef413
Nora Goldschlager, Andrew E. Epstein, Gerald V. Naccarelli, Brian Olshansky, Bramah Singh, Harold R. Collard, Elizabeth Murphy. (2007) A Practical Guide for Clinicians Who Treat Patients with Amiodarone: 2007. Heart Rhythm 4:9, 1250-1259
CrossRef414
SCOTT L. GREENBERG, J. MAURICIO SNCHEZ, JONAS A. COOPER, MICHAEL E. CAIN, JANE CHEN, MARYE J. GLEVA, BRUCE D. LINDSAY, TIMOTHY W. SMITH, MITCHELL N. FADDIS. (2007) Sustained Polymorphic Arrhythmias Induced by Programmed Ventricular Stimulation have Prognostic Value in Patients Receiving Defibrillators. Pacing and Clinical Electrophysiology 30:9, 1067-1075
CrossRef415
DAVID T. HUANG, HENRY W. SESSELBERG, SCOTT McNITT, KATIA NOYES, MARK L. ANDREWS, W. JACKSON HALL, ANDREW DICK, JAMES P. DAUBERT, WOJCIECH ZAREBA, ARTHUR J. MOSS, . (2007) Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy. Journal of Cardiovascular Electrophysiology 18:8, 833-838
CrossRef416
M. Roser, S. Götze. (2007) ICD-Therapie. Der Kardiologe 1:2, 149-164
CrossRef417
JOHN D. FISHER, HUGO E. ECTOR. (2007) Relative and Absolute Benefits: Main Results Should be Reported in Absolute Terms. Pacing and Clinical Electrophysiology 30:8, 935-937
CrossRef418
Douglas C Shook, Wendy Gross. (2007) Offsite anesthesiology in the cardiac catheterization lab. Current Opinion in Anaesthesiology 20:4, 352-358
CrossRef419
Hong Yu, Hanno Oswald, Ajmal Gardiwal, Christoph Lissel, Gunnar Klein. (2007) Comparison of N-Terminal Pro-Brain Natriuretic Peptide Versus Electrophysiologic Study for Predicting Future Outcomes in Patients With an Implantable Cardioverter Defibrillator After Myocardial Infarction. The American Journal of Cardiology 100:4, 635-639
CrossRef420
Martin Cadeiras, Manuel Prinz von Bayern, Mario C. Deng. (2007) Cardiac Transplantation: Any Role Left?. Heart Failure Clinics 3:3, 321-347
CrossRef421
Daniel P. Morin, Eran S. Zacks, Andreas C. Mauer, Shaun Ageno, Matthew Janik, Steven M. Markowitz, Suneet Mittal, Sei Iwai, Bindi K. Shah, Bruce B. Lerman, Kenneth M. Stein. (2007) Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy. Heart Rhythm 4:7, 904-912
CrossRef422
SAMUEL F. SEARS, LAUREN D. VAZQUEZ SOWELL, EMILY A. KUHL, ADRIENNE H. KOVACS, EVA R. SERBER, EILEEN HANDBERG, SHAWN M. KNEIPP, ISSAM ZINEH, JAMIE B. CONTI. (2007) The ICD Shock and Stress Management Program: A Randomized Trial of Psychosocial Treatment to Optimize Quality of Life in ICD Patients. Pacing and Clinical Electrophysiology 30:7, 858-864
CrossRef423
David R. Holmes, Lauren J. Kim, Maria Mori Brooks, Kevin E. Kip, Hartzell V. Schaff, Katherine M. Detre, Robert L. Frye. (2007) The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation. The Journal of Thoracic and Cardiovascular Surgery 134:1, 38-46.e1
CrossRef424
Jacob A. Udell, David N. Juurlink, Alexander Kopp, Douglas S. Lee, Jack V. Tu, Muhammad M. Mamdani. (2007) Inequitable distribution of implantable cardioverter defibrillators in Ontario. International Journal of Technology Assessment in Health Care 23:03,
CrossRef425
Ayesha Hasan, Clyde W. Yancy. (2007) Treatment of Ventricular Dysrhythmias and Sudden Cardiac Death: A Guideline-Based Approach for Patients With Chronic Left Ventricular Dysfunction. Congestive Heart Failure 13:4, 228-235
CrossRef426
Daniel J. Cantillon, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, Bindi K. Shah, Daniel P. Morin, Eran S. Zacks, Matthew Janik, Shaun Ageno, Andreas C. Mauer, Bruce B. Lerman, Sei Iwai. (2007) Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 50:2, 166-173
CrossRef427
Michael R. Gold, Hue-Teh Shih, John Herre, David Breiter, Yunlong Zhang, Mark Schwartz. (2007) Comparison of Defibrillation Efficacy and Survival Associated With Right Versus Left Pectoral Placement for Implantable Defibrillators. The American Journal of Cardiology 100:2, 243-246
CrossRef428
Salvatore Rosanio, Ernst R. Schwarz, Antonio Vitarelli, Ignatius Gerardo E. Zarraga, Sanjay Kunapuli, David L. Ware, Yochai Birnbaum, Enrique Tuero, Barry F. Uretsky. (2007) Sudden death prophylaxis in heart failure. International Journal of Cardiology 119:3, 291-296
CrossRef429
Sana M. Al-Khatib, Gillian D. Sanders, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne Curtis, Jeptha Curtis, Eric Fain, Bernard J. Gersh, Michael R. Gold, Ali Haghighi-Mood, Stephen C. Hammill, Jeff Healey, Mark Hlatky, Stefan Hohnloser, Raymond J. Kim, Kerry Lee, Daniel Mark, Marcus Mianulli, Brent Mitchell, Eric N. Prystowsky, Joseph Smith, David Steinhaus, Wojciech Zareba. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 941-950
CrossRef430
Gillian D. Sanders, Sana M. Al-Khatib, Elise Berliner, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne B. Curtis, Jeptha P. Curtis, Michael Domanski, Eric Fain, Bernard J. Gersh, Michael R. Gold, Jeffrey Goldberger, Ali Haghighi-Mood, Stephen C. Hammill, Joel Harder, Jeffrey Healey, Mark A. Hlatky, Stefan H. Hohnloser, Kerry L. Lee, Daniel B. Mark, Brent Mitchell, Steve Phurrough, Eric Prystowsky, Joseph M. Smith, Norman Stockbridge, Robert Temple. (2007) Preventing tomorrow's sudden cardiac death today. American Heart Journal 153:6, 951-959
CrossRef431
David A.B. Richards, A. Robert Denniss. (2007) Assessment, Significance and Mechanism of Ventricular Electrical Instability after Myocardial Infarction. Heart, Lung and Circulation 16:3, 149-155
CrossRef432
Sumeet S. Chugh, Kyndaron Reinier, Eric C. Stecker. (2007) Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients. Journal of the American College of Cardiology 49:25, 2416-2418
CrossRef433
Giuseppe Boriani, Paolo Artale, Mauro Biffi, Cristian Martignani, Lorenzo Frabetti, Cinzia Valzania, Igor Diemberger, Matteo Ziacchi, Matteo Bertini, Claudio Rapezzi, Mario Parlapiano, Angelo Branzi. (2007) Outcome of cardioverter–defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart and Vessels 22:3, 184-192
CrossRef434
Alessandro Proclemer, Marco Ghidina. (2007) Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of Cardiovascular Medicine 8:5, 320-323
CrossRef435
Edward K. Rhee, Charles E. Canter, Susan Basile, Steven A. Webber, David C. Naftel. (2007) Sudden Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?. The Journal of Heart and Lung Transplantation 26:5, 447-452
CrossRef436
Michael E. Field, Michael O. Sweeney. (2007) Socio-economic analysis of cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology 17:3, 225-236
CrossRef437
Timothy W. Smith, Michael E. Cain. (2007) Sudden cardiac death: Epidemiologic and financial worldwide perspective. Journal of Interventional Cardiac Electrophysiology 17:3, 199-203
CrossRef438
Stephan B. Danik, Moussa Mansour, Jagmeet Singh, Vivek Y. Reddy, Patrick T. Ellinor, David Milan, E. Kevin Heist, Andre d’Avila, Jeremy N. Ruskin, Theofanie Mela. (2007) Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4:4, 439-442
CrossRef439
A. Selcuk Adabag, Barry J. Maron. (2007) Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology 12:2, 171-180
CrossRef440
Fulvio Bellocci, Luigi M Biasucci, Gian Franco Gensini, Luigi Padeletti, Antonio Raviele, Massimo Santini, Giovanna Giubilato, Maurizio Landolina, Giuseppe Biondi-Zoccai, Giovanni Raciti, Massimo Sassara, Antonello Castro, Antoine Kheir, Filippo Crea. (2007) Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Journal of Cardiovascular Medicine 8:4, 293-299
CrossRef441
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews. (2007) Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. Journal of the American College of Cardiology 49:13, 1427-1433
CrossRef442
Andrew E. Epstein, Christina A. Baessler, Anne B. Curtis, N.A. Mark Estes, Bernard J. Gersh, Blair Grubb, L. Brent Mitchell. (2007) Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”. Heart Rhythm 4:3, 386-393
CrossRef443
HAITHAM HREYBE, SAMIR SABA. (2007) A Clinical Risk Score to Predict the Time to First Appropriate Device Therapy in Recipients of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 30:3, 385-389
CrossRef444
Alexander Crössmann, Paul Pauli, Wilhelm Dengler, Volker Kühlkamp, Georg Wiedemann. (2007) Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: A longitudinal two-year follow-up. Heart & Lung: The Journal of Acute and Critical Care 36:2, 87-95
CrossRef445
E. Friedmann, S. A. Thomas, P. Inguito, C. W. Kao, M. Metcalf, F. J. Kelley, S. S. Gottlieb. (2007) Quality of life and psychological status of patients with implantable cardioverter defibrillators. Journal of Interventional Cardiac Electrophysiology 17:1, 65-72
CrossRef446
Ilan Goldenberg, Arthur J. Moss. (2007) Treatment of Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Elderly Patients with Cardiac Disease. Clinics in Geriatric Medicine 23:1, 205-219
CrossRef447
Jordana Kron, Jamie B. Conti. (2007) Cardiac Resynchronization Therapy for Treatment of Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 193-203
CrossRef448
OLIVER R. SEGAL, ANTHONY W.C. CHOW, TOM WONG, NICOLA TREVISI, MARTIN D. LOWE, D. WYN DAVIES, PAOLO DELLA BELLA, DOUGLAS L. PACKER, NICHOLAS S. PETERS. (2007) A Novel Algorithm for Determining Endocardial VT Exit Site from 12-Lead Surface ECG Characteristics in Human, Infarct-Related Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 18:2, 161-168
CrossRef449
Kavitha M. Chinnaiyan, Justin Trivax, Barry A. Franklin, Brian Williamson, Joel K. Kahn. (2007) Stress Testing in Patients With Implantable Cardioverter-Defibrillators: A Preliminary Report. Preventive Cardiology 10:2, 92-95
CrossRef450
Lauren A. Stutts, Natalie J. Cross, Jamie B. Conti, Samuel F. Sears. (2007) Examination of Research Trends on Patient Factors in Patients with Implantable Cardioverter Defibrillators. Clinical Cardiology 30:2, 64-68
CrossRef451
Susan Todd. (2007) A 25-year review of sequential methodology in clinical studies. Statistics in Medicine 26:2, 237-252
CrossRef452
Anne M Dubin, Charles I Berul. (2007) Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease. Expert Review of Cardiovascular Therapy 5:1, 111-118
CrossRef453
Angelo Auricchio, Marco Metra, Maurizio Gasparini, Barbara Lamp, Catherine Klersy, Antonio Curnis, Cecilia Fantoni, Edoardo Gronda, Juergen Vogt. (2007) Long-Term Survival of Patients With Heart Failure and Ventricular Conduction Delay Treated With Cardiac Resynchronization Therapy. The American Journal of Cardiology 99:2, 232-238
CrossRef454
Giovanni Quarta, Laura Marino, Jasmine Passerini, Valentina Francione, Francesco Paneni, Camillo Autore. (2007) The Microvolt T-Wave Alternans Test. High Blood Pressure & Cardiovascular Prevention 14:4, 213-219
CrossRef455
STEVEN M. GREENBERG, ANDREW E. EPSTEIN, THOMAS DEERING, DANIEL S. GOLDMAN, MARCO GHIDINA, CURTIS NEASON, ALESSANDRO PROCLEMER. (2007) A Comparison of ICD Implantations in the United States Versus Italy. Pacing and Clinical Electrophysiology 30:s1,
CrossRef456
Serkan Topaloglu, Dursun Aras, Onur Sahin, Kumral Ergun, Bulent Deveci, Ozcan Ozdemir, Ozcan Ozeke, Ali Yildiz, Omer Alyan, Ahmet Duran Demir, Mustafa Soylu, Halil Lutfi Kisacik, Sule Korkmaz. (2007) QT Dispersion Significantly Increases after Implantable Cardioverter-Defibrillator Shocks. Annals of Noninvasive Electrocardiology 12:1, 44-49
CrossRef457
Sae Sasaki, Shinichi Niwano, Hidehira Fukaya, Masaru Yuge, Ryuta Imaki, Takayuki Inomata, Tohru Izumi. (2007) Clinical Usefulness of Electrophysiologic Study (EPS)-Guided Risk Stratification for Life-Threatening Arrhythmia in Patients With Heart Failure. International Heart Journal 48:2, 155-163
CrossRef458
Akira Ueno, Yoshinori Kobayashi, Kenji Yodogawa, Yasushi Miyauchi, Toshimi Yajima, Takashi Nitta, Takao Kato, Teruo Takano. (2007) A Prospective Study on the Risk-Stratification for Patients With Non-Sustained Ventricular Tachycardia Using a Novel Algorithm. Circulation Journal 71:7, 1107-1114
CrossRef459
Rishi Sukhija, Vimal Mehta, Marino Leonardi, Jawahar L. Mehta. (2007) Implantable cardioverter defibrillators for prevention of sudden cardiac Death. Clinical Cardiology 30:1, 3-8
CrossRef460
Warren Smith, Margaret Hood. 2007. Arrhythmias. , 316-341.
CrossRef461
Takashi Kurita. (2007) Primary Prevention of Sudden Cardiac Death in Patients with Ischemic Heart Disease-Possible Role of the Shock Device in the Asia-. Journal of Arrhythmia 23:4, 264-268
CrossRef462
Rahul Mehra, Paul DeGroot. (2007) Where are we, and where are we heading in the device management of ventricular tachycardia/ventricular fibrillation?. Heart Rhythm 4:1, 99-103
CrossRef463
Anil-Martin Sinha, Rainer Schimpf, Jörg Otto Schwab, Frank Birkenhauer, Ole A. Breithardt, Johannes Brachmann, Volker Schibgilla, Peter Hanrath, Christoph Stellbrink. (2007) A new method to investigate the response to the morphology discrimination algorithm in patients with ICD. International Journal of Cardiology 114:3, 323-331
CrossRef464
Michiel Rienstra, Marcelle D. Smit, Wybe Nieuwland, Eng S. Tan, Ans C.P. Wiesfeld, Rutger L. Anthonio, Maarten P. Van den Berg, Dirk J. Van Veldhuisen, Isabelle C. Van Gelder. (2007) Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator. American Heart Journal 153:1, 120-126
CrossRef465
Reiner Buchhorn, Andreas Eicken, Hans Peter Gildein, Joachim Kreuder, Thomas Paul, Achim A. Schmaltz, Ingram Schulze-Neick. 2007. Erkrankungen des Herzens. , 917-965.
CrossRef466
Jackie Bryant, Hakan Brodin, Emma Loveman, Andrew Clegg. (2007) Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 23:01,
CrossRef467
Jan W. Kantelhardt, Axel Bauer, Aicko Y. Schumann, Petra Barthel, Raphael Schneider, Marek Malik, Georg Schmidt. (2007) Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk. Chaos: An Interdisciplinary Journal of Nonlinear Science 17:1, 015112
CrossRef468
Masaomi Chinushi, Yoshifusa Aizawa. (2007) Non-Pharmacological Management of Ventricular Tachycardia. Circulation Journal 71:SupplementA, A97-A105
CrossRef469
Isaac Pourati, Lawrence Rosenthal. (2006) Indications for cardiac defibrillators in patients with congestive heart failure. Current Heart Failure Reports 3:4, 197-202
CrossRef470
GIOVANNI LUCA BOTTO, MARIO LUZI, FRANCO RUFFA, GIOVANNI RUSSO, GIOVANNI FERRARI. (2006) Atrial Tachyarrhythmias in Primary and Secondary Prevention ICD Recipients: Clinical and Prognostic Data. Pacing and Clinical Electrophysiology 29:s2, S48-S53
CrossRef471
Adnan Siddiqui, Peter R Kowey. (2006) Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Current Opinion in Internal Medicine 5:6, 544-552
CrossRef472
STEFAN ASBACH, INGO WEISS, BEATE WENZEL, CHRISTOPH BODE, MANFRED ZEHENDER. (2006) Intrathoracic Far-Field Electrocardiogram Allows Continuous Monitoring of Ischemia After Total Coronary Occlusion. Pacing and Clinical Electrophysiology 29:12, 1334-1340
CrossRef473
PAOLO DELLA BELLA, STEFANIA RIVA. (2006) Hybrid Therapies for Ventricular Arrhythmias. Pacing and Clinical Electrophysiology 29:s2, S40-S47
CrossRef474
DAVID N. KENIGSBERG, KENNETH A. ELLENBOGEN. (2006) ICD Arrhythmia Detection and Discrimination: Are We There Yet?. Journal of Cardiovascular Electrophysiology 17:12, 1320-1322
CrossRef475
(2006) Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita.Versión resumida. Revista Española de Cardiología 59:12, 1328.e1-1328.e51
CrossRef476
ALESSANDRO PROCLEMER, MARCO GHIDINA, GLORIA CICUTTINI, DARIO GREGORI, PAOLO MARIA FIORETTI. (2006) Impact of the Main Implantable Cardioverter-Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001?2004. Pacing and Clinical Electrophysiology 29:s2, S20-S28
CrossRef477
MAURIZIO LUNATI, MAURIZIO GASPARINI, MARIO BOCCHIARDO, ANTONIO CURNIS, MAURIZIO LANDOLINA, ANGELO CARBONI, GIANNI LUZZI, GABRIELE ZANOTTO, PIERANTONIO RAVAZZI, GIOVANNI MAGENTA, ALESSANDRA DENARO, PAOLA DISTEFANO, ANDREA GRAMMATICO, . (2006) Clustering of Ventricular Tachyarrhythmias in Heart Failure Patients Implanted with a Biventricular Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 17:12, 1299-1306
CrossRef478
MICHAEL CAO, LESLIE A. SAXON. (2006) Selection of Patients for CRT?Prevention or Reversal of Remodeling as a Therapeutic Endpoint for CRT. Journal of Cardiovascular Electrophysiology 17:12, 1293-1294
CrossRef479
Sandeep Nathan, William Piccione, Arun Kumar, Steve Attanasio, Gary L. Schaer. (2006) Erosion of an Extrapericardial Implantable Cardioverter Defibrillator Patch Through the Gastric Fundus With Fistulous Tract Formation. Cardiology in Review 14:6, e21-e23
CrossRef480
N. N. HENYAN, C. M. WHITE, E. L. GILLESPIE, K. SMITH, C. I. COLEMAN, J. KLUGER. (2006) The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. Journal of Internal Medicine 260:5, 467-473
CrossRef481
Michael J. Yarnoz, Anne B. Curtis. (2006) Sex-Based Differences in Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapies. Cardiology in Review 14:6, 292-298
CrossRef482
P. Bru, C. Duplantier, M. Fratu, M. Bourrat, B. Vaquette, C. Moreau, R. Lorillard. (2006) Suivi des défibrillateurs automatiques implantables en centre hospitalier général. Annales de Cardiologie et d'Angéiologie 55:6, 342-345
CrossRef483
D. Müller, S. Spencker. (2006) Fehlfunktionen von Defibrillatoren. Notfall + Rettungsmedizin 9:7, 626-629
CrossRef484
Michael A. Weber, Nanette K. Wenger, Stephen Scheidt. (2006) Who Should Be Treated With Implantable Cardioverter-Defibrillators?. The American Journal of Geriatric Cardiology 15:6, 336-337
CrossRef485
Alfred E. Boxton. (2006) Implantable Cardioverter-Defibrillators Should Be Used Routinely in the Elderly. The American Journal of Geriatric Cardiology 15:6, 361-364
CrossRef486
Michael J. Yarnoz, Anne B. Curtis. (2006) Why Cardioverter-Defibrillator Implantation Might Not Be the Best Idea for Your Elderly Patient. The American Journal of Geriatric Cardiology 15:6, 367-371
CrossRef487
Samuel F. Sears, Lauren A. Stutts, Juan M. Aranda, Eileen M. Handberg, Jamie B. Conti. (2006) Managing Congestive Heart Failure Patient Factors in the Device Era. Congestive Heart Failure 12:6, 335-340
CrossRef488
Liza A. Prudente, Juanita Reigle, Cheryl Bourguignon, David E. Haines, John P. DiMarco. (2006) Psychological indices and phantom shocks in patients with ICD. Journal of Interventional Cardiac Electrophysiology 15:3, 185-190
CrossRef489
H. U. Klein. (2006) Prävention des plötzlichen Herztodes. Der Internist 47:10, 1040-1050
CrossRef490
Michael G. McLaughlin, Peter J. Zimetbaum. (2006) Electrocardiographic Predictors of Arrhythmic Death. Annals of Noninvasive Electrocardiology 11:4, 327-337
CrossRef491
Cynthia M. Tracy, Masood Akhtar, John P. DiMarco, Douglas L. Packer, Howard H. Weitz, Mark A. Creager, David R. Holmes, Geno Merli, George P. Rodgers, Cynthia M. Tracy, Howard H. Weitz. (2006) American College of Cardiology/American Heart Association 2006 Update of the Clinical Competence Statement on Invasive ElectrophysiologyStudies,CatheterAblation,andCardioversion. Journal of the American College of Cardiology 48:7, 1503-1517
CrossRef492
CHRISTOF KOLB, ISABEL DEISENHOFER, SEBASTIAN SCHMIEDER, PETRA BARTHEL, BERNHARD ZRENNER, MARTIN R. KARCH, CLAUS SCHMITT. (2006) Long-Term Follow-Up of Patients Supplied with Single-Chamber or Dual-Chamber Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 29:9, 946-952
CrossRef493
CHRISTIAN G. WOLLMANN, ULRICH GOTTKER, DIRK BOCKER, RAINER GRADAUS. (2006) Near Fatal Arrhythmia Induction by An Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 17:9, 1026-1028
CrossRef494
Michael W. Rich. (2006) Heart Failure in Older Adults. Medical Clinics of North America 90:5, 863-885
CrossRef495
Lauren Vazquez Sowell, Emily A. Kuhl, Samuel F. Sears, Charles T. Klodell, Jamie B. Conti. (2006) Device Implant Technique and Consideration of Body Image: Specific Procedures for Implantable Cardioverter Defibrillators in Female Patients. Journal of Women's Health 15:7, 830-835
CrossRef496
O. Lynne Nelson, Sunshine Lahmers, Terri Schneider, Pam Thompson. (2006) The Use of an Implantable Cardioverter Defibrillator in a Boxer Dog to Control Clinical Signs of Arrhythmogenic Right Ventricular Cardiomyopathy. Journal of Veterinary Internal Medicine 20:5, 1232-1237
CrossRef497
Andrew Ho, Ramin Assadi, Sudha M. Pai, Ramdas G. Pai. (2006) Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?. Current Cardiology Reports 8:5, 365-369
CrossRef498
NEIL K. SANGHVI, PAUL LELORIER, ARJUN V. GURURAJ, KEVIN M. MONAHAN. (2006) Influence of Drive Cycle Length on Initiation of Ventricular Fibrillation During Implantable Cardioverter Defibrillator Threshold Testing. Pacing and Clinical Electrophysiology 29:9, 926-929
CrossRef499
Apiradee Thammanomai, Michael O. Sweeney, Solomon R. Eisenberg. (2006) A comparison of the output characteristics of several implantable cardioverter-defibrillators. Heart Rhythm 3:9, 1053-1059
CrossRef500
Peter Cram, David Katz, Sandeep Vijan, David M. Kent, Kenneth M. Langa, A. Mark Fendrick. (2006) Implantable or External Defibrillators for Individuals at Increased Risk of Cardiac Arrest: Where Cost-Effectiveness Hits Fiscal Reality. Value in Health 9:5, 292-302
CrossRef501
Jeanne E. Poole. (2006) New indications for implantable defibrillator therapy. Current Cardiology Reports 8:5, 330-335
CrossRef502
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Journal of the American College of Cardiology 48:5, e247-e346
CrossRef503
ROBERT E. ECKART, LORNE J. GULA, MATTHEW R. REYNOLDS, ERIC A. SHRY, WILLIAM H. MAISEL. (2006) Mortality Following Defibrillator Implantation in Patients with Renal Insufficiency. Journal of Cardiovascular Electrophysiology 17:9, 940-943
CrossRef504
Douglas P. Zipes, A. John Camm, Martin Borggrefe, Alfred E. Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J. Moss, Robert J. Myerburg, Silvia G. Priori, Miguel A. Quinones, Dan M. Roden, Michael J. Silka, Cynthia Tracy, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Elliott M. Antman, Jeffrey L. Anderson, Sharon A. Hunt, Jonathan L. Halperin, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary. Journal of the American College of Cardiology 48:5, 1064-1108
CrossRef505
Maureen M. Henneman, Frank M. Bengel, Jeroen J. Bax. (2006) Will innervation imaging predict ventricular arrhythmias in ischaemic cardiomyopathy?. European Journal of Nuclear Medicine and Molecular Imaging 33:8, 862-865
CrossRef506
Ivan C.K. Ho, David J. Milan, Moussa C. Mansour, Theofanie Mela, Mary L. Guy, Jeremy N. Ruskin, Patrick T. Ellinor. (2006) Fungal infection of implantable cardioverter-defibrillators: Case series of five patients managed over 22 years. Heart Rhythm 3:8, 919-923
CrossRef507
Leslie A. Saxon. (2006) Patient Selection for Primary Prevention ICDs—Are EPs Shocking Patients Into Consent?. Journal of Cardiac Failure 12:6, 413-415
CrossRef508
David Seo, Geoffrey S. Ginsburg, Pascal J. Goldschmidt-Clermont. (2006) Gene Expression Analysis of Cardiovascular Diseases. Journal of the American College of Cardiology 48:2, 227-235
CrossRef509
Charles I. Berul, Anne M. Dubin. (2006) Rhythm Management in Pediatric Heart Failure. Congenital Heart Disease 1:4, 140-147
CrossRef510
B. A. SCHAER, C. STICHERLING, S. OSSWALD. (2006) What are the professional and logistic demands to appropriately follow patients with an implantable cardioverter-defibrillator?. Journal of Internal Medicine 260:1, 88-92
CrossRef511
HIDEYUKI KAMOCHI, YOSHIO YAMANOUCHI, KEIJIRO SAKU. (2006) Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on Ventricular Defibrillation Threshold. Pacing and Clinical Electrophysiology 29:7, 747-752
CrossRef512
Mitsuru Itoh, Konosuke Ohmori, Kenichiro Yata, Hideho Wada, Tetsuo Tsuchiya, Noriko Okahashi, Sohei Hamanaka, Kiyoshi Yoshida, Kazuo Tanemoto, Takashi Sugihara. (2006) Implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis. American Journal of Hematology 81:7, 560-561
CrossRef513
N. A. MARK ESTES. (2006) Discrimination When Dual-Chamber Termination Fails: A New Paradigm for ICDs?. Journal of Cardiovascular Electrophysiology 17:7, 702-704
CrossRef514
SAMIR SABA, LINDA BAKER, LEONARD GANZ, WILLIAM BARRINGTON, SANDEEP JAIN, OGUNDU NGWU, JILL CHRISTENSEN, MARK BROWN. (2006) Simultaneous Atrial and Ventricular Anti-Tachycardia Pacing as a Novel Method of Rhythm Discrimination. Journal of Cardiovascular Electrophysiology 17:7, 695-701
CrossRef515
Majid Haghjoo, Arash Arya, Mohammad Ali Sadr-Ameli. (2006) Value of Microvolt T-Wave Alternans for Predicting Patients Who Would Benefit from Implantable Cardioverter???Defibrillator Therapy. Cardiology in Review 14:4, 173-179
CrossRef516
Adrienne H. Kovacs, Suzannef Eigofsky, J. Sean Goff, Arwa S. Saidi, Anne B. Curtis, Jamie B. Conti, Samuel F. Sears. (2006) Implantable cardioverter defibrillator implant-explant-implant case study: Addressing the psychological adjustment to multiple shocks. Clinical Cardiology 29:6, 274-276
CrossRef517
Eric C. Stecker, Megan Sono, Erin Wallace, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 3:6, 697-700
CrossRef518
Francisco Marín, Juan R. Gimeno, Eduardo Payá, Arcadio García-Alberola, Luisa Pérez-Álvarez, Xusto Fernández, Gonzalo de la Morena, Francisco Sogorb, Alfonso Castro-Beiras, Mariano Valdés, Juan G. Martínez, Lorenzo Monserrat. (2006) Desfibrilador automático en la miocardiopatía hipertrófica. Experiencia de 3 centros. Revista Española de Cardiología 59:6, 537-544
CrossRef519
Jack Zwanziger, W. Jackson Hall, Andrew W. Dick, Hongwei Zhao, Alvin I. Mushlin, Rebecca Marron Hahn, Hongkun Wang, Mark L. Andrews, Cathleen Mooney, Hongyue Wang, Arthur J. Moss. (2006) The Cost Effectiveness of Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:11, 2310-2318
CrossRef520
P. Gil, M. L. Fernandez Guerrero, J. F. Bayona, J. M. Rubio, M. de Gorgolas, J. J. Granizo, J. Farre. (2006) Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance. Clinical Microbiology and Infection 12:6, 533-537
CrossRef521
Oscar Bernal, Concepción Moro. (2006) Arritmias cardiacas en la mujer. Revista Española de Cardiología 59:6, 609-618
CrossRef522
Fred Kusumoto, Nora Goldschlager. (2006) Implantable cardiac arrhythmia devices-Part II: Implantable cardioverter defibrillators and implantable loop recorders. Clinical Cardiology 29:6, 237-242
CrossRef523
Eric J. Rashba, Stephen R. Shorofsky, Avram Scheiner, Robert W. Peters, Carol Ma, Michael R. Gold. (2006) Coronary sinus electrode does not reduce atrial defibrillation thresholds. Heart Rhythm 3:6, 647-652
CrossRef524
Matthew R. Reynolds, David J. Cohen, Aaron D. Kugelmass, Phillip P. Brown, Edmund R. Becker, Steven D. Culler, April W. Simon. (2006) The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators. Journal of the American College of Cardiology 47:12, 2493-2497
CrossRef525
Lee A. Biblo, Johan Aasbo. (2006) To catch a moving target. Heart Rhythm 3:6, 638-639
CrossRef526
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Wojciech Zareba, W. Jackson Hall, Mark L. Andrews, David J. Wilber, Helmut U. Klein. (2006) Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology 47:9, 1811-1817
CrossRef527
E. M. L. Wong, E. B. Wu, W. W. M. Chan, C. M. Yu. (2006) A review of the management of patients after percutaneous coronary intervention. International Journal of Clinical Practice 60:5, 582-589
CrossRef528
Sami Viskin. (2006) Prediction versus prevention of sudden cardiac death. The Lancet 367:9523, 1639-1641
CrossRef529
Axel Bauer, Jan W Kantelhardt, Petra Barthel, Raphael Schneider, Timo Mäkikallio, Kurt Ulm, Katerina Hnatkova, Albert Schömig, Heikki Huikuri, Armin Bunde, Marek Malik, Georg Schmidt. (2006) Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. The Lancet 367:9523, 1674-1681
CrossRef530
MICHAEL H. LEHMANN, KEITH D. AARONSON. (2006) CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?. Journal of Cardiovascular Electrophysiology 17:5, 491-494
CrossRef531
Sheharyar Ali, Eduardo S. Antezano. (2006) Sudden Cardiac Death. Southern Medical Journal 99:5, 502-510
CrossRef532
Bradley J. Roth. 2006. Defibrillators. .
CrossRef533
Gabor Duray, Carsten W Israel, Stefan H Hohnloser. (2006) Recent primary prevention implantable cardioverter defibrillator trials. Current Opinion in Internal Medicine 5:2, 154-158
CrossRef534
P. Brugada. (2006) What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up?. Clinical Research in Cardiology 95:S3, iii3-iii9
CrossRef535
S. Jolly, P. Dorian, D. A. Alter. (2006) The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. Journal of Evaluation in Clinical Practice 12:2, 190-195
CrossRef536
Kevin J. Makati, Airley E. Fish, Hannah H. England, Hocine Tighiouart, N.A. Mark Estes, Mark S. Link. (2006) Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Heart Rhythm 3:4, 397-403
CrossRef537
PETRI KORHONEN, TERHI HUSA, ILKKA TIERALA, HEIKKI VAANANEN, MARKKU MAKIJARVI, TOIVO KATILA, LAURI TOIVONEN. (2006) Increased Intra-QRS Fragmentation in Magnetocardiography as a Predictor of Arrhythmic Events and Mortality in Patients with Cardiac Dysfunction After Myocardial Infarction. Journal of Cardiovascular Electrophysiology 17:4, 396-401
CrossRef538
Stephen Hammill, Steve Phurrough, Ralph Brindis. (2006) The National ICD Registry: Now and into the future. Heart Rhythm 3:4, 470-473
CrossRef539
H.-J. Trappe. (2006) New perspectices in arrhythmia and heart failure monitoring. Clinical Research in Cardiology 95:S3, iii1-iii2
CrossRef540
Lars Eckardt, Günter Breithardt. (2006) Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?. Heart Rhythm 3:4, 484-487
CrossRef541
Gastone Sabbadini, Marco Metra, Andrea Di Lenarda, Savina Nodari, Gianfranco Sinagra, Livio Dei Cas. (2006) Managing heart failure in the very old. Aging Health 2:2, 253-275
CrossRef542
David A. Cesario, G. William Dec. (2006) Implantable Cardioverter- Defibrillator Therapy in Clinical Practice. Journal of the American College of Cardiology 47:8, 1507-1517
CrossRef543
C. Perings, T. Korte, H.-J. Trappe, . (2006) IEGM-online based evaluation of implantable cardioverter defibrillator therapy appropriateness. Clinical Research in Cardiology 95:S3, iii22-iii28
CrossRef544
Eric C. Stecker, Catherine Vickers, Justin Waltz, Carmen Socoteanu, Benjamin T. John, Ronald Mariani, John H. McAnulty, Karen Gunson, Jonathan Jui, Sumeet S. Chugh. (2006) Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction. Journal of the American College of Cardiology 47:6, 1161-1166
CrossRef545
Aldo Casaleggio, Paolo Rossi, Andrea Faini, Tiziana Guidotto, Vincenzo Malavasi, Giacomo Musso, Giuseppe Sartori. (2006) Analysis of implantable cardioverter defibrillator signals for non conventional cardiac electrical activity characterization. Medical & Biological Engineering & Computing 44:1-2, 45-53
CrossRef546
James P. Daubert, Henry W. Sesselberg, David T. Huang. (2006) Implantable Cardioverter-Defibrillators for Primary Prevention: How Do the Data Pertain to the Aged?. The American Journal of Geriatric Cardiology 15:2, 88-92
CrossRef547
A. Bauer, J. Bauer, M. Bauer, K. Kelemen, F. Voss, J. Senges-Becker, S. Weretka, H. A. Katus, R. Becker. (2006) Effizienzpotential in der Nachsorge von Schrittmachern und implantierbaren Kardioverter Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 17:1, 26-34
CrossRef548
Tiong Keng Lim, Leah Burden, Rajesh Janardhanan, Girish Dwivedi, Chai Ping, James Moon, Dudley J. Pennell, Roxy Senior. (2006) Contrast Echocardiography Versus Gated Single Photon Emission Computed Tomography for the Assessment of Parameters of Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of the American Society of Echocardiography 19:3, 280-284
CrossRef549
Usha B. Tedrow, William G. Stevenson. 2006. Management of Ventricular Arrhythmias in Heart Failure. , 183-202.
CrossRef550
Claudia Martinez, Assaf Tzur, Hakop Hrachian, Joseph Zebede, Gervasio A. Lamas. (2006) Pacemakers and Defibrillators: Recent and Ongoing Studies That Impact the Elderly. The American Journal of Geriatric Cardiology 15:2, 82-87
CrossRef551
James D. Allred, Andrew E. Epstein, Raymond E. Ideker. (2006) The Sign of Four and the SDNN of one of three. Heart Rhythm 3:3, 287-289
CrossRef552
Robert D Winslow, Sean Pinney, Valentin Fuster. (2006) Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure. Nature Clinical Practice Cardiovascular Medicine 3:2, 86-93
CrossRef553
BRYAN C. CANNON, RICHARD A. FRIEDMAN, ARNOLD L. FENRICH, CHARLES D. FRASER, E. DEAN McKENZIE, NAOMI J. KERTESZ. (2006) Innovative Techniques for Placement of Implantable Cardioverter-Defibrillator Leads in Patients with Limited Venous Access to the Heart. Pacing and Clinical Electrophysiology 29:2, 181-187
CrossRef554
Andrew McKeon, Carl Vaughan, Norman Delanty. (2006) Seizure versus syncope. The Lancet Neurology 5:2, 171-180
CrossRef555
Heart Failure Society of America. (2006) Section 9: Electrophysiologic Testing and the Use of Devices in Heart Failure. Journal of Cardiac Failure 12:1, e70-e75
CrossRef556
James P. Daubert, Wojciech Zareba, W. Jackson Hall, Claudio Schuger, Andrew Corsello, Angel R. Leon, Mark L. Andrews, Scott McNitt, David T. Huang, Arthur J. Moss. (2006) Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients. Journal of the American College of Cardiology 47:1, 98-107
CrossRef557
Germanas Marinskis, Audrius Aidietis. (2006) Advances in nonpharmacologic therapies for ventricular arrhythmias. Therapy 3:1, 125-138
CrossRef558
HIROSHI KASANUKI. (2006) Present status and prospect of non-pharmacotherapy of arrhythmia.. Nihon Naika Gakkai Zasshi 95:9, 1912-1921
CrossRef559
Richard G. Sheahan. 2006. Taquicardia ventricular. , 196-204.
CrossRef560
Daniel M. Bloomfield, J. Thomas Bigger, Richard C. Steinman, Pearila B. Namerow, Michael K. Parides, Anne B. Curtis, Elizabeth S. Kaufman, Jorge M. Davidenko, Timothy S. Shinn, John M. Fontaine. (2006) Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction. Journal of the American College of Cardiology 47:2, 456-463
CrossRef561
Kazuhiro Satomi, Takashi Kurita, Seiji Takatsuki, Yasuhiro Yokoyama, Masaomi Chinushi, Naoya Tsuboi, Takashi Nitta, Morio Shoda, Hideo Mitamura. (2006) Amiodarone Therapy in Patients Implanted With Cardioverter-Defibrillator for Life-Threatening Ventricular Arrhythmias. Circulation Journal 70:8, 977-984
CrossRef562
Michael H Gollob. (2006) Genetic profiling as a marker for risk of sudden cardiac death. Current Opinion in Cardiology 21:1, 42-46
CrossRef563
Margaret C. Herbst, William E. Sanders. 2006. Marcapasos y desfibriladores cardíacos. , 248-255.
CrossRef564
CHARLES D. SWERDLOW, PAUL A. FRIEDMAN. (2006) Advanced ICD Troubleshooting: Part II. Pacing and Clinical Electrophysiology 29:1, 70-96
CrossRef565
Albert Farrugia. (2006) Assessing Efficacy and Therapeutic Claims in Emerging Indications for Recombinant Factor VIIa: Regulatory Perspectives. Seminars in Hematology 43, S64-S69
CrossRef566
Sanjiv M. Narayan. (2006) T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias. Journal of the American College of Cardiology 47:2, 269-281
CrossRef567
Kathryn A. Glatter, J. Nilas Young, Matthew D. McElvany. (2006) Implantable Cardioverter?Defibrillators: A New Preventive Medical Option. Preventive Cardiology 9:1, 49-55
CrossRef568
Harold L. Kennedy. (2006) The History, Science, and Innovation of Holter Technology. Annals of Noninvasive Electrocardiology 11:1, 85-94
CrossRef569
José Azpitarte. (2006) Profilaxis primaria con desfibrilador-cardioversor implantable en la insuficiencia cardiaca: un punto de vista clínico. Revista Española de Cardiología 59, 10-22
CrossRef570
Masaru Yuge, Shinichi Niwano, Masahiko Moriguchi, Takeshi Sasaki, Shoji Hirasawa, Ryuta Imaki, Daisuke Sato, Tohru Izumi. (2006) Clinical Significance of the Electrophysiologic Study (EPS)-Guided Therapy for the Secondary Prevention of Ventricular Tachycardia. Circulation Journal 70:3, 268-272
CrossRef571
Robert J. Myerburg, Agustin Castellanos. (2006) Clinical Research Designs and Implantable Defibrillator Indications. Journal of the American College of Cardiology 47:1, 108-111
CrossRef572
TAKAYUKI OTSUKA. (2006) Nihon Naika Gakkai Zasshi 95:2, 234-239
CrossRef573
Stephen Minor, Toshio Akiyama. (2006) Ventricular Arrhythmias in the Elderly. Journal of Arrhythmia 22:1, 19-30
CrossRef574
Ivan C.K. Ho, Jonathan J. Passeri, Mary L. Guy, Jeremy N. Ruskin, Patrick T. Ellinor. (2006) Impact of the Multicenter Automatic Defibrillator Implantation Trial on Clinical Practice. Annals of Noninvasive Electrocardiology 11:1, 20-27
CrossRef575
Kenneth A. Ellenbogen, Mark A. Wood, Helmut U. Klein. (2005) Why Should We Care About CARE-HF?. Journal of the American College of Cardiology 46:12, 2199-2203
CrossRef576
Rafael Peinado, Ángel Arenal, Fernando Arribas, Esteban Torrecilla, Miguel Álvarez, José M. Ormaetxe, Nicasio Pérez-Castellano. (2005) Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004). Revista Española de Cardiología 58:12, 1435-1449
CrossRef577
Harald C. Ott, Bryce H. Davis, Doris A. Taylor. (2005) Cell Therapy for Heart Failure—Muscle, Bone Marrow, Blood, and Cardiac-Derived Stem Cells. Seminars in Thoracic and Cardiovascular Surgery 17:4, 348-360
CrossRef578
H. Volkmann, C. Bergmann, M. Walter. (2005) Kardiale Resynchronisation: Wer ist geeignet?—. Zeitschrift für Kardiologie 94:S4, iv60-iv64
CrossRef579
Jeroen J. Bax, Theodore Abraham, S. Serge Barold, Ole A. Breithardt, Jeffrey W.H. Fung, Stephane Garrigue, John Gorcsan, David L. Hayes, David A. Kass, Juhani Knuuti, Christophe Leclercq, Cecilia Linde, Daniel B. Mark, Mark J. Monaghan, Petros Nihoyannopoulos, Martin J. Schalij, Christophe Stellbrink, Cheuk-Man Yu. (2005) Cardiac Resynchronization Therapy. Journal of the American College of Cardiology 46:12, 2168-2182
CrossRef580
Dhanunjaya Lakkireddy, Dimpi Patel, Kay Ryschon, Rohit Bhateja, Mihir Bhakru, Sergio Thal, Atul Verma, Oussama Wazni, Fethi Kilicaslan, Ashok Kondur, Subramanya Prasad, Jennifer Cummings, William Belden, David Burkhardt, Walid Saliba, Robert Schweikert, Mandeep Bhargava, Mina Chung, Bruce Wilkoff, Patrick Tchou, Andrea Natale. (2005) Safety and efficacy of radiofrequency energy catheter ablation of atrial fibrillation in patients with pacemakers and implantable cardiac defibrillators. Heart Rhythm 2:12, 1309-1316
CrossRef581
Gabor Duray, Sergio Richter, Johannes Manegold, Carsten W. Israel, Gerian Grönefeld, Stefan H. Hohnloser. (2005) Efficacy and Safety of ICD Therapy in a Population of Elderly Patients Treated with Optimal Background Medication. Journal of Interventional Cardiac Electrophysiology 14:3, 169-173
CrossRef582
James A. Reiffel. (2005) Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clinical Cardiology 28:S1, 28-37
CrossRef583
John D. Fisher. (2005) Who Needs a Defibrillator?. Journal of the American College of Cardiology 46:9, 1727-1728
CrossRef584
James O. O’Neill, Randall C. Starling, Yaariv Khaykin, Patrick M. McCarthy, James B. Young, Melanie Hail, Nancy M. Albert, Nicholas Smedira, Mina K. Chung. (2005) Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery. The Journal of Thoracic and Cardiovascular Surgery 130:5, 1250-1256
CrossRef585
Gerald V. Naccarelli. (2005) Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clinical Cardiology 28:S1, 51-57
CrossRef586
Eric N. Prystowsky. (2005) Prevention of sudden cardiac death. Clinical Cardiology 28:S1, 12-18
CrossRef587
Philip J. Podrid, Robert J. Myerburg. (2005) Epidemiology and stratification of risk for sudden cardiac death. Clinical Cardiology 28:S1, 3-11
CrossRef588
H. C. Ott, J. McCue, D. A. Taylor. (2005) Cell–based cardiovascular repair. Basic Research in Cardiology 100:6, 504-517
CrossRef589
NICHOLAS S. PETERS. (2005) Arrhythmias After Cell Transplantation for Myocardial Regeneration: Natural History or Result of the Intervention?. Journal of Cardiovascular Electrophysiology 16:11, 1255-1257
CrossRef590
Kelley P. Anderson. (2005) Sudden Cardiac Death Unresponsive to Implantable Defibrillator Therapy: An Urgent Target for Clinicians, Industry and Government. Journal of Interventional Cardiac Electrophysiology 14:2, 71-78
CrossRef591
Abdou Elhendy, Scott Chapman, Thomas R. Porter, John Windle. (2005) Association of Myocardial Ischemia With Mortality and Implantable Cardioverter-Defibrillator Therapy in Patients With Coronary Artery Disease at Risk of Arrhythmic Death. Journal of the American College of Cardiology 46:9, 1721-1726
CrossRef592
Sanders, Gillian D., Hlatky, Mark A., Owens, Douglas K., . (2005) Cost-Effectiveness of Implantable Cardioverter–Defibrillators. New England Journal of Medicine 353:14, 1471-1480
Full Text593
Sana M. Al-Khatib, F. Lee Lucas, James G. Jollis, David J. Malenka, David E. Wennberg. (2005) The Relation Between Patients’ Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. Journal of the American College of Cardiology 46:8, 1536-1540
CrossRef594
Loren D. Berenbom, Brian C. Weiford, James L. Vacek, Martin P. Emert, W. Jackson Hall, Mark L. Andrews, Scott McNitt, Wojciech Zareba, Arthur J. Moss, . (2005) Differences in Outcomes Between Patients Treated with Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Annals of Noninvasive Electrocardiology 10:4, 429-435
CrossRef595
V. Suberviola Sánchez-Caballero, R. Salguero Bodes, J.J. Parra Fuertes, C. Sáenz de la Calzada Campos. (2005) Infarto agudo de miocardio. Criterios diagnósticos y pronósticos. Cardiopatía isquémica en la tercera edad. Medicine - Programa de Formación Médica Continuada Acreditado 9:40, 2633-2642
CrossRef596
Gerard M. Guiraudon, Douglas L. Jones, Allan C. Skanes, Daniel Bainbridge, Colette M. Guiraudon, Steen M. Jensen, Xiaping Yuan, Maria Drangova, Terry M. Peters. (2005) En Bloc Exclusion of the Pulmonary Vein Region in the Pig Using Off Pump, Beating, Intra-Cardiac Surgery: A Pilot Study of Minimally Invasive Surgery for Atrial Fibrillation. The Annals of Thoracic Surgery 80:4, 1417-1423
CrossRef597
David S. Cannom, Morton Mower. (2005) Relationship of the Implantable Cardioverter Defibrillator and Chronic Resynchronization Therapy: The Perfect Marriage?. Annals of Noninvasive Electrocardiology 10:s4, 24-33
CrossRef598
R. Matía Francés, V. Suberviola Sánchez-Caballero, I. Sánchez Pérez, C. Sáenz de la Calzada Campos. (2005) Tratamiento de las complicaciones del infarto de miocardio. Medicine - Programa de Formación Médica Continuada Acreditado 9:40, 2671-2681
CrossRef599
PHILIPPINE KIES, ERIC BOERSMA, JEROEN J. BAX, ALIDA E. BORGER van der BURG, MARIANNE BOOTSMA, LIESELOT van ERVEN, ERNST E. van der WALL, MARTIN J. SCHALIJ. (2005) Determinants of Recurrent Ventricular Arrhythmia or Death in 300 Consecutive Patients with Ischemic Heart Disease Who Experienced Aborted Sudden Death: Data from the Leiden Out-of-Hospital Cardiac Arrest Study. Journal of Cardiovascular Electrophysiology 16:10, 1049-1056
CrossRef600
Etsuko Tsuda, Yoshio Arakaki, Toshio Shimizu, Heima Sakaguchi, Shinichiro Yoshimura, Satoshi Yazaki, Shigeyuki Echigo. (2005) Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease. Cardiology in the Young 15:05, 481
CrossRef601
M. Di Donato, M. Sabatier, V. Dor, G. Buckberg, . (2005) Ventricular Arrhythmias after LV Remodelling: Surgical Ventricular Restoration or ICD?. Heart Failure Reviews 9:4, 299-306
CrossRef602
Veronique Sebille, Eric Bellissant. (2005) Impact of a misspecification of the response rate under standard treatment in sequential clinical trials. Fundamental and Clinical Pharmacology 19:5, 569-578
CrossRef603
Vinod Jayam, Menekhem Zviman, Venku Jayanti, Ariel Roguin, Henry Halperin, Ronald D. Berger. (2005) Internal defibrillation with minimal skeletal muscle activation: A new paradigm toward painless defibrillation. Heart Rhythm 2:10, 1108-1113
CrossRef604
Jennifer S. Davids, Craig A. McPherson, Christine Earley, William P. Batsford, Rachel Lampert. (2005) Benefits of Cardiac Rehabilitation in Patients With Implantable Cardioverter-Defibrillators: A Patient Survey. Archives of Physical Medicine and Rehabilitation 86:10, 1924-1928
CrossRef605
SANA M. AL-KHATIB. (2005) Does ICD Therapy Benefit Women with a History of Myocardial Infarction and Severe Left Ventricular Dysfunction?. Journal of Cardiovascular Electrophysiology 0:0, 050902082157002
CrossRef606
(2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Revista Española de Cardiología 58:9, 1062-1092
CrossRef607
Manolis Michalodimitrakis, Anna Mavroforou, Athanasios D. Giannoukas. (2005) Lessons learnt from the autopsies of 445 cases of sudden cardiac death in adults. Coronary Artery Disease 16:6, 385-389
CrossRef608
Zachary Goldberger, Brian Elbel, Craig A. McPherson, A. David Paltiel, Rachel Lampert. (2005) Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal of the American College of Cardiology 46:5, 850-857
CrossRef609
DAVID S. CANNOM. (2005) Prevention of Sudden Cardiac Death. Journal of Cardiovascular Electrophysiology 16:s1, S21-S24
CrossRef610
M. U. Braun, M. Knaut, T. Rauwolf, R. H. Strasser. (2005) Microwave Ablation of an Ischemic Sustained Ventricular Tachycardia During Aortocoronary Bypass, Mitral Valve and Tricuspid Valve Surgery Guided by a Three-Dimensional Nonfluoroscopic Mapping System (CARTO). Journal of Interventional Cardiac Electrophysiology 13:3, 243-247
CrossRef611
W. Jung, R. Birkemeyer. (2005) Home Monitoring mit implantierbaren Defibrillatoren. Herzschrittmachertherapie & Elektrophysiologie 16:3, 183-190
CrossRef612
Wataru Shimizu, Kazuhiro Satomi. (2005) Implications and problems of the Sudden Cardiac Death in Heart Failure Trial. Future Cardiology 1:5, 599-603
CrossRef613
ALFRED E. BUXTON. (2005) Identifying the High Risk Patient with Coronary Artery Disease-Is Ejection Fraction All You Need?. Journal of Cardiovascular Electrophysiology 16:s1, S25-S27
CrossRef614
Leon M. Ptaszek, Paul J. Wang, Sharon A. Hunt, Hannah Valantine, Mark Perlroth, Amin Al-Ahmad. (2005) Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. Heart Rhythm 2:9, 931-933
CrossRef615
BEATRICE BREMBILLA-PERROT, CHRISTINE SUTY-SELTON, OLIVIER CLAUDON, ARNAUD TERRIER DE LA CHAISE, PIERRE LOUIS, MARC NIPPERT, BATRIC POPOVIC, HUGUES BLANGY, EMAD KHALDI, HADJ BELHAKEM, DANIEL BEURRIER, PIERRE HOURIEZ. (2005) Significance of Inducible Ventricular Flutter-Fibrillation After Myocardial Infarction. Pacing and Clinical Electrophysiology 28:9, 938-943
CrossRef616
Anand Soni, Paul LeLorier. (2005) Sudden death in nondilated cardiomyopathies: Pathophysiology and prevention. Current Heart Failure Reports 2:3, 118-123
CrossRef617
CRAIG J. McCOTTER, J. FRITZ ANGLE, LIZA A. PRUDENTE, J. PAUL MOUNSEY, JOHN D. FERGUSON, JOHN P. DiMARCO, JAMES P. HUMMEL, J. MICHAEL MANGRUM. (2005) Placement of Transvenous Pacemaker and ICD Leads Across Total Chronic Occlusions. Pacing and Clinical Electrophysiology 28:9, 921-925
CrossRef618
K. Seidl, A. Schuchert, J. Tebbenjohanns, W. Hartung. (2005) Kommentar zu den Leitlinien zur Diagnostik und Therapie von Synkopen—der Europäischen Gesellschaft für Kardiologie 2001 und dem Update 2004. Zeitschrift für Kardiologie 94:9, 592-612
CrossRef619
Frank A. Cuoco, Steven N. Singh. (2005) Nonsustained ventricular tachycardia in dilated cardiomyopathy. Current Cardiology Reports 7:5, 368-375
CrossRef620
PETER ALTER, STEFAN WALDHANS, EVELINE PLACHTA, RAINER MOOSDORF, WOLFRAM GRIMM. (2005) Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients. Pacing and Clinical Electrophysiology 28:9, 926-932
CrossRef621
Prash Jayaraj, Kevin M. Monahan. (2005) Sudden cardiac death and the role of device therapy in dilated cardiomyopathy. Current Heart Failure Reports 2:3, 124-127
CrossRef622
Matthew W. Ebinger, Subramaniam Krishnan, Claudio D. Schuger. (2005) Mechanisms of ventricular arrhythmias in heart failure. Current Heart Failure Reports 2:3, 111-117
CrossRef623
(2005) The Leadless Defibrillator or the Return of the Subcutaneous Electrode: Episode III in the ICD Saga?. Journal of Interventional Cardiac Electrophysiology 13:3, 179-180
CrossRef624
ELIYAH STOUPEL, JAIRO KUSNIEC, ALEXANDER MAZUR, RONIT ZABARSKY, GREGORY GOLOVCHINER, EVGENY ABRAMSON, BORIS STRASBERG, ALEXANDER BATTLER. (2005) Temporal Relationship of Implantable Cardioverter Defibrillator Discharges and Environmental Physical Activity. Pacing and Clinical Electrophysiology 28:8, 777-781
CrossRef625
Daniel J. Garry, Sean C. Goetsch, Amanda J. McGrath, Pradeep P.A. Mammen. (2005) Alternative Therapies for Orthotopic Heart Transplantation. The American Journal of the Medical Sciences 330:2, 88-101
CrossRef626
Arjun D. Sharma, Carlos Rizo-Patron, Alfred P. Hallstrom, Gearoid P. O’Neill, Stephen Rothbart, James B. Martins, Marc Roelke, Jonathan S. Steinberg, H. Leon Greene. (2005) Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2:8, 830-834
CrossRef627
Eric C. Stecker, Katherine R. Strelich, Sumeet S. Chugh, Kathy Crispell, John H. McAnulty. (2005) Arrhythmias After Orthotopic Heart Transplantation. Journal of Cardiac Failure 11:6, 464-472
CrossRef628
Y. Juillière. (2005) Stratification du risque dans l'insuffisance cardiaque chronique. Annales de Cardiologie et d'Angéiologie 54:4, 172-178
CrossRef629
N. A. Mark Estes III. (2005) Primary Prevention of Sudden Cardiac Death: A Rational Approach to the Use of the Implantable Cardioverter Defibrillator. Journal of Interventional Cardiac Electrophysiology 13:2, 91-93
CrossRef630
LORNE J. GULA, ALYSON AMES, ASHLEY WOODBURN, JOHN MATKINS, MICHAEL McCORMICK, JEFFREY BELL, DEBORAH SINK, JAMES McCONVILLE, LAURENCE M. EPSTEIN. (2005) Central Venous Occlusion Is Not an Obstacle to Device Upgrade with the Assistance of Laser Extraction. Pacing and Clinical Electrophysiology 28:7, 661-666
CrossRef631
C. Richard Conti. (2005) Ventricular arrhythmias: A general cardiologist's assessment of therapies in 2005. Clinical Cardiology 28:7, 314-316
CrossRef632
Robert D Winslow, Davendra Mehta, Valentin Fuster. (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nature Clinical Practice Cardiovascular Medicine 2:7, 352-360
CrossRef633
Alfred E. Buxton, Michael O. Sweeney, Mark S. Wathen, Mark E. Josephson, Mary F. Otterness, Elaine Hogan-Miller, Alice J. Stark, Paul J. DeGroot. (2005) QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators. Journal of the American College of Cardiology 46:2, 310-316
CrossRef634
ANDREW T. HO, SUDHA M. PAI, PAM TIMOTHY, RAMDAS G. PAI. (2005) Effect of Concomitant Antiarrhythmic Therapy on Survival in Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:7, 647-653
CrossRef635
A. Maybhate, S.C. Hao, S. Iwai, J.U. Lee, A.B. Guttigoli, K.M. Stein, B.B. Lerman, D.J. Christini. (2005) Detection of Repolarization Alternans With an Implantable Cardioverter Defibrillator Lead in a Porcine Model. IEEE Transactions on Biomedical Engineering 52:7, 1188-1194
CrossRef636
Buxton, Alfred E., . (2005) Sudden Death after Myocardial Infarction — Who Needs Prophylaxis, and When?. New England Journal of Medicine 352:25, 2638-2640
Full Text637
A. García Alberola, J. Martínez Sánchez, M. Valdés Mas, M. Valdés Chávarri. (2005) Protocolo terapéutico de las arritmias asociadas a cardiopatía isquémica. Medicine - Programa de Formación Médica Continuada Acreditado 9:37, 2478-2480
CrossRef638
I.P. Garrido Bravo, J.Á. Rodríguez Fernández, J. García de Lara, A. Castro Beiras. (2005) Tratamiento de la insuficiencia cardíaca crónica. Medicine - Programa de Formación Médica Continuada Acreditado 9:35, 2318-2326
CrossRef639
H.-R Arntz, H.-J. Trappe. (2005) Frühdefibrillation: Perspektiven und Ausblick. Herzschrittmachertherapie & Elektrophysiologie 16:2, 112-117
CrossRef640
M.C. Viana Llamas, A. Hernández Madrid, C. Moro Serrano. (2005) Tratamiento de las taquiarritmias por métodos no farmacológicos. Técnicas de ablación. Desfibriladores. Medicine - Programa de Formación Médica Continuada Acreditado 9:36, 2391-2399
CrossRef641
Roy S. Gardner, Kwok S. Chong, James J. Morton, Theresa A. Mcdonagh. (2005) N-Terminal Brain Natriuretic Peptide, But Not Anemia, Is a Powerful Predictor of Mortality in Advanced Heart Failure. Journal of Cardiac Failure 11:5, S47-S53
CrossRef642
A. García Alberola, E. Pinar Bermúdez, M. Valdés Mas, M. Valdés Chávarri. (2005) Arritmias en situaciones especiales. Anciano. Enfermedades metabólicas e hidroelectrolíticas. Arritmias en la cardiopatía isquémica. Medicine - Programa de Formación Médica Continuada Acreditado 9:37, 2455-2462
CrossRef643
A. Hernández Madrid, C. Moro Serrano. (2005) Indicaciones de estudio electrofisiológico cardíaco. Medicine - Programa de Formación Médica Continuada Acreditado 9:36, 2418-2419
CrossRef644
T. Jared Bunch, Stephen C. Hammill, Roger D. White. (2005) Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival. Mayo Clinic Proceedings 80:6, 774-782
CrossRef645
D. Stephen Coad, Anastasia Ivanova. (2005) The use of the triangular test with response-adaptive treatment allocation. Statistics in Medicine 24:10, 1483-1493
CrossRef646
Paul S. Chan, Rodney A. Hayward. (2005) Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia. Journal of the American College of Cardiology 45:9, 1474-1481
CrossRef647
Andrea M. Russo, William Sauer, Edward P. Gerstenfeld, Henry H. Hsia, David Lin, Joshua M. Cooper, Sanjay Dixit, Ralph J. Verdino, Hemal M. Nayak, David J. Callans, Vickas Patel, Francis E. Marchlinski. (2005) Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2:5, 456-461
CrossRef648
Eric M. Crespo, Jane Kim, Kimberly A. Selzman. (2005) The Use of Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: A Review of the Evidence and Implications. The American Journal of the Medical Sciences 329:5, 238-246
CrossRef649
Aslan T. Turer, Sunil V. Rao. (2005) Device Therapy in the Management of Congestive Heart Failure. Cardiology in Review 13:3, 130-138
CrossRef650
MICHAEL O. SWEENEY. (2005) The Nature of the Game. Journal of Cardiovascular Electrophysiology 16:5, 483-485
CrossRef651
Mahi Lakshmi Ashwath, Felix O. Sogade. (2005) Ejection Fraction and QRS Width as Predictors of Event Rates in Patients with Implantable Cardioverter Defibrillators. Southern Medical Journal 98:5, 513-517
CrossRef652
R. Sukhija, W. S. Aronow, C. Sorbera, K. Yalamanchili, M. Cohen. (2005) Patients, Mean Age 70 Years, With Automatic Implantable Cardioverter-Defibrillators Treated With Dual-Chamber Rate Responsive Pacing (DDDR-70) Have a Higher Mortality Than Patients With Backup Ventricular Pacing (VVI-40) at 3.7-Year Follow-Up. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:5, 603-604
CrossRef653
Oliver R. Segal, Anthony W.C. Chow, Vias Markides, Richard J. Schilling, Nicholas S. Peters, D. Wyn Davies. (2005) Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm 2:5, 474-482
CrossRef654
Isaac Pourati, Michael Hyder, Lawrence Rosenthal. (2005) Indications for implantable cardiac defibrillators in patients with congestive heart failure: Implications of the sudden cardiac death in heart failure trial. Current Cardiology Reports 7:3, 223-228
CrossRef655
Gerald V. Naccarelli, Mary Ann Lukas. (2005) Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction. Clinical Cardiology 28:4, 165-173
CrossRef656
HIROSHI WATANABE, MASAOMI CHINUSHI, TAKASHI WASHIZUKA, HIROTAKA SUGIURA, TAKASHI HIRONO, SATORU KOMURA, YUKIO HOSAKA, YASUTAKA TANABE, HIROSHI FURUSHIMA, SATOSHI FUJITA, KIMINORI KATO, YOSHIFUSA AIZAWA. (2005) Electrophysiologic Study-Guided Therapy with Sotalol for Life-Threatening Ventricular Tachyarrhythmias. Pacing and Clinical Electrophysiology 28:4, 285-290
CrossRef657
José Mauricio Sánchez, William T. Katsiyiannis, Brian F. Gage, Jane Chen, Mitchell N. Faddis, Marye J. Gleva, Timothy W. Smith, Bruce D. Lindsay. (2005) Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study. Heart Rhythm 2:4, 367-373
CrossRef658
Alan Kadish. (2005) Should every patient with left-ventricular systolic dysfunction receive implantable cardioverter-defibrillators?. Nature Clinical Practice Cardiovascular Medicine 2:4, 188-189
CrossRef659
Anne B Curtis. (2005) Do implantable cardioverter-defibrillators benefit patients immediately after acute myocardial infarction?. Nature Clinical Practice Cardiovascular Medicine 2:4, 192-193
CrossRef660
Eric J. Rashba. (2005) Should T-wave alternans testing be used to risk stratify candidates for prophylactic implantable cardioverter-defibrillator therapy?. Heart Rhythm 2:3, 242-244
CrossRef661
William H Maisel. (2005) Cardiovascular Device Development: Lessons Learned from Pacemaker and Implantable Cardioverter-Defibrillator Therapy. American Journal of Therapeutics 12:2, 183-185
CrossRef662
Timothy D. Brennan, Garrie J. Haas. (2005) The role of prophylactic implantable cardioverter defibrillators in heart failure: Recent trials usher in a new era of device therapy. Current Heart Failure Reports 2:1, 40-45
CrossRef663
Peter Cram, Sandeep Vijan, David Katz, A. Mark Fendrick. (2005) Cost-effectiveness of In-home Automated External Defibrillators for Individuals at Increased Risk of Sudden Cardiac Death. There's No Place Like Home?. Journal of General Internal Medicine 20:3, 251-258
CrossRef664
MICHAEL O. SWEENEY, MARK H. SCHOENFELD, DAVID S. CANNOM. (2005) Rules of Evidence:. CMS and Primary Prevention of Sudden Cardiac Death in Systolic Heart Failure. Pacing and Clinical Electrophysiology 28:2, 81-88
CrossRef665
Kathy A. Hodgkinson, Patrick S. Parfrey, Anne S. Bassett, Christine Kupprion, Jörg Drenckhahn, Mark W. Norman, Ludwig Thierfelder, Susan N. Stuckless, Elizabeth L. Dicks, William J. McKenna, Sean P. Connors. (2005) The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). Journal of the American College of Cardiology 45:3, 400-408
CrossRef666
G. D. Veenhuyzen, C. S. Simpson. (2005) LETTERS TO THE EDITOR: 1. Pacing and Clinical Electrophysiology 28:2, 173-174
CrossRef667
Steven Higgins, David Mann, Hugh Calkins, N.A.Mark Estes, S.Adam Strickberger, David Breiter, Douglas Lang, Stephen Hahn. (2005) One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: An analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2:2, 117-122
CrossRef668
Beena B Johnson, Johnson Francis, Beena B Johnson. 2005. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators. .
CrossRef669
Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H., . (2005) Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure. New England Journal of Medicine 352:3, 225-237
Full Text670
Kadish, Alan, . (2005) Prophylactic Defibrillator Implantation — Toward an Evidence-Based Approach. New England Journal of Medicine 352:3, 285-287
Full Text671
Takashi Washizuka, Masaomi Chinushi, Hiroshi Watanabe, Yukio Hosaka, Satoru Komura, Hirotaka Sugiura, Takashi Hirono, Hiroshi Furushima, Yasutaka Tanabe, Yoshifusa Aizawa. (2005) Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias. Circulation Journal 69:12, 1508-1513
CrossRef672
Syusuke Yagi, Etsuko Tsuda, Wataru Shimizu, Takashi Kurita, Osamu Seguchi, Hiroshi Nonogi, Shiro Kamakura. (2005) Two Adults Requiring Implantable Defibrillators Because of Ventricular Tachycardia and Left Ventricular Dysfunction Caused by Presumed Kawasaki Disease. Circulation Journal 69:7, 870-874
CrossRef673
Eric J. Rashba, Stephen R. Shorofsky, Traci Brown, Robert W. Peters, Michael R. Gold. (2005) Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2:1, 49-54
CrossRef674
Shahriar Iravanian, Aysha Arshad, Jonathan S. Steinberg. (2005) Role of Electrophysiologic Studies, Signal-Averaged Electrocardiography, Heart Rate Variability, T-Wave Alternans, and Loop Recorders for Risk Stratification of Ventricular Arrhythmias. The American Journal of Geriatric Cardiology 14:1, 16-19
CrossRef675
Antoni Martínez-Rubio, Gabriel Gusi, Eva Guillaumet, Montse Cazorla, Sonia Galán, Rosa Bagà, Elena Guilera, Manel Bonastre, Joan Raimón Gumà, Ignaci Anguera, Sonia Ibars, Ana Ochagavia, Jaume Mestre, Juli Font, Pilar Saura, Martí Dalmases, Lluís Blanch, Antoni Artigas. (2005) The fully automatic external cardioverter defibrillator: reality of a new meaningful scenario for in-hospital cardiac arrests. Expert Review of Medical Devices 2:1, 33-39
CrossRef676
Sanjeev Saksena. (2005) Federal Guidelines for Prophylactic ICD Therapy in High Risk Populations for Sudden Cardiac Death: Is this a Necessary Course Correction?. Journal of Interventional Cardiac Electrophysiology 12:1, 5-7
CrossRef677
Kevin J. Ferrick. (2005) Antiarrhythmic Therapy in Elderly Persons: A Device-Based Approach. The American Journal of Geriatric Cardiology 14:1, 10-15
CrossRef678
Sergio Richter, Gabor Duray, Gerian Grönefeld, Carsten W Israel, Stefan H Hohnloser. (2005) Prevention of Sudden Cardiac Death. Circulation Journal 69:6, 625-629
CrossRef679
ALEXANDER DELVECCHIO, HEATHER A. TRIVEDI, JOHN D. FISHER, SOO G. KIM, KEVIN J. FERRICK, JAY N. GROSS, EUGEN C. PALMA. (2005) Value of Pre-Hospital Discharge Defibrillation Testing in Recipients of Implanted Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 28:s1, S260-S262
CrossRef680
C. Leclercq. (2005) La resynchronisation cardiaque : quel type d’appareil utiliser ?. Annales de Cardiologie et d'Angéiologie 54:1, 12-16
CrossRef681
Hohnloser, Stefan H., Kuck, Karl Heinz, Dorian, Paul, Roberts, Robin S., Hampton, John R., Hatala, Robert, Fain, Eric, Gent, Michael, Connolly, Stuart J., . (2004) Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction. New England Journal of Medicine 351:24, 2481-2488
Full Text682
Gillis, Anne M., . (2004) Prophylactic Implantable Cardioverter–Defibrillators after Myocardial Infarction — Not for Everyone. New England Journal of Medicine 351:24, 2540-2542
Full Text683
Dominic A.M.J. Theuns, A. Peter J. Klootwijk, Dick M. Goedhart, Luc J.L.M. Jordaens. (2004) Prevention of inappropriate therapy in implantable cardioverter-defibrillators. Journal of the American College of Cardiology 44:12, 2362-2367
CrossRef684
Kumaraswamy Nanthakumar, Andrew E. Epstein, G. Neal Kay, Vance J. Plumb, Douglas S. Lee. (2004) Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology 44:11, 2166-2172
CrossRef685
David Rosenthal, Maryanne R.K. Chrisant, Erik Edens, Lynn Mahony, Charles Canter, Steven Colan, Anne Dubin, Jacque Lamour, Robert Ross, Robert Shaddy, Linda Addonizio, Lee Beerman, Stuart Berger, Daniel Bernstein, Elizabeth Blume, Mark Boucek, Paul Checchia, Anne Dipchand, Jonathan Drummond-Webb, Jay Fricker, Richard Friedman, Sara Hallowell, Robert Jaquiss, Seema Mital, Elfriede Pahl, Bennett Pearce, Larry Rhodes, Kathy Rotondo, Paolo Rusconi, Janet Scheel, Tajinder Pal Singh, Jeffrey Towbin. (2004) International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. The Journal of Heart and Lung Transplantation 23:12, 1313-1333
CrossRef686
Wojciech Zareba. (2004) Implantable cardioverter defibrillator therapy in postinfarction patients. Current Opinion in Cardiology 19:6, 619-624
CrossRef687
W. S. Aronow. (2004) Management of the Elderly Person After Myocardial Infarction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:11, 1173-1185
CrossRef688
Robert M. Lobel, Daniel L. Lustgarten. (2004) Treatment of arrhythmias in patients with congestive heart failure. Current Treatment Options in Cardiovascular Medicine 6:6, 519-529
CrossRef689
John C Somberg, Janos Molnar. (2004) The Pharmacologic Treatment of Heart Failure. American Journal of Therapeutics 11:6, 480-488
CrossRef690
Heather M. Ross, Dusan Z. Kocovic. (2004) Cardiac resynchronization therapy for heart failure. Current Treatment Options in Cardiovascular Medicine 6:5, 365-370
CrossRef691
GERALD V. NACCARELLI. (2004) Can We Predict Antiarrhythmic Efficacy or Inefficacy of Amiodarone or Any Other Antiarrhythmic? What This Patient Needs Is a Doctor!. Journal of Cardiovascular Electrophysiology 15:10, 1155-1156
CrossRef692
MANINDER S. BEDI, LISA A. POSTAVA, SRINIVAS MURALI, GUY A. MACGOWAN, MICHAEL MATHIER, DENNIS M. MCNAMARA, BARRY LONDON. (2004) Interaction of Implantable Defibrillator Therapy with Angiotensin-Converting Enzyme Deletion/Insertion Polymorphism. Journal of Cardiovascular Electrophysiology 15:10, 1162-1166
CrossRef693
Jill Vesty, Kismet D. Rasmusson, Jill Hall, Sandy Schmitz, Sally Brush. (2004) Cardiac Resynchronization Therapy and Automatic Implantable Cardiac Defibrillators in the Treatment of Heart Failure: A Review Article. Journal of the American Academy of Nurse Practitioners 16:10, 441-450
CrossRef694
Robert G. Hauser, Linda Kallinen. (2004) Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 1:4, 399-405
CrossRef695
KLAUS KETTERING, CHRISTIAN MEWIS, VOLKER DORNBERGER, REINHARD VONTHEIN, RALPH F. BOSCH, LUDGER SEIPEL, VOLKER KUHLKAMP. (2004) Long-Term Experience with Subcutaneous ICD Leads:. A Comparison Among Three Different Types of Subcutaneous Leads. Pacing and Clinical Electrophysiology 27:10, 1355-1361
CrossRef696
Omer L. Shedd, Samuel F. Sears, Jane L. Harvill, Aysha Arshad, Jamie B. Conti, Jonathan S. Steinberg, Anne B. Curtis. (2004) The World Trade Center attack: Increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. Journal of the American College of Cardiology 44:6, 1265-1267
CrossRef697
Hein J.J. Wellens. (2004) Cardiac arrhythmias: The quest for a cure. Journal of the American College of Cardiology 44:6, 1155-1163
CrossRef698
BRIAN F. MCBRIDE, DANETTE GUERTIN, C. MICHAEL WHITE, JEFFREY KLUGER. (2004) Inappropriate Implantable Cardioverter Defibrillator Discharge Following Consumption of a Dietary Weight Loss Supplement. Pacing and Clinical Electrophysiology 27:9, 1317-1320
CrossRef699
Abrar H. Shah, David T. Huang, Spencer Z. Rosero, James P. Daubert. (2004) Update on implantable cardioverter defibrillator trials. Current Cardiology Reports 6:5, 327-332
CrossRef700
Lydia A. Conlay. (2004) Special Concerns in the Cardiac Catheterization Lab. International Anesthesiology Clinics 41:2, 63-67
CrossRef701
T.Jared Bunch, Roger D. White, Paul A. Friedman, Thomas E. Kottke, Lambert A. Wu, Douglas L. Packer. (2004) Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-year population-based study. Heart Rhythm 1:3, 255-259
CrossRef702
Sri Sundaram, Jeffrey J. Goldberger. (2004) Risk stratification and epidemiology of sudden death. Current Cardiology Reports 6:5, 333-338
CrossRef703
ANNE B. CURTIS. (2004) Prevention of Sudden Cardiac Death:. When Is a Woman Just Like a Man?. Journal of Cardiovascular Electrophysiology 15:9, 999-1001
CrossRef704
BRUCE L. WILKOFF, MIKE HESS, JAMES YOUNG, WILLIAM T. ABRAHAM. (2004) Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients. Journal of Cardiovascular Electrophysiology 15:9, 1002-1009
CrossRef705
Steven Kang, David S. Cannom. (2004) Current role of device therapy to reduce sudden cardiac death in heart failure. Current Heart Failure Reports 1:3, 104-110
CrossRef706
Anne B. Curtis, Kenneth A. Ellenbogen, Stephen C. Hammill, David L. Hayes, Dwight W. Reynolds, David J. Wilber, Michael E. Cain. (2004) Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1:3, 371-375
CrossRef707
Samuel F. Sears, Eva R. Serber, Tara Saia Lewis, Robyn L. Walker, Nancy Conners, John T. Lee, Anne B. Curtis, Jamie B. Conti. (2004) Do Positive Health Expectations and Optimism Relate to Quality-of-Life Outcomes for the Patient With an Implantable Cardioverter Defibrillator?. Journal of Cardiopulmonary Rehabilitation 24:5, 324-331
CrossRef708
JOHN R. PAISEY, ARTHUR M. YUE, FREDERICK BESSOULE, STUART ALLEN, PAUL R. ROBERTS, JOHN M. MORGAN. (2004) Examination of a Middle Cardiac Vein Defibrillation Coil as Stand-Alone Anode, Auxiliary Anode, and Bystander Electrode in a Transvenous Defibrillation Circuit. Pacing and Clinical Electrophysiology 27:8, 1089-1093
CrossRef709
Peter Ammann, Hanspeter Brunner-La Rocca, Thomas Fehr, Thomas M
CrossRef710
CENGIZ ERMIS, KEITH G. LURIE, ALAN X. ZHU, JOANNE COLLINS, LAURA VANHEEL, SCOTT SAKAGUCHI, FEI LU, SCOTT PHAM, DAVID G. BENDITT. (2004) Biventricular Implantable Cardioverter Defibrillators Improve Survival Compared with Biventricular Pacing Alone in Patients with Severe Left Ventricular Dysfunction. Journal of Cardiovascular Electrophysiology 15:8, 862-866
CrossRef711
Julia H Indik. (2004) The evolution and revolution of the implantable cardioverter defibrillator. Expert Review of Cardiovascular Therapy 2:4, 461-464
CrossRef712
Rajan Krishnamani, David DeNofrio. (2004) Device therapy for the management of advanced heart failure. Expert Review of Cardiovascular Therapy 2:4, 573-580
CrossRef713
ROSE M.F.L. SILVA, LLUIS MONT, SANTIAGO NAVA, ULISES ROJEL, MARIONA MATAS, JOSEP BRUGADA. (2004) Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:7, 971-975
CrossRef714
F. JAMES BRENNAN. (2004) Ethical Issues with Implantable Defibrillators. Pacing and Clinical Electrophysiology 27:7, 897-898
CrossRef715
THOMAS KORTE, HARALD KODITZ, MICHAEL NIEHAUS, THOMAS PAUL, JURGEN TEBBENJOHANNS. (2004) High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:7, 924-932
CrossRef716
S.Adam Strickberger, George J Klein. (2004) Is defibrillation testing required for defibrillator implantation?. Journal of the American College of Cardiology 44:1, 88-91
CrossRef717
Nanette K. Wenger, Gabriel Gregoratos, Dalane W. Kitzman, Stephen Scheidt, Michael A. Weber, Joseph S. Alpert. (2004) Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: Commentary by Editorial Board Members of The American Journal of Geriatric Cardiology. CARDIAC ARRHYTHMIAS. HEART FAILURE. CORONARY ARTERY DISEASE (CHRONIC STABLE ANGINA, ACUTE CORONARY SYNDROME, ACUTE MI). SYSTEMIC ARTERIAL HYPERTENSION. VALVULOPATHIES. CARDIOVASCULAR RISK PREVENTION. The American Journal of Geriatric Cardiology 13:4, 209-209
CrossRef718
Gerald V Naccarelli. (2004) Implantable cardioverter-defibrillators: expanding indications. Current Opinion in Cardiology 19:4, 317-322
CrossRef719
Rachel Lampert, Craig A. McPherson, Jude F. Clancy, Teresa L. Caulin-Glaser, Lynda E. Rosenfeld, William P. Batsford. (2004) Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. Journal of the American College of Cardiology 43:12, 2293-2299
CrossRef720
MARK H. SCHOENFELD, STEVEN J. COMPTON, R. HARDWIN MEAD, DANIEL N. WEISS, LOU SHERFESEE, JENNIFER ENGLUND, LUC R. MONGEON. (2004) Remote Monitoring of Implantable Cardioverter Defibrillators:. A Prospective Analysis. Pacing and Clinical Electrophysiology 27:6p1, 757-763
CrossRef721
ANIL-MARTIN SINHA, CHRISTOPH STELLBRINK, ANDREAS SCHUCHERT, BERNHARD MOX, LUC JORDAENS, DOMINIQUE LAMAISON, JASWINDER GILL, ANDREW KAPLAN, BELA MERKELY, . (2004) Clinical Experience with a New Detection Algorithm for Differentiation of Supraventricular from Ventricular Tachycardia in a Dual-Chamber Defibrillator. Journal of Cardiovascular Electrophysiology 15:6, 646-652
CrossRef722
Frank Godemann, Christian Butter, Felix Lampe, Michael Linden, Michael Schlegl, Hans-Peter Schultheiss, Steffen Behrens. (2004) Panic disorders and agoraphobia: Side effects of treatment with an implantable cardioverter/defibrillator. Clinical Cardiology 27:6, 321-326
CrossRef723
Anne M Williams, Jeanne Young, Sue Nikoletti, Shelley McRae. (2004) Reasons for attending and not attending a support group for recipients of implantable cardioverter defibrillators and their carers. International Journal of Nursing Practice 10:3, 127-133
CrossRef724
R. Buchhorn. (2004) Medikamentöse Therapie der Herzinsuffizienz im Kindesalter. Monatsschrift Kinderheilkunde 152:6, 659-665
CrossRef725
Kadish, Alan, Dyer, Alan, Daubert, James P., Quigg, Rebecca, Estes, N.A. Mark, Anderson, Kelley P., Calkins, Hugh, Hoch, David, Goldberger, Jeffrey, Shalaby, Alaa, Sanders, William E., Schaechter, Andi, Levine, Joseph H., . (2004) Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. New England Journal of Medicine 350:21, 2151-2158
Full Text726
ANTONIS A. ARMOUNDAS, CHRISTINE M. ALBERT, RICHARD J COHEN, THEOFANIE MELA, . (2004) Utility of Implantable Cardioverter Defibrillator Electrograms to Estimate Repolarization Alternans Preceding a Tachyarrhythmic Event. Journal of Cardiovascular Electrophysiology 15:5, 594-597
CrossRef727
Tapan Rami, Hue-Teh Shih. (2004) Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure. Current Opinion in Cardiology 19:3, 264-269
CrossRef728
T. J. Bunch, R. D. White, B. J. Gersh, W.-K. Shen, S. C. Hammill, D. L. Packer. (2004) Outcomes and In-hospital Treatment of Out-of-Hospital Cardiac Arrest Patients Resuscitated From Ventricular Fibrillation by Early Defibrillation. Mayo Clinic Proceedings 79:5, 613-619
CrossRef729
Henry Greenberg, Robert B. Case, Arthur J. Moss, Mary W. Brown, Elizabeth R. Carroll, Mark L. Andrews. (2004) Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II). Journal of the American College of Cardiology 43:8, 1459-1465
CrossRef730
Chandra Kunavarapu, Daniel M. Bloomfield. (2004) Role of noninvasive studies in risk stratification for sudden cardiac death. Clinical Cardiology 27:4, 192-197
CrossRef731
G. G. Urizar. (2004) Psychosocial Intervention for a Geriatric Patient to Address Fears Related to Implantable Cardioverter Defibrillator Discharges. Psychosomatics 45:2, 140-144
CrossRef732
PETER A. NOSEWORTHY, ILAN LASHEVSKY, PAUL DORIAN, MARY GREENE, SUZAN CVITKOVIC, DAVID NEWMAN. (2004) Feasibility of Implantable Cardioverter Defibrillator Use in Elderly Patients:. Pacing and Clinical Electrophysiology 27:3, 373-378
CrossRef733
DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) The Evolution of the Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology 27:3, 419-431
CrossRef734
RISHI ARORA, ANDREW KRUMMERMAN, PUGAZHENDIHI VIJAYARAMAN, MICHAEL ROSENGARTEN, VANA SURYADEVARA, THIERRY LEJEMTEL, KEVIN J. FERRICK. (2004) Heart Rate Variability and Diastolic Heart Failure. Pacing and Clinical Electrophysiology 27:3, 299-303
CrossRef735
WILLIAM J. GROH, DEEPAK BHAKTA, MIRIAM R. LOWE, SUSAN J. BENNETT. (2004) Come See the Softer Side of Clinical Outcomes:. Journal of Cardiovascular Electrophysiology 15:3, 292-294
CrossRef736
DAVID S. CANNOM, ERIC N. PRYSTOWSKY. (2004) Evolution of the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 15:3, 375-385
CrossRef737
ERIC J. RASHBA, AHMED F. OSMAN, KAREN MACMURDY, MALCOLM M. KIRK, SAMANTHA E. SARANG, ROBERT W. PETERS, STEPHEN R. SHOROFSKY, MICHAEL R. GOLD. (2004) Enhanced Detection of Arrhythmia Vulnerability Using T Wave Alternans, Left Ventricular Ejection Fraction, and Programmed Ventricular Stimulation:. A Prospective Study in Subjects with Chronic Ischemic Heart Disease. Journal of Cardiovascular Electrophysiology 15:2, 170-176
CrossRef738
Ole A. Breithardt, Christoph Stellbrink. (2004) Current status of cardiac resynchronization therapy. Current Opinion in Anaesthesiology 17:1, 75-83
CrossRef739
J. Jason Sims, Michael R. Ujhelyi. (2004) Better Living Through Medical Device Technology. Pharmacotherapy 24:2, 298-306
CrossRef740
MARK E. ALEXANDER, FRANK CECCHIN, EDWARD P. WALSH, JOHN K. TRIEDMAN, LAURA M. BEVILACQUA, CHARLES I. BERUL. (2004) Implications of Implantable Cardioverter Defibrillator Therapy in Congenital Heart Disease and Pediatrics. Journal of Cardiovascular Electrophysiology 15:1, 72-76
CrossRef741
Rosemary S. Bubien, Elizabeth A. Ching, G. Neal Kay. (2004) Cardiac Defibrillation and Resynchronization Therapies. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 340-361
CrossRef742
Anne B Curtis. (2004) Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. Journal of the American College of Cardiology 43:1, 44-46
CrossRef743
Melanie T. Gura, Lynne Foreman. (2004) Cardiac Resynchronization Therapy for Heart Failure Management. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 326-339
CrossRef744
Steven L. Higgins, Sharon G. O'Grady, Isabelle Banville, Fred W. Chapman, Paul W. Schmitt, Paula Lank, Robert G. Walker, Marina Ilina. (2004) E
FFICACY OF LOWER-ENERGY BIPHASIC SHOCKS FOR TRANSTHORACIC DEFIBRILLATION : A FOLLOW-UP CLINICAL STUDY . Prehospital Emergency Care 8:3, 262-267
CrossRef745
Samuel F. Sears, Adrienne H. Kovacs, Lora Azzarello, Karin Larsen, Jamie B. Conti. (2004) Innovations in Health Psychology: The Psychosocial Care of Adults With Implantable Cardioverter Defibrillators.. Professional Psychology: Research and Practice 35:5, 520-526
CrossRef746
PATRICIO A. FRIAS. (2004) Implantable Cardioverter Defibrillators in Children:. Journal of Cardiovascular Electrophysiology 15:1, 77-78
CrossRef747
Samuel F. Sears, Adrienne H. Kovacs, Jamie B. Conti, Eileen Handberg. (2004) Expanding the Scope of Practice for Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation 24:4, 209-215
CrossRef748
Julie B. Shea. (2004) Quality of Life Issues in Patients With Implantable Cardioverter Defibrillators. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 478-489
CrossRef749
ARTHUR M. FELDMAN, HELMUT KLEIN, PATRICK TCHOU, SRINIVAS MURALI, W. JACKSON HALL, DONNA MANCINI, JOHN BOEHMER, MARK HARVEY, M. STEPHEN HEILMAN, STEVEN J. SZYMKIEWICZ, ARTHUR J. MOSS, . (2004) Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:. Results of WEARIT/BIROAD. Pacing and Clinical Electrophysiology 27:1, 4-9
CrossRef750
William S Weintraub, Hugh Kawabata, Michele Tran, Gilbert J L???italien, Roland S Chen. (2004) Cost of Heart Failure in Patients Receiving ??-Blockers and Angiotensin-Converting Enzyme Inhibitors. Clinical Drug Investigation 24:5, 255-264
CrossRef751
Dulce Obias-Manno, Mevan Wijetunga. (2004) Risk Stratification and Primary Prevention of Sudden Cardiac Death. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15:3, 404-418
CrossRef752
ANNIE DORE, PATRIZIA SANTAGATA, MARC DUBUC, LISE-ANDREE MERCIER. (2004) Implantable Cardioverter Defibrillators in Adults with Congenital Heart Disease:. A Single Center Experience. Pacing and Clinical Electrophysiology 27:1, 47-51
CrossRef753
Yoshifusa AIZAWA, Masaomi CHINUSHI, Takashi WASHIZUKA. (2004) Indications for an Implantable Cardioverter Defibrillator (ICD). Internal Medicine 43:5, 360-367
CrossRef754
Zoran Cosic, Dragan Tavciovski, Aleksandra Jovelic, Radoslav Romanovic. (2004) Late ventricular potentials in risk assessment of the occurrence of complex ventricular arrhythmia in patients with myocardial infarction and heart failure. Vojnosanitetski pregled 61:6, 589-597
CrossRef755
ANDREA M. RUSSO, HEMAL NAYAK, RALPH VERDINO, JAMIE SPRINGMAN, EDWARD GERSTENFELD, HENRY HSIA, FRANCIS E. MARCHLINSKI. (2003) Implantable Cardioverter Defibrillator Events in Patients with Asymptomatic Nonsustained Ventricular Tachycardia:. Pacing and Clinical Electrophysiology 26:12, 2289-2295
CrossRef756
Rajan Krishnamani, Mohamad El-Zaru, David DeNofrio. (2003) Contemporary medical, surgical, and device therapies for end-stage heart failure. Current Treatment Options in Cardiovascular Medicine 5:6, 487-499
CrossRef757
DAN M. RODEN. (2003) Antiarrhythmic Drugs:. Pacing and Clinical Electrophysiology 26:12, 2340-2348
CrossRef758
DiMarco, John P., . (2003) Implantable Cardioverter–Defibrillators. New England Journal of Medicine 349:19, 1836-1847
Full Text759
Sheila A Doggrell. (2003) Are implantable cardioverter-defribrillators always superior to amiodarone?. Expert Opinion on Pharmacotherapy 4:11, 2111-2114
CrossRef760
Lofty L. Basta. (2003) Routine Implantation of Cardioverter/Defibrillator Devices in Patients Aged 75 Years and Older With Prior Myocardial Infarction and Left Ventricular Ejection Fraction <30: Antagonist Viewpoint. The American Journal of Geriatric Cardiology 12:6, 363-365
CrossRef761
CHIA-TI TSAI, SHOEI K. STEPHEN HUANG, JIUNN-LEE LIN, LING-PING LAI, . (2003) Distinct Clinical Features in the Recipients of the Implantable Cardioverter Defibrillator in Taiwan:. A Multicenter Registry Study. Pacing and Clinical Electrophysiology 26:11, 2083-2090
CrossRef762
Arthur E. Fass. (2003) Perspectives in the Management of Chronic Coronary Artery Disease. Heart Disease 5:6, 365-367
CrossRef763
ERIC J. RASHBA, MATT BONNER, JOHN WILSON, STEPHEN R. SHOROFSKY, ROBERT W. PETERS, MICHAEL R. GOLD. (2003) Distal Right Ventricular Coil Position Reduces Defibrillation Thresholds. Journal of Cardiovascular Electrophysiology 14:10, 1036-1040
CrossRef764
Stephen J. Hahn, Joseph M. Smith. (2003) ICD therapy for the prevention of sudden cardiac death in post-MI patients. Current Treatment Options in Cardiovascular Medicine 5:5, 369-376
CrossRef765
NABIL EL-SHERIF, GIOIA TURITTO. (2003) Risk Stratification and Management of Sudden Cardiac Death:. Journal of Cardiovascular Electrophysiology 14:10, 1113-1119
CrossRef766
Veronique Sebille, Eric Bellissant. (2003) Sequential methods and group sequential designs for comparative clinical trials. Fundamental and Clinical Pharmacology 17:5, 505-516
CrossRef767
EDUARDO B. SAAD, WALID I. SALIBA, ROBERT A. SCHWEIKERT, AYMAN S. AL-KHADRA, AHMAD ABDUL-KARIM, MARK J. NIEBAUER, BRUCE L. WILKOFF. (2003) Nonthoracotomy Implantable Defibrillator Lead Extraction:. Results and Comparison with Extraction of Pacemaker Leads. Pacing and Clinical Electrophysiology 26:10, 1944-1950
CrossRef768
B. Hygriv Rao, Sanjeev Saksena. (2003) Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications. Current Opinion in Critical Care 9:5, 362-368
CrossRef769
SVEN REEK, J. CHRISTOPH GELLER, ULF MELTENDORF, ANKE WOLLBRUECK, STEVEN J. SZYMKIEWICZ, HELMUT U. KLEIN. (2003) Clinical Efficacy of a Wearable Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation Using Biphasic Shocks. Pacing and Clinical Electrophysiology 26:10, 2016-2022
CrossRef770
Michiel J. Janse. (2003) A brief history of sudden cardiac death and its therapy. Pharmacology & Therapeutics 100:1, 89-99
CrossRef771
A. JOHN CAMM. (2003) Translation of Clinical Trials into Clinical Practice:. Journal of Cardiovascular Electrophysiology 14, S9-S14
CrossRef772
RICHARD C. KLEIN, MERRITT H. RAITT, BRUCE L. WILKOFF, KAREN J. BECKMAN, JAMES COROMILAS, D. GEORGE WYSE, PETER L. FRIEDMAN, JAMES B. MARTINS, ANDREW E. EPSTEIN, ALFRED P. HALLSTROM, ROBERT B. LEDINGHAM, KAREN M. BELCO, H. LEON GREENE, . (2003) Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Journal of Cardiovascular Electrophysiology 14:9, 940-948
CrossRef773
Marina Roshini Sooriyarachchi, John Whitehead, Kim Bolland, Anne Whitehead. (2003) Incorporating Data Received after a Sequential Trial Has Stopped into the Final Analysis: Implementation and Comparison of Methods. Biometrics 59:3, 701-709
CrossRef774
SAMI VISKIN, MAYA ISH-SHALOM, EDWARD KOIFMAN, URI ROZOVSKI, DAVID ZELTSER, AHARON GLICK, ARIEL FINKELSTEIN, AMIR HALKIN, ROMAN FISH, BERNARD BELHASSEN. (2003) Ventricular Flutter Induced During Electrophysiologic Studies in Patients with Old Myocardial Infarction:. Clinical and Electrophysiologic Predictors, and Prognostic Significance. Journal of Cardiovascular Electrophysiology 14:9, 913-919
CrossRef775
Etienne J. Pruvot, David S. Rosenbaum. (2003) T-wave alternans for risk stratification and prevention of sudden cardiac death. Current Cardiology Reports 5:5, 350-357
CrossRef776
ARTHUR J. MOSS. (2003) MADIT-I and MADIT-II. Journal of Cardiovascular Electrophysiology 14, S96-S98
CrossRef777
LARRY D. LYND, BERNIE J. O'BRIEN. (2003) Cost-Effectiveness of the Implantable Cardioverter Defibrillator:. Journal of Cardiovascular Electrophysiology 14, S99-S103
CrossRef778
C. ALDO RINALDI, RON D.B. SIMON, PETER GEELEN, SVEN REEK, ARTUR BASZKO, MARTIN KUEHL, JASWINDER S. GILL. (2003) A Randomized Prospective Study of Single Coil Versus Dual Coil Defibrillation in Patients with Ventricular Arrhythmias Undergoing Implantable Cardioverter Defibrillator Therapy. Pacing and Clinical Electrophysiology 26:8, 1684-1690
CrossRef779
Heikki V Huikuri, Jari M Tapanainen, Kai Lindgren, Pekka Raatikainen, Timo H Mäkikallio, K.E Juhani Airaksinen, Robert J Myerburg. (2003) Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. Journal of the American College of Cardiology 42:4, 652-658
CrossRef780
Tomas Kara, Jiri Nykodym, Virend K. Somers. (2003) Heart Rate Variability:. Journal of Cardiovascular Electrophysiology 14:8, 800-802
CrossRef781
OSNAT GUREVITZ, RICHARD I. FOGEL, MARK E. HERNER, ROSS SAMPLE, ADAM S. STRICKBERGER, EMILE G. DAOUD, FRED MORADY, ERIC N. PRYSTOWSKY. (2003) Patients with an ICD Can Safely Resume Work in Industrial Facilities Following Simple Screening for Electromagnetic Interference. Pacing and Clinical Electrophysiology 26:8, 1675-1678
CrossRef782
Arthur J Moss. (2003) Dead is dead, but can we identify patients at increased risk for sudden cardiac death?. Journal of the American College of Cardiology 42:4, 659-660
CrossRef783
Joshua M. Rosenow, Howard Tarkin, Elias Zias, Carmine Sorbera, Alon Mogilner. (2003) Simultaneous use of bilateral subthalamic nucleus stimulators and an implantable cardiac defibrillator. Journal of Neurosurgery 99:1, 167-169
CrossRef784
RAINER GRADAUS, MICHAEL BLOCK, JOHANNES BRACHMANN, GUNTER BREITHARDT, HANS G. HUBER, WERNER JUNG, WOLFGANG KRANIG, RALPH U. MLETZKO, WOLFGANG SCHOELS, KARLHEINZ SEIDL, JOCHEN SENGES, JURGEN SIEBELS, GERHARD STEINBECK, CHRISTOPH STELLBRINK, DIETRICH ANDRESEN, . (2003) Mortality, Morbidity, and Complications in 3,344 Patients with Implantable Cardioverter Defibrillators:. Results From the German ICD Registry EURID. Pacing and Clinical Electrophysiology 26:7p1, 1511-1518
CrossRef785
Mohammad Saeed, Anna Jin, Gregory Pontone, Steve Higgins, Michael Gold, David Harari, Steven Nunley, Mark S. Link, Munther K. Homoud, N.A. Mark Estes, Paul J. Wang, . (2003) Prevalence of Sensing Abnormalities in Dual Chamber Implantable Cardioverter Defibrillators. Annals of Noninvasive Electrocardiology 8:3, 219-226
CrossRef786
WALTER F. KERWIN, OFFIR PAZ. (2003) Cardiac Resynchronization Therapy: Overcoming Ventricular Dyssynchrony in Dilated Heart Failure. Cardiology in Review 11:4, 221-239
CrossRef787
Vivek Y Reddy, Petr Neuzil, Milos Taborsky, Jeremy N Ruskin. (2003) Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. Journal of the American College of Cardiology 41:12, 2228-2236
CrossRef788
Thomas F. Oppelt, Rodel V. Bobadilla. (2003) Better Living Through Chemistry: Does It Still Apply to Patients After Myocardial Infarction?. Pharmacotherapy 23:6, 816-822
CrossRef789
Lynda L Mickleborough, Naeem Merchant, Yves Provost, Susan Carson, Joan Ivanov. (2003) Ventricular reconstruction for ischemic cardiomyopathy. The Annals of Thoracic Surgery 75:6, S6-S12
CrossRef790
J.Vijay Jayachandran, Douglas P. Zipes. (2003) Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?. Journal of the American College of Cardiology 41:10, 1713-1715
CrossRef791
Anne M. Gillis, Robert S. Sheldon, D. George Wyse, Henry J. Duff, Margaret R. Cassidy, L. Brent Mitchell. (2003) Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology 14:5, 492-498
CrossRef792
Douglas S Lee, Lawrence D Green, Peter P Liu, Paul Dorian, David M Newman, F.Curry Grant, Jack V Tu, David A Alter. (2003) Effectiveness of implantable defibrillators for preventing arrhythmic events and death. Journal of the American College of Cardiology 41:9, 1573-1582
CrossRef793
S.Adam Strickberger, John D Hummel, Thomas G Bartlett, Howard I Frumin, Claudio D Schuger, Scott L Beau, Cynthia Bitar, Fred Morady. (2003) Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT. Journal of the American College of Cardiology 41:10, 1707-1712
CrossRef794
Andrew D. Feingold, David DeNofrio. (2003) Management issues for patients with coronary artery disease and heart failure. Current Cardiology Reports 5:3, 216-222
CrossRef795
Cabot, Richard C.Harris, Nancy Lee, McNeely, William F., Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Malhotra, Atul, Muse, Victorine V., Mark, Eugene J., . (2003) Case 12-2003. New England Journal of Medicine 348:16, 1574-1585
Full Text796
Samir Saba, Walter L Atiga, William Barrington, Leonard I Ganz, Robert L Kormos, Guy A MacGowan, Michael A Mathier, Dennis M McNamara, Ogundu Obioha-Ngwu, Srinivas Murali. (2003) Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. The Journal of Heart and Lung Transplantation 22:4, 411-418
CrossRef797
Steven E Lipshultz, Stacy D Fisher, Wyman W Lai, Tracie L Miller. (2003) Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 17, S96-S122
CrossRef798
Chim C Lang, Shelley Hankins, Helen Hauff, Simon Maybaum, Niloo Edwards, Donna M Mancini. (2003) Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home. The Journal of Heart and Lung Transplantation 22:4, 419-426
CrossRef799
Jean-Sébastien Hulot, Michel Cucherat, Andrew Charlesworth, Dirk J. Van Veldhuisen, Jean-Christophe Corvol, Alain Mallet, Jean-Pierre Boissel, John Hampton, Philippe Lechat. (2003) Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods. British Journal of Clinical Pharmacology 55:3, 299-306
CrossRef800
Peter Lercher, Brigitte Rotman, Daniel Scherr, Wilfried Kraxner, Olef Luha, Werner Klein. (2003) Die Auswirkungen nach dem Multicenter Automatic Defibrillator Implantation Trial II in einem kardiologischen Schwerpunktzentrum — müssen alle Postinfarktpatienten mit reduzierter Linksventrikelfunktion einen implantierbaren Kardioverter-Defibrillator erhalten?. Wiener Klinische Wochenschrift 115:5-6, 167-174
CrossRef801
Helmut U. Klein. (2003) MADIT II — oder wie ernst nehmen wir Primärprävention des Plötzlichen Herztodes?. Wiener Klinische Wochenschrift 115:5-6, 152-154
CrossRef802
Jan Nemec, Win-Kuang Shen. (2003) Antiarrhythmic drugs: new agents and evolving concepts. Expert Opinion on Investigational Drugs 12:3, 435-453
CrossRef803
R. Ferrari, G. Cicchitelli, E. Merli, I. Andreadou, G. Guardigli. (2003) Metabolic modulation and optimization of energy consumption in heart failure. Medical Clinics of North America 87:2, 493-507
CrossRef804
Kristin E. Ellison, William G. Stevenson, Michael O. Sweeney, Laurence M. Epstein, William H. Maisel. (2003) Management of Arrhythmias in Heart Failure. Congestive Heart Failure 9:2, 91-99
CrossRef805
JOERG CARLSSON, BRITTA SCHULTE, ALI ERDOGAN, JOHANNES SPERZEL, NORBERT GUTTLER, TORSTEN SCHWARZ, HEINZ-F. PITSCHNER, JOERG NEUZNER. (2003) Prospective Randomized Comparison of Two Defibrillation Safety Margins in Unipolar, Active Pectoral Defibrillator Therapy. Pacing and Clinical Electrophysiology 26:2p1, 613-618
CrossRef806
CHRISTOPHER J. PLUMMER, R. JOHN IRVING, JANET M. MCCOMB. (2003) Implications of National Guidance for Implantable Cardioverter Defibrillation Implantation in the United Kingdom. Pacing and Clinical Electrophysiology 26:1p2, 479-482
CrossRef807
PATRICK T. ELLINOR, MARY L. GUY, JEREMY N. RUSKIN, BRIAN A. MCGOVERN. (2003) Variability in Implantable Cardioverter Defibrillator Pulse Generator Longevity Between Manufacturers. Pacing and Clinical Electrophysiology 26:1p1, 71-75
CrossRef808
HEIKKI V. HUIKURI, VERONIQUE MAHAUX, POUL-ERIK BLOCH-THOMSEN, . (2003) Cardiac Arrhythmias and Risk Stratification After Myocardial Infarction:. Results of the CARISMA Pilot Study. Pacing and Clinical Electrophysiology 26:1p2, 416-419
CrossRef809
DIRK VOLLMANN, LARS LUETHJE, DIETER ZENKER, SEBASTIAN DOMHOF, CHRISTINA UNTERBERG. (2003) Subthreshold Test Pulses Versus Low Energy Shock Delivery to Estimate High Energy Lead Impedance in Implanted Cardioverter Defibrillator Patients. Pacing and Clinical Electrophysiology 26:1p2, 457-460
CrossRef810
VELISLAV BATCHVAROV, KATERINA HNATKOVA, AZAD GHURAN, JAN POLONIECKI, A. JOHN CAMM, MAREK MALIK. (2003) Ventricular Gradient as a Risk Factor in Survivors of Acute Myocardial Infarction. Pacing and Clinical Electrophysiology 26:1p2, 373-376
CrossRef811
MICHAEL R. GOLD, DAVID BREITER, ROBERT LEMAN, ERIC J. RASHBA, STEPHEN R. SHOROFSKY, STEPHEN J. HAHN. (2003) Safety of a Single Successful Conversion of Ventricular Fibrillation Before the Implantation of Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 26:1p2, 483-486
CrossRef812
Thomas Klingenheben, Stefan H. Hohnloser. (2003) Usefulness of Risk Stratification for Future Cardiac Events in Infarct Survivors with Severely Depressed Versus Near-Normal Left Ventricular Function: Results From a Prospective Long-Term Follow-Up Study. Annals of Noninvasive Electrocardiology 8:1, 68-74
CrossRef813
Uday N. Kumar, Leslie A. Saxon. (2003) Ventricular Resynchronization: A Promising Therapy for Heart Failure. The American Journal of Geriatric Cardiology 12:1, 41-48
CrossRef814
K.H. Tscheliessnigg. (2002) Surgical Treatment of Heart Failure - A Changing Paradigm?. European Surgery-Acta Chirurgica Austriaca 34:6, 347-353
CrossRef815
Michael E. Bourke, Jeffrey S. Healey. (2002) Pacemakers, recent directions and developments. Current Opinion in Anaesthesiology 15:6, 681-686
CrossRef816
Abeel A Mangi, Theodore J Boeve, Gus J Vlahakes, Cary W Akins, Alan D Hilgenberg, Jeremy N Ruskin, Brian M McGovern, David F Torchiana. (2002) Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest. The Annals of Thoracic Surgery 74:5, 1510-1516
CrossRef817
Mohamad El-Zaru, David Nofrio. (2002) End-stage heart failure: Surgical therapy and implantable devices. Current Treatment Options in Cardiovascular Medicine 4:6, 511-520
CrossRef818
Gabriel Gregoratos, Jonathan Abrams, Andrew E Epstein, Roger A Freedman, David L Hayes, Mark A Hlatky, Richard E Kerber, Gerald V Naccarelli, Mark H Schoenfeld, Michael J Silka, Stephen L Winters, Raymond J Gibbons, Elliott M Antman, Joseph S Alpert, Gabriel Gregoratos, Loren F Hiratzka, David P Faxon, Alice K Jacobs, Valentin Fuster, Sidney C Smith. (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article. Journal of the American College of Cardiology 40:9, 1703-1719
CrossRef819
B. John Hynes, Jerry C. Luck, Deborah L. Wolbrette, John Boehmer, Gerald V. Naccarelli. (2002) Arrhythmias in patients with heart failure. Current Treatment Options in Cardiovascular Medicine 4:6, 467-485
CrossRef820
Johan De Sutter, Vida Firsovaite, Rene Tavernier. (2002) Prevention of Sudden Death in Patients With Coronary Artery Disease: Do Lipid-Lowering Drugs Play a Role?. Preventive Cardiology 5:4, 177-182
CrossRef821
Petri Korhonen, Ilkka Tierala, Kim Simelius, Heikki Väänänen, Markku Mäkijärvi, Jukka Nenonen, Toivo Katila, Lauri Toivonen. (2002) Late QRS Activity in Signal-Averaged Magnetocardiography, Body Surface Potential Mapping, and Orthogonal ECG in Postinfarction Ventricular Tachycardia Patients. Annals of Noninvasive Electrocardiology 7:4, 389-398
CrossRef822
Andreas Kliegel, Philip Eisenburger, Fritz Sterz, Michael Holzer, Heidrun Losert, Christof Havel, Günter Stix, Anton N Laggner. (2002) Survivors of ventricular tachyarrhythmias due to a transient or reversible disorder have a high recurrence rate of lethal cardiac events. Resuscitation 54:3, 237-243
CrossRef823
Steven L. Higgins. (2002) Automatic implantable cardiac defibrillators. Current Treatment Options in Cardiovascular Medicine 4:4, 287-293
CrossRef824
Arthur J. Moss. (2002) MADIT-II and Implications for Noninvasive Electrophysiologic Testing. Annals of Noninvasive Electrocardiology 7:3, 179-180
CrossRef825
Antonis A Armoundas, Gordon F Tomaselli, Hans D Esperer. (2002) Pathophysiological basis and clinical application of T-wave alternans. Journal of the American College of Cardiology 40:2, 207-217
CrossRef826
Marion Eckert, Tina Jones. (2002) How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?. International Journal of Nursing Practice 8:3, 152-157
CrossRef827
J MCCOMB. (2002) Ventricular Arrhythmias. Medicine 30:6, 151-158
CrossRef828
Lambert A Wu, Thomas E Kottke, Paul A Friedman, David M Luria, Diane E Grill, Matthew J Maurer. (2002) Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, Population. Journal of Clinical Epidemiology 55:5, 458-461
CrossRef829
Carmine A. Sorbera, Evelyn J. Cusack. (2002) Indications for Implantable Cardioverter Defibrillator Therapy. Heart Disease 4:3, 166-170
CrossRef830
BARRY J. MARON. (2002) Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Cardiology in Review 10:3, 173-181
CrossRef831
Moss, Arthur J., Zareba, Wojciech, Hall, W. Jackson, Klein, Helmut, Wilber, David J., Cannom, David S., Daubert, James P., Higgins, Steven L., Brown, Mary W., Andrews, Mark L., . (2002) Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. New England Journal of Medicine 346:12, 877-883
Full Text832
Bigger, J. Thomas, . (2002) Expanding Indications for Implantable Cardiac Defibrillators. New England Journal of Medicine 346:12, 931-933
Full Text833
J. Engdahl, M Holmberg, B.W Karlson, R Luepker, J Herlitz. (2002) The epidemiology of out-of-hospital ‘sudden’ cardiac arrest. Resuscitation 52:3, 235-245
CrossRef834
Alan Kadish. (2002) Primary prevention ofsudden death using ICD therapy: incremental steps. Journal of the American College of Cardiology 39:5, 788-789
CrossRef835
Wolfram Grimm, J.ürgen Hoffmann, Hans-Helge Müller, Bernhard Maisch. (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. Journal of the American College of Cardiology 39:5, 780-787
CrossRef836
Michel Accad, Andrew D. Michaels. (2002) Management after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 4:1, 41-54
CrossRef837
WILLIAM G. STEVENSON, KRISTIN E. ELLISON, MICHAEL O. SWEENEY, LAURENCE M. EPSTEIN, WILLIAM H. MAISEL. (2002) Management of Arrhythmias in Heart Failure. Cardiology in Review 10:1, 8-14
CrossRef838
Craig Swygman, Paul J. Wang, Mark S. Link, Munther K. Homoud, N.A. Mark Estes. (2002) Advances in implantable cardioverter defibrillators. Current Opinion in Cardiology 17:1, 24-28
CrossRef839
Marian A. Spath, Bernie J. O??Brien. (2002) Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death. PharmacoEconomics 20:11, 727-738
CrossRef840
Steven Fishberger. (2002) Management of ventricular arrhythmias in adults with congenital heart disease. Current Cardiology Reports 4:1, 76-80
CrossRef841
David S. Cannom. (2002) Implantable cardioverter defibrillator trials: what's new?. Current Opinion in Cardiology 17:1, 29-35
CrossRef842
James J Bailey, Alan S Berson, Harry Handelsman, Morrison Hodges. (2001) Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. Journal of the American College of Cardiology 38:7, 1902-1911
CrossRef843
Hongwei Zhao, Lili Tian. (2001) On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data. Biometrics 57:4, 1002-1008
CrossRef844
Franck Paganelli, Pierre Barnay, Frédéric Franceschi, Florence Yapo, Richard Geélaisse, Samuel Lévy. (2001) Inducible ventricular arrhythmias and patency of infarct-related artery in survivors of acute myocardial infarction. Clinical Cardiology 24:12, 782-785
CrossRef845
Huikuri, Heikki V., Castellanos, Agustin, Myerburg, Robert J., . (2001) Sudden Death Due to Cardiac Arrhythmias. New England Journal of Medicine 345:20, 1473-1482
Full Text846
Kewal K. Talwar, Nitish Naik, Rajnish Juneja. (2001) Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators?. Current Cardiology Reports 3:6, 459-466
CrossRef847
STEVEN E. LIPSHULTZ, STACY D. FISHER, WYMAN W. LAI, TRACIE L. MILLER. (2001) Cardiovascular Monitoring and Therapy for HIV-Infected Patients. Annals of the New York Academy of Sciences 946:1, 236-273
CrossRef848
John L. Atlee, Alan D. Bernstein. (2001) Cardiac Rhythm Management Devices (Part I). Anesthesiology 95:5, 1265-1280
CrossRef849
Sheila A Doggrell. (2001) Amiodarone - waxed and waned and waxed again. Expert Opinion on Pharmacotherapy 2:11, 1877-1890
CrossRef850
Wilbert S. Aronow. (2001) Treatment of the Elderly Post-Myocardial Infarction Patient. The American Journal of Geriatric Cardiology 10:6, 316-323
CrossRef851
Christoph Scharf, Hermann Redecker, Firat Duru, Reto Candinas, Hans Peter Brunner-La Rocca, Andreas Gerber, Osmund Bertel, Marko I Turina, Wolfgang Kiowski. (2001) Sudden cardiac death after coronary artery bypass grafting is not predicted by signal-averaged ECG. The Annals of Thoracic Surgery 72:5, 1546-1551
CrossRef852
J.F. Leclercq. (2001) Les indications du défibrillateur automatique implantable ventriculaire. Implications pour la pratique quotidienne. Annales de Cardiologie et d'Angéiologie 50:6, 319-325
CrossRef853
P. Göudde, R. Agrawal, H.-P. Müuller, K. Czerski, P. Endt, U. Steinhoff, M. Oeff, H.-P. Schultheiss, S. Behrens. (2001) Magnetocardiographic mapping of QRS fragmentation in patients with a history of malignant tachyarrhythmias. Clinical Cardiology 24:10, 682-688
CrossRef854
Eric J Rashba, Mary R Olsovsky, Stephen R Shorofsky, Malcolm M Kirk, Robert W Peters, Michael R Gold. (2001) Temporal decline in defibrillation thresholds with an active pectoral lead system. Journal of the American College of Cardiology 38:4, 1150-1155
CrossRef855
Nabil El-Sherif, Gioia Turitto, Ronald P. Pedalino, Dyonissios Robotis. (2001) T-Wave Alternans and Arrhythmia Risk Stratification. Annals of Noninvasive Electrocardiology 6:4, 323-332
CrossRef856
Luis A. Pires, Lynette M. May, Srihari Ravi, Vinit R. Lal, Jaskamal P. S. Kahlon. (2001) Safety and potential cost savings of same-setting electrophysiologic testing and placement of transvenous implantable cardioverter-defibrillators. Clinical Cardiology 24:9, 592-596
CrossRef857
Stephen B. Sloan, Howard H. Weitz. (2001) POSTOPERATIVE ARRHYTHMIAS AND CONDUCTION DISORDERS. Medical Clinics of North America 85:5, 1171-1189
CrossRef858
B. Yakir, P. Huang, W. J. Hall. (2001) COMPLETENESS FOR A BROWNIAN MOTION WITH POLYGONAL STOPPING BOUNDARIES. Sequential Analysis 20:3, 201-208
CrossRef859
D.George Wyse, Mario Talajic, Gail E Hafley, Alfred E Buxton, L.Brent Mitchell, Teresa K Kus, Douglas L Packer, William H Kou, Robert Lemery, Peter Santucci, Denise Grimes, Kathleen Hickey, Carolyn Stevens, Steven N Singh. (2001) Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. Journal of the American College of Cardiology 38:2, 344-351
CrossRef860
Jay W Mason. (2001) Mindfully mining MUSTT. Journal of the American College of Cardiology 38:2, 352-354
CrossRef861
George A. Stouffer, Richard G. Sheahan, Daniel J. Lenihan, Richard G. Sheahan. (2001) Syncope and Arrhythmias:. The American Journal of the Medical Sciences 322:1, 37-43
CrossRef862
&NA;. (2001) ??-Blockers are best antiarrhythmics for reducing post-MI mortality. Drugs & Therapy Perspectives 17:13, 5-8
CrossRef863
John P DiMarco. (2001) Is programmed stimulation in survivors of myocardial infarction helpful?. Journal of the American College of Cardiology 37:7, 1908-1909
CrossRef864
Nahum A Freedberg, John N Hill, Richard I Fogel, Eric N Prystowsky. (2001) Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy. Journal of the American College of Cardiology 37:7, 1910-1915
CrossRef865
Claus Schmitt, Petra Barthel, Gjin Ndrepepa, Jürgen Schreieck, Andreas Plewan, A Schömig, Georg Schmidt. (2001) Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. Journal of the American College of Cardiology 37:7, 1901-1907
CrossRef866
Mark A Hlatky, Thomas Bigger. (2001) Cost-effectiveness of the implantable cardioverter defibrillator?. The Lancet 357:9271, 1817-1818
CrossRef867
Daniel E. Hilleman, Jerry L. Bauman. (2001) Role of Antiarrhythmic Therapy in Patients at Risk for Sudden Cardiac Death: An Evidence-Based Review. Pharmacotherapy 21:5, 556-575
CrossRef868
Susan Todd, Anne Whitehead, Nigel Stallard, John Whitehead. (2001) Interim analyses and sequential designs in phase III studies. British Journal of Clinical Pharmacology 51:5, 394-399
CrossRef869
Eugen C. Palma. (2001) Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia. Current Cardiology Reports 3:3, 219-223
CrossRef870
Michael Glikson, Paul A Friedman. (2001) The implantable cardioverter defibrillator. The Lancet 357:9262, 1107-1117
CrossRef871
R. Michael Gendreau, . (2001) A Randomized Double-Blind Sham-Controlled Trial of the Prosorba Column for Treatment of Refractory Rheumatoid Arthritis. Therapeutic Apheresis and Dialysis 5:2, 79-83
CrossRef872
L FEI, R TROHMAN. (2001) ADVANCES IN CARDIAC ELECTROPHYSIOLOGY AND PACING. Critical Care Clinics 17:2, 337-364
CrossRef873
Robert W. Peters, Michael R. Gold. (2001) Implantable Cardiac Defibrillators. Medical Clinics of North America 85:2, 343-367
CrossRef874
Marilyn J. Weigner, Alfred E. Buxton. (2001) Nonsustained Ventricular Tachycardia. Medical Clinics of North America 85:2, 305-320
CrossRef875
Alfred P Hallstrom, John H McAnulty, Bruce L Wilkoff, Dean Follmann, Merritt H Raitt, Mark D Carlson, Anne M Gillis, Hue-Teh Shih, Judy L Powell, Hank Duff, Blair D Halperin. (2001) Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Journal of the American College of Cardiology 37:4, 1093-1099
CrossRef876
Walid I. Saliba, Andrea Natale. (2001) Ventricular Tachycardia Syndromes. Medical Clinics of North America 85:2, 267-304
CrossRef877
Gerald V. Naccarelli, Deborah L. Wolbrette, Jerry C. Luck. (2001) Proarrhythmia. Medical Clinics of North America 85:2, 503-526
CrossRef878
Thomas F. Baskett, Peter J.F. Baskett. (2001) Frank Pantridge and mobile coronary care. Resuscitation 48:2, 99-104
CrossRef879
Sue Ann Thomas, Erika Friedmann, Frances J. Kelley. (2001) Living With an Implantable Cardioverter-Defibrillator: A Review of the Current Literature Related to Psychosocial Factors. AACN Clinical Issues: Advanced Practice in Acute & Critical Care 12:1, 156-163
CrossRef880
Lambert A. Wu, Thomas E. Kottke. (2001) Number needed to treat:. Journal of Clinical Epidemiology 54:2, 111-116
CrossRef881
Shinichi Niwano, Yoshikazu Kitano, Masahiko Moriguchi, Naoto Yoshizawa, Tetsuo Kashiwa, Makoto Suyama, Takeshi Toyoshima, Tohru Izumi. (2001) Leakage of Energy to the Body Surface During Defibrillation Shock by an Implantable Cardioverter - Defibrillator (ICD) System. Japanese Circulation Journal 65:3, 219-225
CrossRef882
Takao Katoh, Hiroyuki Iinuma, Hiroshi Inoue, Tohru Ohe, Satoshi Ogawa, Hiroshi Kasanuki, Teruhisa Tanabe, Hirokazu Hayakawa. (2001) Multicenter Prospective Nonrandomized Study of Long-Term Antiarrhythmic Drug Therapy in Patients With Tachyarrhythmias. Japanese Circulation Journal 65:4, 275-278
CrossRef883
Kazumasa Adachi, Yoshio Ohnishi, Mitsuhiro Yokoyama. (2001) Risk Stratification for Sudden Cardiac Death in Dilated Cardiomyopathy Using Microvolt-Level T-Wave Alternans. Japanese Circulation Journal 65:2, 76-80
CrossRef884
Elamana Vijayakumar. (2001) Anesthetic Considerations in Patients With Cardiac Arrhythmias, Pacemakers, and AICDs. International Anesthesiology Clinics 39:4, 21-42
CrossRef885
Mark S. Link, Munther K. Homoud, Paul J. Wang, N.A. Mark Estes. (2001) Cardiac Arrhythmias in the Athlete. Cardiology in Review 9:1, 21-30
CrossRef886
Mark S. Link, Paul J. Wang, N. A. Mark Estes. (2001) Ventricular arrhythmias in the athlete. Current Opinion in Cardiology 16:1, 30-39
CrossRef887
Samuel F. Sears, Sheila Rauch, Eileen Handberg, Jamie B. Conti. (2001) Fear of Exertion Following ICD Storm: Considering ICD Shock and Learning History. Journal of Cardiopulmonary Rehabilitation 21:1, 47-49
CrossRef888
Jose L. Merino. (2001) Mechanisms Underlying Ventricular Arrhythmias in Idiopathic Dilated Cardiomyopathy. American Journal of Cardiovascular Drugs 1:2, 105-118
CrossRef889
Ingeborg Van der Tweel, Paulus A. H. Van Noord. (2000) Sequential analysis of matched dichotomous data from prospective case-control studies. Statistics in Medicine 19:24, 3449-3464
CrossRef890
Michael R Gold, Daniel M Bloomfield, Kelley P Anderson, Nabil E El-Sherif, David J Wilber, William J Groh, N.A.Mark Estes, Elizabeth S Kaufman, Mark L Greenberg, David S Rosenbaum. (2000) A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. Journal of the American College of Cardiology 36:7, 2247-2253
CrossRef891
Hal V Barron. (2000) T-wave alternans and serious ventricular arrhythmias: a tale of two T-waves. Journal of the American College of Cardiology 36:7, 2254-2256
CrossRef892
MARK H. SCHOENFELD. (2000) Deciding Against Defibrillator Replacement: Second-Guessing the Past?. Pacing and Clinical Electrophysiology 23:12, 2019-2021
CrossRef893
MICHAEL GEIST, DAVID NEWMAN, MARY GREENE, MINEY PAQUETTE, PAUL DORIAN. (2000) Permanent Explantation of Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 23:12, 2024-2029
CrossRef894
ROBERT N. GELDER, JOSEPH M. GALVIN, CHRISTINE M. ALBERT, DAVID KEANE, JEREMY N. RUSKIN. (2000) Lead Noise with an Active-Fixation Defibrillation Lead. Pacing and Clinical Electrophysiology 23:12, 2113-2116
CrossRef895
Nigel Stallard, Susan Todd. (2000) Exact sequential tests for single samples of discrete responses using spending functions. Statistics in Medicine 19:22, 3051-3064
CrossRef896
Anthony W. C. Chow, Richard J. Schilling, Nicholas S. Peters, D. Wyn Davies. (2000) Catheter ablation of ventricular tachycardia related to coronary artery disease: The role of noncontact mapping. Current Cardiology Reports 2:6, 529-536
CrossRef897
Jeffrey J Goldberger, Suresh Neelagaru. (2000) Therapeutic developments in sudden cardiac death. Expert Opinion on Investigational Drugs 9:11, 2543-2554
CrossRef898
Barry J. Maron. (2000) Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Current Cardiology Reports 2:6, 522-528
CrossRef899
Cynthia M. Tracy, Masood Akhtar, John P. DiMarco, Douglas L. Packer, Howard H. Weitz, William L. Winters, James L. Achord, Alan W. Boone, John W. Hirshfeld, Beverly H. Lorell, George P. Rodgers, Cynthia M. Tracy, Howard H. Weitz. (2000) American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion. Journal of the American College of Cardiology 36:5, 1725-1736
CrossRef900
Mina K. Chung. (2000) Cardiac surgery: Postoperative arrhythmias. Critical Care Medicine 28:Supplement, N136-N144
CrossRef901
Richard I. Fogel, Eric N. Prystowsky. (2000) Management of malignant ventricular arrhythmias and cardiac arrest. Critical Care Medicine 28:Supplement, N165-N169
CrossRef902
G. Muqtada Chaudhry, Charles I. Haffajee. (2000) Antiarrhythmic agents and proarrhythmia. Critical Care Medicine 28:Supplement, N158-N164
CrossRef903
Karthik Ramaswamy, Mohamed H. Hamdan. (2000) Ischemia, metabolic disturbances, and arrhythmogenesis: Mechanisms and management. Critical Care Medicine 28:Supplement, N151-N157
CrossRef904
OTTO COSTANTINI, CAROLE DRABEK, DAVID S. ROSENBAUM. (2000) Can Sudden Cardiac Death Be Predicted from the T Wave of the ECG? A Critical Examination of T Wave Alternans and QT Interval Dispersion. Pacing and Clinical Electrophysiology 23:9, 1407-1416
CrossRef905
Maria Teresa Olivari, John R. Windle. (2000) Cardiac transplantation in patients with refractory ventricular arrhythmias11The authors wish to thank Tim Furlong for expert secretarial assistance in the preparation of this manuscript.. The Journal of Heart and Lung Transplantation 19:8, S38-S42
CrossRef906
T Klingenheben, M Zabel, RB D'Agostino, RJ Cohen, SH Hohnloser. (2000) Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. The Lancet 356:9230, 651-652
CrossRef907
O.A. Obel. (2000) Revisiting established medical options — antiarrhythmic drugs and β-blocker combinations. Resuscitation 45:3, S7-S10
CrossRef908
SUBRAMANIAM C. KRISHNAN, MARK E. JOSEPHSON. (2000) Surgery for Postinfarction Ventricular Tachycardia: Is it Obsolete?. Pacing and Clinical Electrophysiology 23:8, 1295-1301
CrossRef909
Peter Ott. (2000) Ventricular arrhythmias. Current Treatment Options in Cardiovascular Medicine 2:4, 323-327
CrossRef910
Dietmar Bänsch, Marco Castrucci, Dirk Böcker, Günter Breithardt, Michael Block. (2000) Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators. Journal of the American College of Cardiology 36:2, 557-565
CrossRef911
Walter Kao, Maria Rosa Costanzo. (2000) Sudden death in heart failure patients: effects of optimized medical therapy. The Journal of Heart and Lung Transplantation 19:8, S32-S37
CrossRef912
HEIKO SCHMITT, TANJA HURST, MICHAEL COCH, HOLGER KILLAT, BETTINA WUNN, BERND WALDECKER. (2000) Nonsustained, Asymptomatic Ventricular Tachycardia in Patients with Coronary Artery Disease: Prognosis and Incidence of Sudden Death of Patients Who Are Noninducible by Electrophysiological Testing. Pacing and Clinical Electrophysiology 23:8, 1220-1225
CrossRef913
Angelo Auricchio, Helmut Klein. (2000) Arrhythmias in heart failure. Current Treatment Options in Cardiovascular Medicine 2:4, 329-339
CrossRef914
Michael J. Domanski. (2000) Prevention of sudden cardiac death: management considerations. Current Opinion in Cardiology 15:4, 304-308
CrossRef915
Maryann Z. Skrabal, Julie A. Stading, Kathryn A. Behmer-Miller, Daniel E. Hilleman. (2000) Advances in the Treatment of Congestive Heart Failure: New Approaches for an Old Disease. Pharmacotherapy 20:7, 787-804
CrossRef916
Ajay M. Naik, C. Thomas Peter. (2000) Are implantable cardioverter-defibrillators cost-effective?. Current Cardiology Reports 2:4, 341-345
CrossRef917
Peter A. O'Callaghan. (2000) Prophylactic defibrillator implantation in patients with coronary artery disease. Current Cardiology Reports 2:4, 311-313
CrossRef918
Dietrich Pfeiffer, Maika Mende, Andreas Hagendorff. (2000) Implantable dual-chamber cardioverter-defibrillator-pacemaker. Current Cardiology Reports 2:4, 335-340
CrossRef919
XAVIER COPIE, OLIVIER PIOT, MINA AIT SAID, THOMAS LAVERGNE, JACKY OLLITRAULT, LOUIS GUIZE, JEAN-YVES HEUZEY, . (2000) Temporal and Geographical Trends in Indications for Implantation of Cardiac Defibrillators in Europe 1993-1998. Pacing and Clinical Electrophysiology 23:6, 979-984
CrossRef920
J. JASON SIMS, ALLISON W. MILLER, MICHAEL R. UJHELYI. (2000) Regional Hyperkalemia Increases Ventricular Defibrillation Energy Requirements:.. Journal of Cardiovascular Electrophysiology 11:6, 634-641
CrossRef921
Aiyi Liu, Ming Tan, James M. Boyett, Xiaoping Xiong. (2000) Testing Secondary Hypotheses Following Sequential Clinical Trials. Biometrics 56:2, 640-644
CrossRef922
Allan S. Jaffe. (2000) The Costs of Inadequate Data. Academic Emergency Medicine 7:6, 687-688
CrossRef923
PAUL A. FRIEDMAN, MICHAEL GLIKSON, MARSHALL S. STANTON. (2000) Defibrillator Challenges for the New Millennium:.. Journal of Cardiovascular Electrophysiology 11:6, 697-709
CrossRef924
ALFRED P. HALLSTROM, JEFFREY L. ANDERSON, LEONARD A. COBB, PETER L. FRIEDMAN, JOHN M. HERRE, RICHARD C. KLEIN, JOHN MCANULTY, JONATHAN S. STEINBERG, . (2000) Advantages and Disadvantages of Trial Designs: A Review of Analysis Methods for ICD Studies. Pacing and Clinical Electrophysiology 23:6, 1029-1038
CrossRef925
SAMUEL F. SEARS, JOHN F. TODARO, GUIDO URIZAR, TARA SAIA LEWIS, BRIAN SIROIS, ROBYN WALLACE, WAYNE SOTILE, ANNE B. CURTIS, JAMIE B. CONTI. (2000) Assessing the Psychosocial Impact of the ICD: A National Survey of Implantable Cardioverter Defibrillator Health Care Providers. Pacing and Clinical Electrophysiology 23:6, 939-945
CrossRef926
H. Leon Greene. (2000) The implantable cardioverter-defibrillator. Clinical Cardiology 23:5, 315-326
CrossRef927
Kirkwood F. Adams, Kenneth L. Baughman, William G. Dec, Uri Elkayam, Alan D. Forker, Mihai Gheorghiade, Denise Hermann, Marvin A. Konstam, Peter Liu, Barry M. Massie, J. Herbert Patterson, Marc A. Silver, Lynne Warner Stevenson, Arthur M. Feldman, Jay N. Cohn, Gary S. Francis, Barry Greenberg, Marvin A. Konstam, Carl Leier, Beverly H. Lorell, Milton Packer, Bertram Pitt, Marc A. Silver, Edmund Sonnenblick, John Strobeck, Richard Walsh, Salim Yusuf. (2000) HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches. Pharmacotherapy 20:5, 495-522
CrossRef928
Richard M. Lampman, Bradley P. Knight. (2000) Prescribing Exercise Training for Patients with Defibrillators. American Journal of Physical Medicine & Rehabilitation 79:3, 292-297
CrossRef929
John H. McAnulty. (2000) Arrhythmia Therapy in the Elderly. The American Journal of Geriatric Cardiology 9:3, 151-158
CrossRef930
Jennifer A. Larsen, Alan H. Kadish, Janice B. Schwartz. (2000) Proper Use of Antiarrhythmic Therapy for Reduction of Mortality After Myocardial Infarction. Drugs & Aging 16:5, 341-350
CrossRef931
CAROLYNN S. KOHN, RALPH J. PETRUCCI, CHRIS BAESSLER, DESIREE M. SOTO, COLIN MOVSOWITZ. (2000) The Effect of Psychological Intervention on Patients' Long-Term Adjustment to the ICD: A Prospective Study. Pacing and Clinical Electrophysiology 23:4, 450-456
CrossRef932
Leslie A. Saxon, Uday N. Kumar, Teresa Marco. (2000) Heart Failure and Cardiac Resynchronization Therapies: U.S. Experience in the Year 2000. Annals of Noninvasive Electrocardiology 5:2, 188-194
CrossRef933
Seth J. Rials, David Britchkow, Roger A. Marinchak, Peter R. Kowey. (2000) Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia. Clinical Cardiology 23:3, 171-174
CrossRef934
Angela S. Eads, Samuel F. Sears, Wayne M. Sotile, Jamie B. Conti. (2000) Supportive Communication With Implantable Cardioverter Defibrillator Patients: Seven Principles to Facilitate Psychosocial Adjustment. Journal of Cardiopulmonary Rehabilitation 20:2, 109-114
CrossRef935
ALAN KADISH, REBECCA QUIGG, I SCHAECHTER, KELLEY P. ANDERSON, MARK ESTES, JOSEPH LEVINE. (2000) Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation. Pacing and Clinical Electrophysiology 23:3, 338-343
CrossRef936
Vend Menon, Jonathan S. Steinberg, Luis Carillo, Toshio Akiyama, Karen Beckman, Steven Kutalek. (2000) Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structural heart disease, and inducible ventricular tachycardia at electrophysiologic study. Clinical Cardiology 23:3, 195-200
CrossRef937
S. WALKER, T. LEVY, S. REX, S. BRANT, V. PAUL. (2000) Preliminary Results with the Simultaneous Use of Implantable Cardioverter Defibrillators and Permanent Biventricular Pacemakers: Implications for Device Interaction and Development. Pacing and Clinical Electrophysiology 23:3, 365-372
CrossRef938
Maron, Barry J., Shen, Win-Kuang, Link, Mark S., Epstein, Andrew E., Almquist, Adrian K., Daubert, James P., Bardy, Gust H., Favale, Stefano, Rea, Robert F., Boriani, Giuseppe, Estes, N.A. Mark, Spirito, Paolo, Casey, Susan A., Stanton, Marshall S., Betocchi, Sandro, . (2000) Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. New England Journal of Medicine 342:6, 365-373
Full Text939
Rajendra H. Mehta, Eduardo Bossone, Kim A. Eagle. (2000) Current concepts in secondary prevention after acute myocardial infarction. Herz 25:1, 47-60
CrossRef940
NEAL G. KAVESH, SAMANTHA E. SARANG, MICHAEL R. GOLD. (2000) Signal-Averaged Isoharmonic Body Surface Maps of Patients with Ischemic Cardiomyopathy. Journal of Cardiovascular Electrophysiology 11:2, 160-167
CrossRef941
Gerald V. Naccarelli, Deborah L. Wolbrette, Joseph T. Dell'Orfano, Hemantkumar M. Patel, Jerry C. Luck. (2000) Amiodarone: What have we learned from clinical trials?. Clinical Cardiology 23:2, 73-82
CrossRef942
Gerald V. Naccarelli, Deborah L. Wolbrette, Hemantkumar M. Patel, Jerry C. Luck. (2000) Amiodarone: clinical trials. Current Opinion in Cardiology 15:1, 64-72
CrossRef943
Toby C. Trujillo, Paul E. Nolan. (2000) Antiarrhythmic Agents. Drug Safety 23:6, 509-532
CrossRef944
Annette Peters, Emerson Liu, Richard L. Verrier, Joel Schwartz, Diane R. Gold, Murray Mittleman, Jeff Baliff, J. Annie Oh, George Allen, Kevin Monahan, Douglas W. Dockery. (2000) Air Pollution and Incidence of Cardiac Arrhythmia. Epidemiology 11:1, 11-17
CrossRef945
FLORIN T. DEGERATU, KOROUSH KHALIGHI, ROBERT W. PETERS, STEPHEN R. SHOROFSKY, MICHAEL R. GOLD. (2000) Sensing Lead Failure in Implantable Defibrillators:.. Journal of Cardiovascular Electrophysiology 11:1, 21-24
CrossRef946
B. BREMBILLA-PERROT, P. HOURIEZ, O. CLAUDON, J.P. PREISS, D. BEURRIER, P. LOUIS, A. TERRIER LACHAISE. (2000) Long-Term Reproducibility of Ventricular Tachycardia Induction with Electrophysiological Testing in Patients with Coronary Heart Disease and Depressed Left Ventricular Ejection Fraction. Pacing and Clinical Electrophysiology 23:1, 47-53
CrossRef947
ANTONIS S. MANOLIS, THEMOS MAOUNIS, VASSILIS VASSILIKOS, JOHN CHILADAKIS, DENNIS V. COKKINOS. (2000) Electrophysiologist-Implanted Transvenous Cardioverter Defibrillators Using Local Versus General Anesthesia. Pacing and Clinical Electrophysiology 23:1, 96-105
CrossRef948
Arthur J. Moss. (2000) Introductory Note. Annals of Noninvasive Electrocardiology 5:1, 92-93
CrossRef949
LARS ECKARDT, WILHELM HAVERKAMP, ROBERT JOHNA, DIRK BÖCKER, MARIO C. DENG, GÜNTER BREITHARDT, MARTIN BORGGREEE. (2000) Arrhythmias in Heart Failure:.. Journal of Cardiovascular Electrophysiology 11:1, 106-117
CrossRef950
Gregory P. Walcott, Raymond E. Ideker. 1999. Defibrillators. .
CrossRef951
Buxton, Alfred E., Lee, Kerry L., Fisher, John D., Josephson, Mark E., Prystowsky, Eric N., Hafley, Gail, . (1999) A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. New England Journal of Medicine 341:25, 1882-1890
Full Text952
Ihab Girgis, Gabriel Contreras, Simon Chakko, Guido Perez, Judy McLoughlin, James Lafferty, Lisa Gualberti, Michael Ammazzalorso, Thomas Constantino, Mary Lynn Bresznyak, Morton Kleiner, Thomas G. McGinn, Robert J. Myerburg. (1999) Effect of hemodialysis on the signal-averaged electrocardiogram. American Journal of Kidney Diseases 34:6, 1105-1113
CrossRef953
Heart Failure Society Of America. (1999) HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches. Journal of Cardiac Failure 5:4, 357-382
CrossRef954
CRAIG M. BRODSKY, FANG CHANG, STEPHEN C. VLAY, . (1999) Multicenter Evaluation of Implantable Cardioverter Defibrillator Testing after Implant: The Post Implant Testing Study (PITS). Pacing and Clinical Electrophysiology 22:12, 1769-1776
CrossRef955
Ryszard B. Krol, Sanjeev Saksena, Atul Prakash. (1999) Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias. Current Cardiology Reports 1:4, 282-288
CrossRef956
CRAIG M. PRATT, A. JOHN CAMM, J. THOMAS BIGGER, GÜNTER BREITHARDT, RONALD W.F. CAMPBELL, ANDREW E. EPSTEIN, LUKAS J. KAPPENBERGER, KARL-HEINZ KUCK, STUART POCOCK, SANJEEV SAKSENA, ALBERT L. WALDO. (1999) Evaluation of Antiarrhythmic Drug Efficacy in Patients with an ICD:.. Journal of Cardiovascular Electrophysiology 10:11, 1534-1549
CrossRef957
H. LEON GREENE. (1999) Testing Antiarrhythmic Drugs with the ICD:.. Journal of Cardiovascular Electrophysiology 10:11, 1550-1552
CrossRef958
J. Anthony Gomes. (1999) The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia. Current Cardiology Reports 1:4, 297-301
CrossRef959
Knight, Bradley P., Pelosi, Frank, Michaud, Gregory F., Strickberger, S. Adam, Morady, Fred, . (1999) Clinical Consequences of Electrocardiographic Artifact Mimicking Ventricular Tachycardia. New England Journal of Medicine 341:17, 1270-1274
Full Text960
David T. Felson, Michael P. LaValley, Andrew R. Baldassare, Joel A. Block, Jacques R. Caldwell, Grant W. Cannon, Chad Deal, Stephen Evans, Roy Fleischmann, R. Michael Gendreau, E. Robert Harris, Eric L. Matteson, Sanford H. Roth, H. Ralph Schumacher, Michael H. Weisman, Daniel E. Furst. (1999) The prosorba column for treatment of refractory rheumatoid arthritis: A randomized, double-blind, sham-controlled trial. Arthritis & Rheumatism 42:10, 2153-2159
CrossRef961
Kelley P. Anderson, Vladimir Shusterman, Susan Brode, Venkateshwar Gottipaty, David Schwartzman, Raul Weiss. (1999) Noninvasive Testing for Selection of Patients for Electrophysiological Study. Annals of Noninvasive Electrocardiology 4:4, 434-442
CrossRef962
John Whitehead. (1999) A unified theory for sequential clinical trials. Statistics in Medicine 18:17-18, 2271-2286
CrossRef963
G Altemose. (1999) Assessment of electrical devices for arrhythmia control and prevention: past and future. ACC Current Journal Review 8:5, 47-50
CrossRef964
Michael H Crawford, Steven J Bernstein, Prakash C Deedwania, John P DiMarco, Kevin J Ferrick, Arthur Garson, Lee A Green, H.Leon Greene, Michael J Silka, Peter H Stone, Cynthia M Tracy, Raymond J Gibbons, Joseph S Alpert, Kim A Eagle, Timothy J Gardner, Arthur Garson, Gabriel Gregoratos, Richard O Russell, Thomas J Ryan, Sidney C Smith. (1999) ACC/AHA guidelines for ambulatory electrocardiography. Journal of the American College of Cardiology 34:3, 912-948
CrossRef965
Herbert Nägele, Wilfried Rödiger. (1999) Sudden death and tailored medical therapy in elective candidates for heart transplantation. The Journal of Heart and Lung Transplantation 18:9, 869-876
CrossRef966
Patrick J Welch, Richard L Page, Mohamed H Hamdan. (1999) Management of ventricular arrhythmias. Journal of the American College of Cardiology 34:3, 621-630
CrossRef967
PEARILA B. NAMEROW, BEVERLY R. FIRTH, GEOFFREY M. HEYWOOD, JOHN R. WINDLE, MICHAEL K. PARIDES, . (1999) Quality-of-Life Six Months After CABG Surgery in Patients Randomized to ICD Versus No ICD Therapy: Findings from the CABG Patch Trial. Pacing and Clinical Electrophysiology 22:9, 1305-1313
CrossRef968
Jeffrey N. Rottman, Bruce Levin, Myunghee Cho Paik, Wei Yann Tsai, J. Thomas Bigger, . (1999) Using missing data techniques to explore the lack of survival effect: illustration with the CABG patch trial. Statistics in Medicine 18:15, 1943-1959
CrossRef969
Michael Cooklin, Mary R Olsovsky, Randall G Brockman, Stephen R Shorofsky, Michael R Gold. (1999) Atrial defibrillation with a transvenous lead. Journal of the American College of Cardiology 34:2, 358-362
CrossRef970
PAUL A. FRIEDMAN, MARY JANE RASMUSSEN, SUELLEN GRICE, JANE TRUSTY, MICHAEL GLIKSON, MARSHALL S. STANTON. (1999) Defibrillation Thresholds are Increased by Right-Sided Implantation of Totally Transvenous Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 22:8, 1186-1192
CrossRef971
Jose A. Joglar, Mohamed H. Hamdan. (1999) Symptomatic ventricular tachycardia. Current Treatment Options in Cardiovascular Medicine 1:2, 145-152
CrossRef972
Jeffrey J. Goldberger. (1999) Sudden cardiac death. Current Treatment Options in Cardiovascular Medicine 1:2, 127-135
CrossRef973
Ted C Braun, Neil A Hagen, Robert E Hatfield, D.George Wyse. (1999) Cardiac Pacemakers and Implantable Defibrillators in Terminal Care. Journal of Pain and Symptom Management 18:2, 126-131
CrossRef974
MARK E. ALEXANDER, EDWARD P. WALSH, J. PHILIP SAUL, MICHAEL R. EPSTEIN, JOHN K. TRIEDMAN. (1999) Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease. Journal of Cardiovascular Electrophysiology 10:8, 1033-1044
CrossRef975
GREGORY F. MICHAUD, QUAN LI, XENOPHON COSTEAS, ROBERT STEARNS, MARK ESTES III, PAUL J. WANG. (1999) Correlation Waveform Analysis to Discriminate Monomorphic Ventricular Tachycardia from Sinus Rhythm Using Stored Electrograms from Implantable Defibrillators. Pacing and Clinical Electrophysiology 22:8, 1146-1151
CrossRef976
Antonio Pacifico, Laura L Ferlic, Félix R Cedillo-Salazar, Nadim Nasir, Timothy K Doyle, Philip D Henry. (1999) Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. Journal of the American College of Cardiology 34:1, 204-210
CrossRef977
A. John Camm, Samuel F. Sears, John F. Todaro, Tara Saia Lewis, Wayne Sotile, Jamie B. Conti. (1999) Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clinical Cardiology 22:7, 481-489
CrossRef978
Pacifico, Antonio, Hohnloser, Stefan H., Williams, John H., Tao, Ben, Saksena, Sanjeev, Henry, Philip D., Prystowsky, Eric N., . (1999) Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol. New England Journal of Medicine 340:24, 1855-1862
Full Text979
Bradley P Knight, Rajiva Goyal, Frank Pelosi, Matthew Flemming, Laura Horwood, Fred Morady, S.Adam Strickberger. (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. Journal of the American College of Cardiology 33:7, 1964-1970
CrossRef980
Stefan H Hohnloser, Thomas Klingenheben, Markus Zabel, Matthias Schöpperl, Oliver Mauß. (1999) Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. Journal of the American College of Cardiology 33:7, 1895-1902
CrossRef981
Christian Mewis, Volker Kühlkamp, Johann Mermi, Ralph F Bosch, Ludger Seipel. (1999) Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias. Journal of the American College of Cardiology 33:7, 1989-1995
CrossRef982
Juan Carlos Rozo, William L. Barry, George A. Stouffer. (1999) New Treatment Strategies in Patients with Impaired Left Ventricular Systolic Function.. The American Journal of the Medical Sciences 317:5, 312
CrossRef983
JEFFREY J. GOLDBERGER, GEORGE HORVATH, RAM CHALLAPALLI, ALAN H. KADISH. (1999) Inappropriate Implantable Cardioverter-Defibrillator Therapy Due to the Detection of Premature Ventricular Complexes. Pacing and Clinical Electrophysiology 22:5, 825-828
CrossRef984
NEAL G. KAVESH, STEPHEN R. SHOROFSKY, SAMANTHA B. SARANG, MICHAEL R. GOLD. (1999) The Effect of Procainamide on T Wave Alternans. Journal of Cardiovascular Electrophysiology 10:5, 649-654
CrossRef985
Maria Teresa. (1999) Baroreflex Sensitivity. Annals of Noninvasive Electrocardiology 4:2, 219-231
CrossRef986
Juha S. Perkiömäki, M. Juhani Koistinen, Heikki V. Huikuri. (1999) Standard 12-Lead and 24-Hour Ambulatory Electrocardiographic Abnormalities in Survivors of Tachyarrhythmic Cardiac Arrest. Annals of Noninvasive Electrocardiology 4:2, 158-166
CrossRef987
Georg Schmidt, Marek Malik, Petra Barthel, Raphael Schneider, Kurt Ulm, Linda Rolnitzky, A John Camm, J Thomas Bigger, Albert Schömig. (1999) Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. The Lancet 353:9162, 1390-1396
CrossRef988
Robert D. Lerman, David S. Cannom. (1999) Sudden electrical death. Current Treatment Options in Cardiovascular Medicine 1:1, 91-96
CrossRef989
Kâmuran A. Kadipaşaoǧlu, Michele Sartori, Takafumi Masai, Hasan B. Cihan, Fred J. Clubb, Jeff L. Conger, O.H. Frazier. (1999) Intraoperative arrhythmias and tissue damage during transmyocardial laser revascularization. The Annals of Thoracic Surgery 67:2, 423-431
CrossRef990
Edward F. Philbin. (1999) Comprehensive Multidisciplinary Programs for the Management of Patients with Congestive Heart Failure. Journal of General Internal Medicine 14:2, 130-135
CrossRef991
Gerald V. Naccarelli, Jerry C. Luck, Deborah L. Wolbrette, Walter E. Pae, Rhonda Weller-Moore, Joseph T. Dell’Orfano, Hemantkumar M. Patel, John P. Boehmer. (1999) Pacing therapy for congestive heart failure: Is it ready for prime time?. Current Opinion in Cardiology 14:1, 1
CrossRef992
Peter Weismüller, Hans-Joachim Trappe. (1999) Update Kardiologie. Medizinische Klinik 94:1, 15-28
CrossRef993
YASUHIRO ENDOH, SATOSHI OHNISHI, HIROSHI KASANUKI. (1999) Clinical Significance of Consecutive Shocks in Patients with Left Ventricular Dysfunction Treated with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology 22:1, 187-191
CrossRef994
Dietrich Andresen, Gerhard Steinbeck, Thomas Brüggemann, Dirk Müller, Ralph Haberl, Steffen Behrens, Ellen Hoffmann, Karl Wegscheider, Rüdiger Dissmann, Hans-Christoph Ehlers. (1999) Risk stratification following myocardial infarction in the thrombolytic era. Journal of the American College of Cardiology 33:1, 131-138
CrossRef995
Masaomi CHINUSHI, Hidehiro KASAI, Minoru TAGAWA, Takashi WASHIZUKA, Yoshifusa AIZAWA. (1999) Ventricular Fibrillation with Small Amplitude of Activation and its Implications for Implantable Cardioverter Defibrillator Treatment.. Japanese Heart Journal 40:1, 87-90
CrossRef996
Shinichi Niwano, Masayuki Yamaura, Naoto Yoshizawa, Masahiko Moriguchi, Yoshikazu Kitano, Yoshifusa Aizawa, Tohru Izumi. (1999) Electrophysiologic Parameters to Predict Clinical Recurrence of Ventricular Tachycardia in Patients Under Electrophysiologic Study-Guided Effective Pharmacological Therapy. Japanese Circulation Journal 63:9, 674-680
CrossRef997
RAYMOND YEE, STUART J. CONNOLLY, ANNE M. GILLIS. (1999) Appropriate Use of the Implantable Cardioverter Defibrillator: A Canadian Perspective. Pacing and Clinical Electrophysiology 22:1, 1-4
CrossRef998
PHILIP ZILO, DANIEL N. WEISS, RICHARD M. LUCERI. (1999) Late Retesting of System Performance in ICD Patients Without Spontaneous Shocks. Pacing and Clinical Electrophysiology 22:1, 197-201
CrossRef999
Craig A. Swygman, Munther K. Homoud, Mark S. Link, Paul J. Wang, N. A. Mark Estes. (1999) Technologic advances in implantable cardioverter defibrillators. Current Opinion in Cardiology 14:1, 9
CrossRef1000
Masaomi Chinushi, Takashi Washizuka, Hidehiro Kasai, Kouji Ohhira, Masahito Satoh, Yoshifusa Aizawa. (1999) Development of Ventricular Fibrillations With Different Characteristics in the Local Electrocardiogram. Japanese Circulation Journal 63:12, 1007-1010
CrossRef1001
Sandra B. Dunbar, Laura P. Kimble, Louise S. Jenkins, Mary Hawthorne, William Dudley, Marina Slemmons, Jonathan J. Langberg. (1999) Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depression and Anxiety 9:4, 163-168
CrossRef1002
Dan M Roden. (1999) An Overview of Contemporary Approaches to Antiarrhythmic Therapy. Japanese Circulation Journal 63:9, 655-658
CrossRef1003
Arthur J. Moss, David S. Cannom, James P. Daubert, W. Jackson Hall, Steven L. Higgins, Helmut Klein, David Wilber, Wojciech Zareba, Mary W. Brown, . (1999) Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol. Annals of Noninvasive Electrocardiology 4:1, 83-91
CrossRef1004
WOLFRAM GRIMM, VOLKER MENZ, JURGEN HOFFMANN, UWE TIMMANN, REINHARD FUNCK, RAINER MOOSDORF, BERNHARD MAISCH. (1999) Complications of Third-Generation Implantable Cardioverter Defibrillator Therapy. Pacing and Clinical Electrophysiology 22:1, 206-211
CrossRef1005
STEFAN H. HOHNLOSER, THOMAS KLINGENHEBEN, YI-GANG LI, MARKUS ZABEL, JOY PEETERMANS, RICHARD J. COHEN. (1998) T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers. Journal of Cardiovascular Electrophysiology 9:12, 1258-1268
CrossRef1006
Eric J. Eichhorn, Mohamed H. Hamdan. (1998) β-Blockade and amiodarone therapy: Twin brothers from different parents. Journal of Cardiac Failure 4:4, 289-294
CrossRef1007
JENS JUNG, DANIEL STRAUSS, THOMAS SINNWELL, GREGOR HOHENBERG, ROLAND FRIES, HARALD WERN, HERMANN SCHIEFFER, ARMIN HEISEL. (1998) Assessment of Intersignal Variability for Discrimination of Atrial Fibrillation from Atrial Flutter. Pacing and Clinical Electrophysiology 21:11, 2426-2430
CrossRef1008
CHARLES GOTTLIEB, DAVID J. CALLANS, FRANCIS MARCHLINSKI. (1998) Implantable Cardioverter Defibrillators in the United States: Understanding the Benefits and Limitations of Implantable Cardioverter Defibrillator Therapy Based on Clinical Trial Results. Pacing and Clinical Electrophysiology 21:11, 2016-2020
CrossRef1009
WOLFRAM GRIMM, CHRISTINA GLAVERIS, JURGEN HOFFMANN, VOLKER MENZ, NADJA MET, STEPHAN BORN, BERNHARD MAISCH. (1998) Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Design and First Results of the Marburg Cardiomyopathy Study. Pacing and Clinical Electrophysiology 21:11, 2551-2556
CrossRef1010
Eric M Grubman, Behzad B Pavri, Tamara Shipman, Nancy Britton, Dusan Z Kocovic. (1998) Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. Journal of the American College of Cardiology 32:4, 1056-1062
CrossRef1011
Wolfram Grimm, Jürgen Hoffmann, Volker Menz, Kathrin Luck, Bernhard Maisch. (1998) Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. Journal of the American College of Cardiology 32:3, 739-745
CrossRef1012
CHARLES M. CARPENTER, JOSEPH GALVIN, MARY GUY, BRIAN A. McGOVERN. (1998) Runaway Pacemaker in an Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 9:9, 1008-1011
CrossRef1013
JACQUES CLEMENTY. (1998) The ICD in FRANCE: Money Problem or Donkey Syndrome?. Pacing and Clinical Electrophysiology 21:9, 1683-1685
CrossRef1014
CHRISTIAN STICHERLING, THOMAS KLINGENHEBEN, DOUGLAS CAMERON, STEFAN H. HOHNLOSER, . (1998) Worldwide Clinical Experience with aDown-Sized Active Can ImplantableCardioverier Defibrillator in 162 ConsecutivePatients. Pacing and Clinical Electrophysiology 21:9, 1778-1783
CrossRef1015
Stuart J Connolly. (1998) Implantable cardioverter defibrillators—for whom?. The Lancet 352:9125, 338-340
CrossRef1016
John GF Cleland, Karl Swedberg, Philip A Poole-Wilson. (1998) Successes and failures of current treatment of heart failure. The Lancet 352, SI19-SI28
CrossRef1017
GERALD V. NACCARELLLI, DEBORAH L. WOLBRETTE, JOSEPH T. DELL'ORFANO, HEMANTKUMAR M. PATEL, JERRY C. LUCK. (1998) A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond. Journal of Cardiovascular Electrophysiology 9:8, 864-891
CrossRef1018
David M Kulick, R.Morton Bolman, Christopher T Salerno, Alan J Bank, Soon J Park. (1998) Management of recurrent ventricular tachycardia with ventricular assist device placement. The Annals of Thoracic Surgery 66:2, 571-573
CrossRef1019
W Groh. (1998) The use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. ACC Current Journal Review 7:4, 48-51
CrossRef1020
C Kimmelstiel. (1998) Current concepts in the treatment of patients with heart failure. ACC Current Journal Review 7:4, 39-43
CrossRef1021
NEAL G. KAVESH, STEPHEN R. SHOROFSKY, SAMANTHA E. SARANG, MICHAEL R. GOLD. (1998) Effect of Heart Rate on T Wave Alternans. Journal of Cardiovascular Electrophysiology 9:7, 703-708
CrossRef1022
SEAH NISAM, MORTON MOWER. (1998) ICD Trials: An Extraordinary Means of Determining Patient Risk?. Pacing and Clinical Electrophysiology 21:7, 1341-1346
CrossRef1023
Arthur J. Moss. (1998) Noninvasive Electrocardiological Identification of Patients Who Will Benefit from an Implantable Defibrillator. Annals of Noninvasive Electrocardiology 3:3, 181-182
CrossRef1024
Christina Unterberg, Heinrich Kreuzer, Arnd B. Buchwald. (1998) Das Renin-Angiotensin-System bei kardiovaskulären Erkrankungen. Medizinische Klinik 93:7, 416-425
CrossRef1025
Scott J. Crow, Joanne Collins, Marcia Justic, Robert Goetz, Stuart Adler. (1998) Psychopathology Following Cardioverter Defibrillator Implantation. Psychosomatics 39:4, 305-310
CrossRef1026
DAVID S. CANNOM. (1998) AVID and Beyond: Lessons Learned. Journal of Interventional Cardiology 11:3, 217-226
CrossRef1027
SEAH NISAM, IGOR SINGER. (1998) Prophylactic Trials With Implantable Cardioverter Defibrillators: MADIT and Beyond. Journal of Interventional Cardiology 11:3, 227-233
CrossRef1028
L. BRENT MITCHELL. (1998) Pharmacological Therapy for Ventricular Arrhythmias in the Era of the Implantable Cardioverter Defibrillator: Indispensable or Inadvisable?. Journal of Interventional Cardiology 11:3, 235-246
CrossRef1029
WERNER PETERS, PETER KOWALLIK, MANFRED REISBERG, MALTE MEESMANN. (1998) Body Surface Potentials During Discharge of the Implantable Cardioverter Defibrillator. Journal of Cardiovascular Electrophysiology 9:5, 491-497
CrossRef1030
PENG-SHENG CHEN, CHARLES D. SWERDLOW, CHUN HWANG, HRAYR S. KARAGUEUZIAN. (1998) Current Concepts of Ventricular Defibrillation. Journal of Cardiovascular Electrophysiology 9:5, 553-562
CrossRef1031
(1998) Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery. New England Journal of Medicine 338:17, 1227-1228
Full Text1032
ALLISON P. WINECOFF MILLER, J. JASON SIMS, ROBERT McSWAIN, MICHAEL R. UJHELYI. (1998) Lidocaine's Effect on Defibrillation Threshold are Dependent on the Defibrillation Electrode System: Epicardial Versus Endocardial. Journal of Cardiovascular Electrophysiology 9:3, 312-320
CrossRef1033
MARIO OLIVEIRA, ANNE STAUNTON, A. JOHN CAMM, MAREK MALIK. (1998) Stepwise Strategy on the Cost of Risk Stratification After Acute Myocardial Infarction: A Retrospective Simulation Study. Pacing and Clinical Electrophysiology 21:3, 603-609
CrossRef1034
Eleanor B Schron, Lawrence M Friedman, H Leon Greene, Chuke Nwachuku. (1998) Ongoing and planned clinical trials of anti-arrhythmic drugs: an update. Expert Opinion on Investigational Drugs 7:3, 427-435
CrossRef1035
Hal V Barron, Sami Viskin. (1998) Autonomic markers and prediction of cardiac death after myocardial infarction. The Lancet 351:9101, 461-462
CrossRef1036
J Bigger, MD. (1998) Changes in Sample Size and Length of Follow-up to Maintain Power in The Coronary Artery Bypass Graft (CABG) Patch Trial. Controlled Clinical Trials 19:1, 1-14
CrossRef1037
Members of the Sicilian Gambit. (1998) The Search for Novel Antiarrhythmic Strategies. Japanese Circulation Journal 62:9, 633-648
CrossRef1038
S. ADAM STRICKBERGER, K. CHING MAN, JOSEPH SOUZA, ADAM ZIVIN, RAUL WEISS, BRADLEY P. KNIGHT, RAJIVA GOYAL, EMILE G. DAOUD, FRED MORADY. (1998) A Prospective Evaluation of Two Defibrillation Safety Margin Techniques in Patients with Low Defibrillation Energy Requirements. Journal of Cardiovascular Electrophysiology 9:1, 41-46
CrossRef1039
A. Bolz, M. Schaldach. (1998) Telekardiologie - ein Dienstleistungsangebot für den Arzt. Biomedizinische Technik/Biomedical Engineering 43:s1, 212-213
CrossRef1040
Simon Chakko, Raul Mitrani. (1998) Recognition and Management of Cardiac Arrhythmias: Part I. General Principles and Supraventricular Tachyarrhythmias. Journal of Intensive Care Medicine 13:1, 15-31
CrossRef1041
Barry F Uretsky, Richard G Sheahan. (1997) Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?. Journal of the American College of Cardiology 30:7, 1589-1597
CrossRef1042
Myerburg, Robert J., Castellanos, Agustin, . (1997) Clinical Trials of Implantable Defibrillators. New England Journal of Medicine 337:22, 1621-1623
Full Text1043
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997) A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. New England Journal of Medicine 337:22, 1576-1584
Full Text1044
Bigger, J. Thomas Jr., . (1997) Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft Surgery. New England Journal of Medicine 337:22, 1569-1575
Full Text1045
ROGER A. MARINCHAK, SETH J. RIALS, ROLAND A. FILART, PETER R. KOWEY. (1997) The Top Ten Fallacies of Nonsustained Ventricular Tachycardia. Pacing and Clinical Electrophysiology 20:11, 2825-2847
CrossRef1046
T. J. Campbell. (1997) The place of amiodarone: an overview of the four recent large controlled trials. Australian and New Zealand Journal of Medicine 27:5, 582-590
CrossRef1047
JOHN C. SCHUDER. (1997) The ICD-Progress, Prospects, and Problems. Pacing and Clinical Electrophysiology 20:10, 2367-2370
CrossRef1048
LARS KOBER, CHRISTIAN TORP-PEDERSEN, HANNE ELMING, . (1997) Use of Left Ventricular Ejection Fraction or Wall-Motion Score Index in Predicting Arrhythmic Death in Patients Following an Acute Myocardial Infarction. Pacing and Clinical Electrophysiology 20:10, 2553-2559
CrossRef1049
CHRISTIAN TORP-PEDERSEN, LARS KOBER, HANNE ELMING, HANS BURCHART. (1997) Classification of Sudden and Arrhythmic Death. Pacing and Clinical Electrophysiology 20:10, 2545-2552
CrossRef1050
Maria I. Anastasiou-Nana, Ronald L. Menlove, Jay W. Mason. (1997) Quantification of Prevalence of Asymptomatic Ventricular Arrhythmias in Patients with Heart Failure. Annals of Noninvasive Electrocardiology 2:4, 346-352
CrossRef1051
WERNER PETERS, PETER KOWALLIK, GÜNTER WITTENBERG, CHRISTOPH SCHOLL, MALTE MEESMANN. (1997) Inappropriate Discharge of an Implantable Cardioverter Defibrillator During Atrial Flutter and Intermittent Ventricular Antibradycardia Pacing. Journal of Cardiovascular Electrophysiology 8:10, 1167-1174
CrossRef1052
HEIN J.J. WELLENS, PETER DOEVENDANS, JOEP SMEETS, LUZ MARIA RODRIGUEZ, KAREL DEN DULK DULK, CARL TIMMERMANS, MARC VOS. (1997) Arrhythmia Risk: Eiectrophysiological Studies and Monophasic Action Potentials. Pacing and Clinical Electrophysiology 20:10, 2560-2565
CrossRef1053
Seah Nisam. (1997) MADIT and the Implications for Holter Monitoring: Results of a 100-Physician Survey. Annals of Noninvasive Electrocardiology 2:4, 378-383
CrossRef1054
ROBERT P. FRANTZ, LYNE J. OLSON. (1997) Recipient Selection and Management Before Cardiac Transplantation. The American Journal of the Medical Sciences 314:3, 139-152
CrossRef1055
R. Dent Underwood, Jasbir Sra, Masood Akhtar. (1997) Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction. Clinical Cardiology 20:9, 753-758
CrossRef1056
Joe K. Bisset, J. David Talley. (1997) Progress in Interventional Cardiology. Journal of Interventional Cardiology 10:4, 309-311
CrossRef1057
Hans-Joachim Trappe. (1997) Defibrillator-Therapie 1997. Medizinische Klinik 92:7, 415-420
CrossRef1058
SVEN REEK, HELMUT U. KLEIN, RAYMOND E. IDEKER. (1997) Can Catheter Ablation in Cardiac Arrest Survivors Prevent Ventricular Fibrillation Recurrence?. Pacing and Clinical Electrophysiology 20:7, 1840-1859
CrossRef1059
(1997) Implantable Defibrillators in Patients with Coronary Artery Disease at High Risk for Ventricular Arrhythmia. New England Journal of Medicine 336:23, 1676-1677
Full Text1060
Thomas Meinertz. (1997) Therapie der Herzrhythmusstörungen im Wandel. Medizinische Klinik 92:4, 211-214
CrossRef1061
Stefan H. Hohnloser. (1997) Medikamentöse Therapie ventrikulärer Arrhythmien. Medizinische Klinik 92:4, 208-210
CrossRef1062
Arthur J. Moss. (1997) Nonsustained Ventricular Tachycardia. Annals of Noninvasive Electrocardiology 2:1, 1-2
CrossRef1063
James P. Daubert, Chee H. Kim. (1997) Nonsustained Ventricular Tachycardia.. Annals of Noninvasive Electrocardiology 2:1, 79-91
CrossRef1064
Friedman, Peter L., Stevenson, William G., . (1996) Unsustained Ventricular Tachycardia — To Treat or Not to Treat. New England Journal of Medicine 335:26, 1984-1985
Full Text
- Letters
